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Introduction 
Introduction 
The focus of this thesis is to explore principles regarding integrated patient care, 
and to search for instruments and interventions to measure and improve 
integrated care, particularly for patients with cancer Patients treated for cancer 
live longer than ever before but often have impairments even after being cured 
That is why most types of cancer can be considered more and more as a chronic 
disease Chronic diseases as cancer, heart disease, stroke, arthritis, diabetes 
mellitus, mental illness and obstructive pulmonary diseases are now the leading 
causes of illness, disability and death Almost 20 percent of the Dutch population 
suffers from a chronic disease, which accounts for the majority of health care 
expenditures 12 Meeting the complex needs of a growing group of patients with 
chronic diseases is one of the greatest challenges that health care faces today34 
Integrated care programmes or disease management programmes have begun to 
receive greater support as approaches to improve quality of care for these groups 
of patients 
The research described in this thesis has two mam purposes 
First, to explore the principles of integrated care (theories, definitions, components 
and effects reported) and to search for instruments to measure the principles of 
integrated care in general, and for patients with cancer in particular 
Second, to assess and improve the quality of integrated care for two specific 
groups of cancer patients, namely patients with head and neck cancer and 
patients with lung cancer 
INTEGRATED CARE 
Principles 
Care for chronic patients has evolved from individual consultations into 
multiprofessional teamwork with care given by various physicians, nurses and 
other health care professionals, who often work in different departments or 
organizations 15 This major change in the way health care is delivered is due to 
the fast growing medical scientific knowledge, leading to more and more in-depth 
sub specializations and more diagnostic procedures and treatment modalities, and 
due to the ageing of the population, leading to larger proportions of people that 
have illnesses with a chronic course 15 Besides, patients are better informed and 
demand more and more being actively involved in their care These developments 
should be supported by new ways of health care delivery that are patient-centred 
and not disease- or provider-centred In the Netherlands69 and in other countries 
51012
 there are many examples of these new models of health care delivery called 
"coordinated care", "transmural care", "disease management" or "integrated care" 
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There is a lot of literature that emphasizes the importance of organizing care 
around the needs and preferences of patients and involving patients in their care, 
and the importance of multidisciplinary care cooperation.13"16 Besides, there are 
several systematic reviews on effects of integrated care or disease management 
programmes for different groups of patients: arthritis17, heart failure18"20, chronic 
obstructive pulmonary disease21 and diabetes mellitus.22,23 However, there is no 
review that evaluates the impact of integrated care interventions on the quality of 
care for patients with cancer and there is no clear picture of underlying principles 
of integrated care delivery and sustaining interventions. 
Instruments 
To assess and improve integrated care for patients with cancer, instruments are 
needed to measure aspects of integrated care as involving patients in their care 
and multidisciplinary cooperation. 
The first aspect has to do with patient-centredness. Patient-centredness is 
organizing care around the physical, social and emotional needs and preferences 
of patients (patient perspective style) and explicitly involving patients in their own 
care (patient activation style).24,25 Patient-centredness can be improved in several 
ways, such as improved communication, information supply and cooperation 
among physicians.26 Assessing the quality of patient-centred care is not 
straightforward, and selecting appropriate indicators applicable to all chronic 
patients, is difficult. A possibility is to use evidence-based guidelines on cancer 
care and search for recommendations for good quality of patient-centredness. The 
available recommendations from these guidelines should be combined with 
opinions of the patients themselves to assess additional aspects for which 
evidence alone is insufficient or absent. Such an instrument to assess patient-
centredness of cancer care is not yet available. 
Multidisciplinary cooperation and team functioning are important for delivering 
high-quality integrated care.15,27 Care is given by various physicians, nurses and 
other health care professionals. Most have a different background of knowledge 
and skills and they often work in different departments or organizations. Team 
functioning is not only determined by structural determinants such as workload, 
team size, or team composition28,29, but also by team processes. Literature shows 
that a climate in which team members are encouraged to develop and implement 
new ideas can lead to better health care and health outcomes.30"32 The most 
studied model for team climate is the model of West.33 This theoretical model led 
to the development of a questionnaire to measure team climate, the Team Climate 
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Inventory (TCI) ^ The TCI has been translated into several languages and has 
been used in many different types of teams However, there is no Dutch translation 
and none of these studies tested the questionnaire specifically for hospital teams 
To be able to use the TCI in Dutch hospital teams, it is important to determine the 
psychometric characteristics of the TCI m this specific setting 
PATIENTS WITH CANCER 
Cancer is the second cause of death in the Netherlands, and in other western 
countries, only preceded by cardiovascular diseases 35 In the Netherlands about 
73 000 new patients are diagnosed with cancer every year The number of 
patients living with cancer will increase from 366 000 in the year 2000 till 692 000 
in the year 2015, an increase of 50 percent in ten years3 6 3 7 The prognosis of 
many cancer types is improving due to more sophisticated diagnostic tools, 
screening, better surgical and radiotherapy techniques and more effective chemo-
and supportive medical therapies But these developments are not such, that 
chances of survival will improve dramatically in the next years Worthwhile 
improvements in cancer care are possible by successful implementation of 
(evidence-based) recommendations from clinical guidelines and literature on 
successful interventions for integrated care 14 
Patients with head and neck cancer 
In the Netherlands nearly 2400 patients are newly diagnosed with head and neck 
cancer each year36 The mainstay of treatment consists of surgery, radiotherapy or 
both, or chemo-radiation The 5-year survival is about 50% The management of 
care for patients with head and neck cancer is very complex First, this type of 
cancer has a very significant impact on the patient because of the location of the 
tumour Patients often have problems with speech, eating, and physical 
appearance due to treatment3Θ Second, as head and neck cancers are 
heterogeneous and occur at several sites, they need to be managed by different 
disciplines in a multimodal treatment Integration of care and integration of these 
disciplines are crucial for optimal care outcome Although studies in the 
Netherlands show that the quality of care for patients with head and neck cancer 
could be improved3940, there are no good examples of studies that evaluate 
successful interventions to improve the quality of care 
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Patients with lung cancer 
Lung cancer is the leading cause of cancer death in Europe. In the Netherlands, 
approximately 9000 new patients are diagnosed with lung carcinoma every year.41 
About 75% of them have non-small cell lung cancer (NSCLC). Despite 
improvement in both diagnosis and treatment, the overall prognosis for patients 
with NSCLC has hardly improved through the years; the median survival is 8 
months, and 5-year survival is less than 15%.41 Patients in the early stages I and II 
who undergo surgical resection have the best chances of survival. For patients 
with stage-IV lung cancer, no curative treatment is available. These patients 
should have the best possible supportive and palliative care. In the Netherlands, 
optimal (evidence-based) care for these patients has been formulated in a 
multidisciplinary guideline in 2004.42 However, there is no insight into actual care 
and possibilities for improvement. 
ASSESSING AND IMPROVING THE QUALITY OF INTEGRATED CARE 
FOR PATIENTS WITH CANCER 
To improve the quality of integrated care for patients with cancer, the current 
performance needs to be reliably assessed and effective approaches to improve 
and change practice performance need to be identified.43 
Assessing the quality of care 
Literature indicates that there is a lack of information about how major illnesses 
are treated, a lack of systematic outcome assessment and persisting variations 
among providers in care for similar patients.44,45 For most diseases, potential 
quality problems and their prevalence and incidence are unknown in many 
countries.46,47 Assessing the quality of integrated care is not straightforward, and 
selecting appropriate indicators to assess integrated care is difficult. Quality 
indicators are "measurable elements of practice performance for which there is 
evidence or consensus that they can be used to assess the quality of care".48 
Evidence-based guidelines for the management of patients with cancer and 
literature on effective integrated care interventions both provide recommendations 
for good-quality integrated care. When scientific evidence is lacking, the 
recommendations can come from an expert panel of health professionals in a 
consensus process based on their experience. To measure the quality of 
integrated care, these recommendations need to be translated into quality 
indicators.49 Indicators can be related to structure, process or outcome of health 
care.50 Structural indicators focus on organizational aspects of service provision. 
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Process indicators focus on the actual care delivered to and negotiated with the 
patients as well as communication with the patient Outcome indicators specify the 
ultimate goal of the care given and can relate either to health status or patient 
evaluations of care45 
Practical examples of indicator development procedures are scarce 5152 There are 
some initiatives for the development of cancer quality indicators53 55 but valid sets 
of indicators to measure the quality of integrated care in general and for patients 
with head and neck cancer and lung cancer in particular are lacking 
Improving the quality of care 
Studies in the USA and the Netherlands suggest that about 30-40% of the patients 
do not receive care according to present scientific evidence, and about 20-25% of 
care provided is not needed or is potentially harmful56 57 Cancer care needs to 
improve and special programmes are being executed to achieve this in the UK5859 
and in the Netherlands60 Best practices and evidence-based recommendations 
from guidelines do not implement themselves and dissemination and 
implementation strategies are needed 
To improve patient care, a systematic approach is important According to Grol 
and others43 59 60 the following steps should be taken get insight into actual care by 
developing indicators and measuring care with them, analyze barriers and 
facilitators (what are the problems in care provision and what factors are 
stimulating or hampering the process of improvement), develop and implement an 
improvement programme and finally, continuously monitor care on basis of 
indicators In our thesis to improve integrated care for patients with head and neck 
cancer and patients with lung cancer this systematic approach for quality 
improvement will be followed 
RESEARCH QUESTIONS AND OUTLINE OF THE THESIS 
This thesis is divided into two sections addressing the following mam research 
questions 
I What are principles and interventions regarding integrated care and what 
are instruments to measure these principles validly and reliably'' 
II How can integrated care for patients with cancer be assessed and 
improved^ 
12 
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Section I: Principles and instruments of Integrated Care 
In chapter 1 we perform a review of systematic reviews to search for principles or 
definitions of integrated care, and for interventions aimed at improving integrated 
care. We summarize the effects reported. In chapter 2 we perform a systematic 
review focussing on the effects of integrated care interventions on the quality of 
care for patients with cancer. In chapter 3 we develop an instrument to measure 
the principle of patient-centredness, based on recommendations regarding patient-
centredness extracted from evidence-based cancer guidelines. The indicators 
(= operationalized recommendations) are being tested on some clinimetric 
characteristics. To assess team climate in multidisciplinary teams, in chapter 4 we 
translate and validate an instrument to measure team climate, the so-called Team 
Climate Inventory (TCI). 
Section II: Assessing and improving the Quality of Integrated Care for 
patients with cancer 
To improve integrated care, first actual care should be assessed. In chapter 5 we 
report on the development and measurement of a set of indicators to assess 
actual care in one centre for head and neck cancer. To generalize our experiences 
on development of indicators for integrated care, we apply the same strategy on 
another patient group with cancer in another study setting. Chapter 6 reports on 
the development and testing of a set of indicators to assess actual integrated care 
for patients with non-small cell lung cancer (NSCLC) in six hospitals in the eastern 
part of the Netherlands. 
In order to estimate room for improvement in the care for patients with non-small 
cell lung cancer we focus in chapter 7 on determinants influencing the quality of 
care, and the variation in the actual quality of integrated care, again in six 
hospitals. Based on the assessment of actual care and insight in determinants and 
variation in care, a tailored integrated care programme is developed and tested in 
one of the six hospitals. 
To improve care for patients with head and neck cancer, an integrated care 
programme is developed and implemented, on basis of the assessment of actual 
care, analyses on barriers and facilitators in this particular setting and literature on 
integrated care interventions. In chapter 8 we report on the evaluation of this 
integrated care programme. 
The thesis concludes with a GENERAL DISCUSSION. A reflection will be given on 
the main findings of our research and suggestions for practice and future research. 
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Chapter 1 
Abstract 
Objective: To investigate effectiveness, definitions, and components of integrated 
care programmes for chronically ill patients on the basis of systematic reviews. 
Design: Literature review from January 1996 to May 2004. 
Main measures: Definitions and components of integrated care programmes and 
all effects reported on the quality of care. 
Results: Searches in the Medline and Cochrane databases identified 13 
systematic reviews of integrated care programmes for chronically ill patients. 
Despite considerable heterogeneity in interventions, patient populations, and 
processes and outcomes of care, integrated care programmes seemed to have 
positive effects on the quality of patient care. No consistent definitions were 
present for the management of patients with chronic illnesses. In all reviews the 
aims of integrated care programmes were very similar, namely reducing 
fragmentation and improving continuity and coordination of care, but the focus and 
content of the programmes differed widely. The most common components of 
integrated care programmes were self-management support and patient 
education, often combined with structured clinical follow-up and case 
management; a multidisciplinary patient care team; multidisciplinary clinical 
pathways and feedback, reminders, and education for professionals. 
Conclusion: Integrated care programmes seemed to have positive effects on the 
quality of care. However, integrated care programmes have widely varying 
definitions and components and failure to recognize these variations leads to 
inappropriate conclusions about the effectiveness of these programmes and to 
inappropriate application of research results. To compare programmes and better 
understand the (cost) effectiveness of the programmes, consistent definitions must 
be used and component interventions must be well described. 
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Introduction 
There are several reasons why it is becoming increasingly complex to provide 
optimal health care. Fast-growing medical scientific knowledge is leading to more 
diagnostic procedures and treatment modalities. Furthermore, ageing of the 
population means larger proportions of people that have illnesses with high impact 
and a chronic course.1 As a result, patient care has changed from individual 
consultation to multiprofessional teamwork and this usually involves many health 
care providers.2 Consequently, optimal collaboration and coordination between 
professionals in the delivery of integrated care have become essential 
requirements for the provision of high-quality care.3,4 
Health care improvement programmes at hospitals usually focus on isolated 
interventions, such as medication supply or multidisciplinary cooperation, rather 
than on the total care process of the patient.5 These programmes offer only partial 
solutions for improving the continuity and coordination of the total care process. 
Integrated care programmes or disease management programmes have begun to 
receive greater support as approaches to reduce fragmentation and to achieve 
improved results for patients at acceptable costs.6,7 These programmes may 
appear effective, but it is less evident which components or interventions should 
be included and how such programmes can be implemented successfully. 
In the literature several systematic reviews are published on integrated care or 
disease management programmes for different chronic patient groups (e.g. 
patients with diabetes or heart failure). However, an overview of similarities in 
reported effects, definitions, and components of these programmes is missing. The 
purpose of this study is to investigate effectiveness, definitions, and components of 
integrated care programmes for chronically ill patients on the basis of systematic 
reviews. 
Methods 
There is no unambiguous definition of integrated care and there are a lot of 
synonyms, such as disease management, care management, managed care, and 
coordinated care. In this study we use the description of Mur-Veeman and others8: 
integrated care is an organizational process of coordination that seeks to achieve 
seamless and continuous care, tailored to the patient's needs, and based on a 
holistic view of the patient. In this overview we searched for systematically 
performed reviews on integrated care programmes. Interventions in these 
programmes could be organizational and/or professional and/or patient oriented. 
We were interested in all effects and components of the programmes mentioned. 
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To identify publications that reported on systematic reviews of integrated care 
programmes between January 1996 and May 2004, we conducted literature 
searches in the Medline and Cochrane databases using medical subject headings 
and free text searches with the following terms "disease management", "patient 
care management", "patient-centred care", "health planning", and "delivery of 
health care integrated" Reference lists of relevant articles were also searched 
Review articles were screened by two reviewers (MO and HW) and included if they 
met the following criteria firstly, the review had been performed as a systematic 
review, secondly, the scope of the review concerned integrated care programmes, 
thirdly, the programmes focused on adult patients with all conditions except for 
AIDS, mental illness, addiction, and the field of midwifery 
Titles and abstracts of articles were reviewed for relevance on the inclusion criteria 
and if potentially relevant, we retrieved the full-text article The studies were 
analyzed qualitatively and we extracted the following items definitions of 
integrated care, components of the programmes, and all the effects or outcomes 
Results 
Search strategy 
The initial search strategy identified about 2800 references We accepted 350 
studies for further screening and 13 reviews met all our inclusion criteria Reviews 
about integrated care programmes dated mainly from the year 2000 or later (10 of 
13) The reviews we included involved the following patient groups patients with 
heart failure9"13, patients with diabetes mellitus1415, patients with rheumatoid 
arthritis16, patients with cardiovascular disease17, stroke patients18, patients with 
chronic obstructive pulmonary diseases19, and patients with chronic illnesses in 
general2021 Seven of the 13 reviews were only descriptive10"1521 and six had also 
performed meta-analyses917"20 
Programme effectiveness (see Table 1) 
Functional health status was the most frequently reported effect outcome of the 
programmes 10-172021 There was a positive trend, but only one of two studies that 
had performed meta-analyses showed a significant positive effect on this 
outcome 20 Seven of the 13 reviews had mentioned effects on hospitalization 9" 
13 17 19 j^gy
 a|| sh^ed a decreasing trend in hospital readmission or length of 
stay, but this was only significant in three reviews91217 Effects on mortality had 
been assessed in six reviews9121317"19, four times in a meta-analysis917"19, but 
effects remained unclear The only positive significant pooled effect on mortality 
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had been found in organized in-patient care for stroke18: significant positive effects 
on death and dependency had been recorded at final follow-up and during 
institutionalized care. The only significant effect on process outcomes, such as 
provider monitoring, compliance, and adherence to guidelines, was found by 
Weingarten et al.20 This was supported by all four descriptive reviews that had also 
reported on process outcomes.12-15 Patient satisfaction and quality of life had been 
mentioned in, respectively, three10"12 and six reviews10-14,17: the trend was positive 
but no significant effects were stated. In four of the seven reviews that had 
performed economic analyses, there were suggestions of financial benefit, but 
these conclusions were based on a small number of studies included in the review 
and had not been based on a meta-analysis.9,101217 
Table 1. Overview of trends in important outcomes of integrated care programmes 
Studies with only 
Descriptive analyses 
Ferguson, 1998 
Moser, 2000 10 
Norns, 2002 " 
Philbm, 1999 11 
Renders, 2002 15 
Rich, 1999 12 
Windham, 2003 13 
Studies with also 
Meta analyses 
Badamgarav, 2003 16 
McAhster, 2001 17 
McAhster, 2001 9 
Sin, 2003 19 
SUTC, 2001 1β 
Weingarten, 2002 20 
Hospitali­
zation 
-
-
* 
-
* 
_* 
? 
Mortality 
? 
? 
? 
? 
? 
* 
Process 
outcomes1 
+ 
+ 
+ 
+ 
+* 
Functional status 
and health 
outcomes 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
? 
+ 
+* 
Patient 
satis­
faction 
+ 
+ 
+ 
Quality Costs 
of life 
+ ? 
+ 
+ ? 
+ 
+ ? 
+ 
-
Process outcomes as provider monitoring, compliance and adherence to guidelines 
? = effect remains unclear 
- = trend shows decrease (in more than half of the included studies) 
+ = trend shows increase (in more than half of the included studies) 
* = trend is significant 
Definitions and components (see Tables 2 and 3) 
The term used most frequently to describe the management of patients with a 
chronic illness was disease management.9,10,12,14,16,17,19,20 Other terms were care 
management13, case management21, or the management of, for example, patients 
with diabetes.15 Although the aims of the programmes were very similar in all the 
reviews, namely to reduce fragmentation and improve continuity and coordination, 
the focus and content of the programmes differed widely. 
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Table 2. Overview of included reviews and their definitions of integrated care programmes 
Review Definition 
Badamgarav 2003 16 Disease management is a systematic and multidisciplinary approach to care for 
chronic conditions including a patient education component. 
Ferguson 1998 21 Case management is a specialized treatment programme that targets high-risk 
and high-use patients These programmes provide comprehensive 
management activities including some or all of the following, prevention and 
detection of acute events through continuous monitoring and assessment; 
patient education and behaviour modification through the use of highly trained 
multidisciplinary personnel; specialized treatment plans coordinated by disease 
experts, and preserved continuity of care across diverse patient care settings. 
McAlister 2001 17 Disease management is a combination of patient education, provider use of 
practice guidelines, appropriate consultation, and supplies of drugs and 
ancillary services 
McAlister 2001 9 Disease management programmes generally involve multidisciplinary teams 
that employ system approaches (such as guidelines or care paths) and 
specialized clinics dedicated to comprehensive management. 
Moser 2000 10 Disease management is an approach to patient care that emphasizes 
coordinated, comprehensive care along the continuum of disease and across 
health care systems. 
Disease management programmes are designed to improve the structure of 
care delivery for a group of patients with a common chronic disease that has 
associated high cost and complex management needs. 
Morris 2002 14 Disease management is an organized, proactive, multi-component approach to 
health care delivery that involves all members of a population with a specific 
disease entity; care is focused on and integrated across (i) the entire spectrum 
of the disease and its complications, (ii) the prevention of comorbid conditions, 
and (lii) the relevant aspects of the delivery system; the goal is to improve short-
and long-term health and/or economic outcomes. 
Philbin 1999 11 Comprehensive multidisciplinary programmes for the management of patients 
with congestive heart failure 
Renders 2002 15 Interventions to improve the management of patients with diabetes, targeted at 
health professionals or the structure in which they deliver care 
Rich 1999 12 Disease management is a multifaceted approach to heart failure management, 
to address all the patient's needs (medical and non-medical), maximizing the 
patient's functional capacity and quality of life, while reducing hospital 
admissions and overall cost of care; an important secondary goal is to improve 
physician prescribing patterns and promote greater adherence to treatment 
guidelines. 
Sin 2003 19 Disease management is an approach to coordinate resources across the health 
care system with the aim of fostering continuity of care and increasing patients' 
knowledge and control over their chronic disease. 
Stroke Unit Tnahsts' Multidisciplinary teams that exclusively manage stroke patients on a dedicated 
Collaboration 2001 18 ward with a mobile stroke team provide organized stroke unit care. 
Weingarten 2002 20 Disease management is a multidisciplinary approach to care for chronic 
diseases that coordinates comprehensive care along the disease continuum 
across health care delivery systems 
A disease management intervention is an intervention designed to manage or 
prevent a chronic condition using a systematic approach to care and with 
multiple treatment modalities. 
Windham 2003 13 A care management programme consists of interventions designed to improve 
care for patients with congestive heart failure 
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Interventions in the programmes had focussed on health care providers and/or the 
organization of care, while patient education had often been added. Six 
components had been explicitly mentioned in the form of definitions or as core 
components of the programmes. The most commonly mentioned component was 
self-management support and patient education.9"11,13"17,19"21 This intervention was 
often combined with structured clinical follow-up9"1113-15·19'21 and case 
management by, for example, a specialized nurse.10,12"1521 Nine reviews had 
explicitly mentioned a multidisciplinary patient care team. 9 1 1 " 1 3 1 5 1 6 1 8 2 0 2 1 A 
systematic, evidence-based approach to care, for example, by using 
multidisciplinary clinical pathways, had been seen as part of the programmes in 
eight of the 13 reviews.9,12"14,16,1720,21 Feedback, reminders, and education that 
provided health care professionals with information regarding appropriate care for 
patients, had been reported in three reviews.1415,20 
Table 3. Description of components of integrated care programmes 
Component Description 
Self-management Self-management support involves collaboratively helping patients and their 
support and patient families acquire the skills and knowledge to manage their own illness, providing 
education self-management tools and routinely assessing problems and 
accomplishments Education is giving the patients information (materials and/or 
instructions) regarding their condition and possible management 
Clinical follow-up Follow-up is monitoring the patient after or during treatment on a close regular 
base This is often done by a nurse case manager who uses a phone, mailings, 
or visits Clinical follow-up can be seen as part of self-management support 
Case management Case management is explicit allocation of coordination tasks to an appointed 
individual (a case manager) or a small team who may or may not be 
responsible for the direct provision of care The case manager or team takes 
responsibility for guiding the patient through the complex care process in the 
most efficient, effective, and acceptable way 
Multidisciplinary patient- A multidisciplinary patient-care team is composed of a group of professionals 
care team who communicate with each other regularly about the care of a defined group 
of patients and participate in that care 
Multidisciplinary clinical Clinical pathways or integrated care pathways are structured multidisciplinary 
pathway care plans which detail essential steps in the care of patients with a specific 
clinical problem and describe the patient's expected clinical course Clinical 
pathways should be derived from evidence-based guidelines translated into 
practice 
Feedback, reminders, The aim of feedback, reminders, and education is to provide health care 
and education for providers with information regarding appropriate care for patients This 
professionals information can come from clinical pathways, medical records, computerized 
databases, patients, or audits by colleagues 
Feedback is given after the consultation, education is given before consultation, 
reminders are given before or during consultation 
Additional requirements (ι) Supportive clinical information system, (n) specialized clinics or centres, (m) 
shared mission on integrated care, (iv) leaders with a clear vision on integrated 
care, (v) finances for implementation and maintenance, (vi) management 
commitment and support, (vu) patients capable and motivated for self-
management, (vm) culture of quality improvement 
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In addition to the six components mentioned above, several requirements or 
operational needs had been referred to as important for the successful 
implementation of care programmes: a supportive clinical information system; 
specialized clinics or centres; a shared mission on integrated care between the 
professionals involved; leaders with a clear vision of the importance of integrated 
care; finances for implementation and maintenance; management commitment 
and support; patients capable of and motivated for self-management; and a culture 
of quality improvement. 
Discussion 
Despite considerable heterogeneity in the reviews regarding the interventions 
used, patient populations, provider populations, and processes and outcomes of 
care, positive trends in effects were reported. This concerned: hospital utilization, 
quality of life, functional health, patient satisfaction, and process outcomes, such 
as adherence to guidelines and compliance with medication. Effects on mortality 
remained unclear and little systematic analysis was performed on the cost-
effectiveness of integrated care programmes. Only 15% of the effects reported in 
the reviews were significant and these came mainly from short-term evaluations. 
This overview underlines the findings of Morris22 that there is a broad range of 
definitions used to date for the management of patients with a chronic illness. 
However, the aims of the programmes were always very similar, namely to reduce 
fragmentation and improve the continuity and coordination of care by placing the 
patient in a central position in the process of health care delivery. Although 
disease management was the term found most frequently in this review, we prefer 
to use the term integrated care instead, as this puts the patient, not the disease, in 
the centre. 
We found in this review a core set of components in the integrated care 
programmes. This is in line with the theory of Wagner.23"28 Wagner identified six 
essential elements for good chronic care: community resources and policies, 
health care organization, self-management support, delivery system design, 
decision support, and clinical information systems. He states that improvements in 
those interrelated components can produce system reform in which informed, 
activated patients interact with prepared, proactive practice teams. On the basis of 
the theory of Wagner and the core set of components found in this review, we 
recommend that integrated care programmes should consist of at least a 
professional-directed intervention, an organizational intervention, and a patient-
related intervention to support selfmanagement. 
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In this study we performed a review of reviews. The main limitation of this method 
is that, by using reviews, it is not possible to draw conclusions from the results of 
the original studies, and that details of the individual studies are washed out. 
Furthermore, there was a risk of publication bias, because of the tendency for 
Journals to publish positive results and suppress negative results. 
In conclusion, this review showed that integrated care programmes seemed to 
have positive effects on the quality of care. However, integrated care programmes 
have widely varying definitions and components. Failure to recognize these 
differences leads to inappropriate conclusions about the effectiveness of these 
programmes and to inappropriate application of research results. To compare and 
better understand the (cost) effectiveness of integrated care programmes, 
consistent definitions must be used and component interventions must be well 
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Abstract 
Purpose: A good overview of possible interventions to improve integrated care and 
their effects in cancer care is currently lacking. The aim of this study is to review 
integrated care interventions and their effects on the quality of care for patients 
with cancer. 
Methods: We searched Medline and the Cochrane Library databases. For 
inclusion, the intervention had to focus on least one of the three principles of 
integrated care: patient-centredness, multidisciplinary care, and coordinated care. 
We used the standard search methods of the Cochrane Effective Practice and 
Organization of Care Group (EPOC). All outcomes reported were extracted. 
Results: Thirty-three studies met the inclusion criteria: no study focussed on all 
three principles of integrated care; 16 studies focussed on patient-centredness 
(48%), 14 on the coordination of care (42%), 1 study on multidisciplinary care and 
2 studies on both patient-centredness and coordination of care. The interventions 
and the outcomes used for evaluation varied greatly. The most effective 
interventions for improving integrated care were: "providing the patient with a 
consultation audiotape", "providing the patient with information", "use of a decision 
aid", "follow-up by a nurse or a general practitioner", "case management" and 
"one-stop clinics". 
Conclusion: To improve integrated care for patients with cancer, a multi-
component intervention programme focussing on patient-centredness, 
multidisciplinary care, and coordination of care is needed. The effective 
interventions found in this review should be part of this programme. These 
programmes should be evaluated with rigorous methods and outcome measures 
linked to the intervention. 
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Introduction 
As a cause of death in the US and Europe, cancer is exceeded only by 
cardiovascular disease.1,2 Earlier diagnosis, improved treatment modalities, and 
enhanced supportive care results in cancer more and more taking on the 
characteristics of a chronic disease.3 The management of care for cancer patients 
is complex. First, cancer has a very significant impact on the patient's physical, 
emotional, and social well-being. Second, various professionals are involved in 
prevention, diagnosis, treatment, and follow-up. This complexity can lead to 
suboptimal care and result in discontinuity and fragmentation of care.4"7 Integrated 
care can help to solve this problem.8 
The essence of integrated care is that it is organized around the needs and 
preferences of patients, and that patients are actively involved in decisions about 
their own care (patient-centredness), that care is given in optimal collaboration of 
all the professionals involved (multidisciplinary care), and that seamless and 
continuous care is given with optimal coordination and organization of the total 
care process (coordination of care)9 Naturally, integrated care should also be 
based on the general principles of evidence-based medicine and continuous 
quality improvement.10,11 
Reviews of integrated care interventions for patients with heart failure12"16, 
diabetes mellitus17,18, rheumatoid arthritis19, cardiovascular disease20, stroke21, 
chronic obstructive pulmonary diseases22, and chronic illnesses in general are 
available23,24, but there are no such reviews for patients with cancer. The 
interventions for improving integrated care in the reviews are: patient self-
management support and education, arrangements for clinical follow-up, case 
management, introduction of a multidisciplinary patient care team, and a 
systematic evidence-based approach to change processes of care, for example, 
by using clinical pathways.25 We found positive trends in effects of integrated care, 
mainly on functional health status, quality of life, patient satisfaction, and 
integrated care outcomes as guideline adherence.25 
To improve integrated care for patients with cancer, it is important to know which 
interventions sustain the principles of integrated care and to find out what is known 
about their effectiveness. 
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Methods 
Data sources 
We searched Medline, the Cochrane Database of Systematic Reviews, the 
Cochrane Database of Abstracts of Reviews of Effects and the Cochrane Central 
Register of Controlled Trials for the period January 1996 to October 2006. Our 
search strategy for Medline combined the "gold standard" search strategy of the 
Cochrane Effective Practice and Organisation of Care Group (EPOC)26 with the 
MeSH terms "organization and administration" or "patient care management" and 
the term "neoplasms". We searched the Cochrane Library with the "gold standard" 
search strategy of the EPOC for the Cochrane Library and the same MeSH terms 
we used for Medline, and with the term "neoplasms" or "cancer". 
Study selection 
We included studies that were written in English and that focus on a rigorous 
evaluation of an integrated care intervention or a programme with the aim of 
improving care for adult patients with cancer in hospital or an out-patient setting. 
Rigorous evaluations comprised randomized controlled trials, interrupted time 
series, and controlled before-after studies. The intervention or programme had to 
consider one of the three principles of integrated care: patient-centredness, 
multidisciplinary care, or coordination of the care processes. Studies that 
evaluated interventions for preventive health care, genetic counselling, 
complementary medicine, and palliative care were excluded. Two reviewers (MO 
and MH) independently screened titles and abstracts, and if they were potentially 
relevant, the full-text articles were retrieved. In addition, the reference lists of the 
studies were screened for relevant publications. 
Data extraction 
A structured form, based on the data collection list of the EPOC, was used to 
extract the data (focus of the study, interventions, outcome measures, results, and 
quality criteria). Study quality was assessed against five methodological criteria 
published by the Cochrane Collaboration: 
- Follow-up (at least 80% of the study population) 
- Reliable outcomes (agreement of 90%, or kappa > 0.8, or outcomes from some 
automated systems, or validated instruments with Cronbach's alpha > 0.7) 
- Protection against contamination (it was unlikely that the control group received 
the intervention) 
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- Baseline measurement (performance and patient outcomes were measured 
prior to the intervention and no substantial differences were present, or the 
study was corrected for baseline) 
- Concealment of allocation (randomization process is described explicitly).26 
To be included, the studies had to fulfil at least three of the five quality criteria. 
The studies were distributed among a group of reviewers (MO, MH, RH, MF, HM, 
and HW) and always two reviewers independently extracted the data and 
assessed the quality of relevant studies. Outcomes within specific patient 
subgroups (e.g. women) were not included if the overall outcomes were reported. 
In the case of discrepancies between the two reviewers, a third reviewer was 
consulted. 
Data analysis 
Because of the heterogeneity of the interventions, patient populations, and 
reported outcomes, we could not statistically pool the results of the studies. 
Instead, we qualitatively assessed the type of integrated care interventions for 
cancer patients and their reported effects. We grouped the studies according to 
intervention type. We distinguished five categories of study outcomes. We 
considered the "integrated care outcomes" the most relevant category. In this 
category, the outcomes most directly linked to the integrated care intervention 
were recorded (e.g. "number of questions asking" and "decision for a specific 
therapy" and "waiting times" and "guideline adherence"). The other categories 
were: "satisfaction" (patient and/or professional), "subjective health outcomes" 
(e.g. "quality of life" and "anxiety") and "objective health outcomes" (e.g. mortality 
and morbidity). The last group ("other outcomes") consisted of all other outcomes 
reported. Outcomes were reported as "having a positive effect" if there was a 
significant difference between the intervention and control groups (p < 0.05). If 
more outcomes were used within one category, the intervention was qualified as 
"having a positive effect" when more than half of the outcomes had significant 
positive effects. 
Results 
Search strategy 
We identified 1397 references with the initial search strategy. We excluded 1187 
studies on the basis of titles and abstracts. After more detailed assessment, 33 
studies met the inclusion criteria and were included in the final analysis (Figure 1). 
The most common reasons for exclusion were non-randomized design, 
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uncontrolled before-and-after design, and an intervention that did not specifically 
maintain integrated care principles. Eighteen studies were excluded because they 
fulfilled fewer than three quality criteria. One new study was found in the reference 
lists of the included studies. Of the 33 included studies, 31 were randomized or 
quasi-randomized controlled trials and 2 were controlled before-and-after studies. 
Figure 1. Selection process for studies included in the analysis 
Number of hits on basis of the search strategy 
n = 1397 
• 421 Cochrane trials 
• 894 Medline 
• 27 Cochrane reviews 
• 55 DARE reviews 
ι 
^ 
' 
Exclusion on the basis of title and abstract not 
meeting design, not integrated care 
n= 1187 
Publications retrieved for more detailed 
evaluation η = 210 
• 95 Cochrane trials 
• 96 Medline 
• 5 Cochrane reviews 
• 14 DARE reviews 
New publications identified in 
reference lists of included studies 
η = 1 
1 
' 1 
fe. 
fe. 
' 
Exclusion on the basis of full text not meeting 
design, nol integrated care, duplicate studies 
n= 159 
Exclusion on the basis of methodological quality 
n = 18 
Publications included in final analysis 
η = 33 
Participants and settings 
Most studies were undertaken in the United Kingdom (39%), the United States of 
America (18%), and Canada (15%). Forty-two percent of the studies involved 
patients with breast cancer and 39% of the studies involved patients with different 
kinds of cancers. The other studies involved patients with lung cancer (2 studies), 
prostate cancer (2 studies), colorectal cancer (1 study) and gastric cancer 
(1 study). 
34 
Integrated care for cancer patients 
Quality criteria 
Only one study fulfilled all five quality criteria 28 Of the 33 included studies, 26 
(79%) had a follow-up of the study population of at least 80% The criteria "reliable 
outcomes" was used m 29 studies (88%), many studies reported satisfaction 
outcomes or subjective health outcomes (67%) that were determined with 
validated instruments A baseline measurement was provided in 24 studies (72%) 
The criterium "protection against contamination" was met in 18 studies (55%) and 
"concealment of allocation" in 19 studies (58%) (see Appendix) 
Interventions and outcomes 
No study focussed on all three principles of integrated care Integrated care 
interventions maintaining the principle of patient-centredness were found in 16 of 
the 33 studies (48%), maintaining the principle of coordination of care in 14 studies 
(42%), and maintaining the principle of multidisciphnary care in one study Further, 
two studies evaluated interventions maintaining both the principles of patient-
centredness and coordination of care (Table 1) Outcomes directly linked to the 
integrated care intervention were measured in 25 studies (76%) Twenty-two 
studies reported on satisfaction (67%) and 22 on subjective health outcomes, such 
as quality of life and anxiety (67%) Objective health outcomes, such as morbidity 
and mortality, were assessed in five studies (15%) 
Paf/eni-cenfredness 
Regarding patient-centredness, 3 of the 16 studies involved the provision of 
information to patients28 30, 5 reported the effects of decision aids3135, 2 tested the 
effectiveness of providing an audiotape of the consultation to the patient36 37, 4 had 
"patient-mediated interventions"38"41 (interventions to change the performance of 
health-care providers by seeking feedback from patients) and 2 reported on the 
effects of communication training for professionals4243 (Table 1 ) 
All studies reported on outcomes that were directly linked to the intervention 
Interventions including some form of information provision to patients (ι e 
information to patients28 30, decision aids3135 and audiotape of the consultation 
given to patients3637) showed significant positive overall effects (Table 2) Decision 
aids and audiotapes of consultations also had positive effects on patient 
satisfaction Only one study33 showed positive effects on subjective health 
outcomes, a decision aid improved the quality of life for patients with breast 
cancer No studies reported on objective health outcomes 
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Table 1. Characteristics of the interventions in the studies categorized by the three principles of 
integrated care 
Author (year) 
Country 
Study Study population 
design Sample size 
(total: intervention-
control) 
Intervention 
(intensity; follow-up) 
Control 
PATIENT-CENTREDNESS 
Walker (2005) 
USA 
Butow (2004) 
Australia 
Jones (1999) 
UK 
Peele (2005) 
USA 
Whelan (2004) 
Canada 
Davison (2002) 
Canada 
Molenaar (2001) 
The Netherlands 
Goel(2001) 
Canada 
Ong (2000) 
The Netherlands 
Bruera(1999) 
Canada 
RCT 
RCT 
RCT 
RCT 
RCT 
RCT 
CBA 
RCT 
RCT 
RCT 
Breast cancer 
(95 48-47) 
Various cancers 
(164 80-84) 
Various cancers 
(525 178-167-189) 
Breast cancer 
(432 250-182) 
Breast cancer 
(208 98-110) 
Breast cancer 
(734 367-367) 
Breast cancer 
stage I and II 
(180 92-88) 
Breast cancer 
(136 86-50) 
Various cancers 
(201 105-96) 
Various advanced 
cancers 
(71 38-33) 
Information to patients 
Preparatory video for patients 
(one showing of 19 mm, 10 days) 
Consultation preparation package for 
patients question prompt sheet, 
booklets on decision making, 
introduction to clinic (once, 1 month) 
1 Personalized computer information 
2 General computer information 
(one 12-min session and, when 
needed, 3 months) 
Decision aids for patients 
Patient-specific decision aid about 
adjuvant therapy (once, unknown) 
Decision aid, written and visual 
Evidence-based information 
(once, 12 months) 
Computer-generated information and 
personal decision profile for patients 
(one 15-min session, 1 day) 
Interactive CD-ROM as decision aid for 
patients (one 7-min session, 9 months) 
Decision aid format audiotape and 
workbook (once, 6 months) 
Audiotaped consultation to patients 
Audiotape of consultation 
(once, 3 months) 
Audiotape of consultation for patients 
and written recommendations 
(once, 8 days) 
Usual care 
written 
pamphlet only 
Only booklet on 
introduction to 
clinic 
3 Usual care 
General 
information 
booklets 
Usual care 
written 
pamphlet only 
Usual care 
Consultation 
with research 
nurse talking 
about general 
issues 15 mm 
Usual care oral 
information and 
brochures 
Pamphlet with 
identical 
information 
Taped but not 
given 
Usual care 
Detmar (2002) RCT 
The Netherlands 
Taenezer (2000) CBA 
Canada 
Sepucha (2002) CCT 
USA 
Brown (2001) RCT 
Australia 
Patient-mediated interventions 
Various cancers Graphic summary profile with Quahty-of- No HLQL -
(214 114-100) life information (QLQ-C30) for patients information 
and their physicians 
Lung cancer Patient-specific computerized Quality- Usual care no 
(53 27-26) of-life information for clinical staff quahty-of-life 
(once before consultation, unknown) information 
Breast cancer Consultation planning session for Proactive 
(132 42-52) patients (CP) (once, 20 mm, "?) listening 
Various cancers 1 Question prompt sheet for patients 3 No question 
(318 79-81-158) (qps) and passive doctor prompt sheet 
2 A qps and active doctor 
(one 15-min session, 10 days) 
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Author (year) 
Country 
Shilling (2003) 
UK 
Fallowfield (2002) 
UK 
Study 
design 
CCT 
RCT 
Study population 
Sample size 
(total: intervention-
control) 
Oncologists 
(160 80-80) 
Oncologists 
(160 39-41-41-39) 
COORDINATION OF CARE 
Ross (2005) 
Denmark 
Wells (2004) 
UK 
Moore (2002) 
UK 
McCorkle (2000) 
USA 
Helgesen (2000) 
Sweden 
Faithfull(2001) 
UK 
Brown (2002) 
UK 
Holtedahl (2005) 
Norway 
Grunfeld (1999) 
UK 
Grunfeld (1996) 
UK 
Goodwin (2003) 
USA 
Rawl (2002) 
USA 
RCT 
RCT 
CCT 
RCT 
RCT 
RCT 
RCT 
RCT 
RCT 
RCT 
RCT 
RCT 
Colorectal cancer 
(249 125-124) 
Breast cancer after 
surgery 
(108 54-54) 
Lung cancer 
(202 99-103) 
Various cancers 
older patients 
discharged after 
surgery 
(375 190-185) 
Prostate cancer 
(400 200-200) 
Intervention 
(intensity; follow-up) 
Control 
Communication training for professionals 
Communication skills training for 
oncology physicians 
(once for 3 days and 3 months) 
Communication course for oncologists 
and feedback package 
(once for 3 days, 3 months) 
Follow-up by nurses 
Home visits and telephone calls by 
specialized nurse (10 visits, 2 years) 
Early discharge within 36 h of surgery 
and with dram and nurse-led follow-up 
(once and if needed, 1 year) 
Nurse-led follow up (monthly contact 
and if needed, 12 months) 
Home visits and telephone calls by 
specialist nurse (3 home visits and 5 
telephone contacts, 44 months) 
Follow-up by specialist nurse 
(every month for 6 months,3 years) 
Prostate and bladder Nurse-led follow-up (two 1h clinic visits 
cancer 
(115 58-57) 
and if needed, 12 weeks) 
Breast cancer stage I Patient-initiated follow-up written 
(61 30-31) 
Various cancers 
(91 36-45) 
Breast cancer in 
remission 
(296 148-148) 
Breast cancer in 
remission 
(296 148-148) 
Breast cancer 
among older women 
(335 169-166) 
Usual care no 
training 
Usual care no 
training 
Usual care 
Usual care 
discharge after 
dram removal 
Usual care 
conventional 
medical follow-
up 
Usual follow-up 
care m 
ambulatory 
setting 
Usual care 
follow-up by 
urologist 
Usual care 
routine medical 
follow-up 
Usual care 
information on signs and symptoms and Standard clinical 
advice to contact specialized nurse 
C, 1 year) 
Follow-up by general practitioner 
Patient invited by general practitioner 
and invitation to further GP follow-up 
(30 mm, 6 months) 
Follow-up by patient's own GP 
(?,18 months) 
Follow-up by GP 
(according to standards, 18 months) 
Case management 
Nurse case-management (once m 
person and monthly by telephone and 
when needed, 12 months) 
Breast, colon, or lung Computer-based nursing intervention 
cancer receiving 
chemotherapy 
(125 55-54) 
for information, coordination and 
emotional support [9 visits (5 m person 
and 4 by telephone),! month after 
intervention] 
follow-up 
Usual care 
follow-up with 
specialist 
Usual care 
Routine follow-
up by oncologist 
Usual care 
Follow-up m 
outpatient 
clinics 
Usual care 
Usual care, no 
extra visits 
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Author (year) 
Country 
Dey (2002) 
UK 
Harcourt(1998) 
UK 
Study 
design 
RCT 
RCT 
Study population 
Sample size 
(total: intervention-
control) 
Suspicion of breast 
cancer 
(695 344-351) 
Suspicion of breast 
cancer 
(791 416-375) 
MULTIDISCIPLINARY CARE 
Barry (2002) 
UK 
RCT Gastric cancer 
(110 60-50) 
Intervention 
(intensity; follow-up) 
One-stop clinic 
One-stop clinic 
(once, 3 months) 
One-stop clinic with same day diagnosis 
(once, 8 weeks) 
Multidisciplinary team 
Radiologist working within an MDT 
Control 
Usual care 
i Usual care 
2 appointments 
with delay 
Usual care 
Radiologist not 
part of MDT 
PATIENT-CENTREDNESS and COORDINATION OF CARE 
Shared care programme 
Nielsen (2003) RCT Various cancers 
Denmark (248 121-127) 
Shared care programme with three 
elements 
1 Knowledge transfer specialist to GP 
2 Names and contact numbers 
3 active patient involvement, written 
and oral information and encouraged to 
contact their GP (4 months, 6 months) 
Usual care 
Usual care 
Patient held record 
Williams (2001) RCT Various cancers Patient-held booklet used by patients 
UK (501 251-250) and professionals 
(once, 6 months) 
CBA, controlled before-after study, CCT, Clinical Controlled Trial , GP, general practitioner, HLQL, Health Related 
Quality of Life, QLQ-C30, Quality of Life Questionnair, RCT, randomized controlled trial 
Coordination of care 
Regarding the coordination of care, only two types of interventions were 
evaluated: "revision of tasks and responsibilities" (follow-up, case management) 
and "changes in settings" (introduction of a one-stop clinic). Six of the 14 studies 
reported integrated care outcomes (i.e. outcomes directly linked to the 
intervention). Follow-up was the most evaluated intervention (in 10 of the 14 
studies; Table 1). Seven studies investigated follow-up by specialist nurses 44"50 
and 3, follow-up by general practitioner.51"53 These studies showed that follow-up 
by nurses or general practitioners can lead to equal or better integrated care 
outcomes, satisfaction, and subjective health outcomes (such as quality of life or 
anxiety and depression) than follow-up by specialists (Table 3). 
Two studies evaluated the effects of case management.54,55 Case management 
can lead to significant improvements of integrated care outcomes (appropriate 
treatment in accordance with the guideline), patient satisfaction, and objective 
health outcomes (arm functioning).54 No significant effects on subjective health 
outcomes (psychosocial functioning, anxiety, and depression) were found. Two 
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studies reported the effects of a "one-stop clinic". • One-stop clinics seemed to 
reduce negative subjective health outcomes (anxiety and depression),56,57 but 
effects on integrated care outcomes (e.g. waiting and throughput times) and on 
costs remained unclear. 
Multidisciplinary care 
Only one study investigated multidisciplinary care. This study shows that "having a 
radiologist as part of multidisciplinary team for patients with gastric cancer" led to a 
significantly better agreement between tumour, nodal involvement, and 
metastases (TNM) staging on the basis of computed tomography and 
histopathological stage (integrated care outcome; Table 4). 
Combinations 
Two studies evaluated combined interventions, both concerning patient-
centredness and coordination of care. One study reported on a "shared care 
programme"58. The second study evaluated a "patient-held record" that aimed at 
informing and involving patients, as well as improving continuity of care between 
professionals59 (Table 1 ). 
The "shared care programme" led to significantly more contacts with the general 
practitioner (integrated care outcome) and more satisfied patients, but had no 
effect on the subjective health outcome "quality of life" (Table 2). The patient-held 
record improved neither patient perceptions of communication (integrated care 
outcome) nor the quality of life. The use of the record did not lead to more use of 
resources or longer consultation times (Table 5). 
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Table 2. Effectiveness of the interventions in the patient-centredness studies 
Author (year) 
Country 
Information to patients 
Walker (2005) 
USA 
Butow (2004) 
Australia 
Jones (1999) 
UK 
Total positive effects 
Decision Aids 
Peele (2005) 
USA 
Whelan (2004) 
Canada 
Davison (2002) 
Canada 
Molenaar (2001) 
The Netherlands 
Goel(2001) 
Canada 
Total positive effects 
Integrated Care 
Outcomes 
Questions Asking 
Questions Asking 
Achieved preferred 
decisional role 
Use of computer 
information 
2/3 
Decision for adjuvant 
therapy 
Patient knowledge 
Decisional conflict 
Achieved preferred 
decisional role 
decision for breast 
conserving therapy 
Knowledge 
Decision conflict 
3/5 
Audiotaped consultation to patients 
Ong (2000) 
The Netherlands 
Bruera (1999) 
Canada 
Total positive effects 
Recall of information 
Recall of information 
2/2 
+ 
+ 
• 
+ 
+ 
+ 
+ 
-
-
+ 
+ 
Satisfaction 
Patient 
Patient 
Patient 
0/3 
Patient 
Patient 
Patient 
2/3 
Patient 
Patient 
2/2 
Subjective 
Health Outcomes 
Distress 
Quality of life 
Anxiety 
Anxiety and 
depression 
0/3 
+ Anxiety 
Depression 
-
+ Quality of life + 
Anxiety 
1/3 
+ Quality of life 
+ 
0/1 
Objective 
Health Outcomes 
Other Outcomes 
Physician behaviour • 
Cost reduction 
0/2 
Author (year) 
Country 
Integrated Care 
Outcomes 
Satisfaction Subjective 
Health Outcomes 
Objective 
Health Outcomes 
Other Outcomes 
Patient-mediated interventions 
Detmar (2002) 
The Netherlands 
Taenezer (2000) 
Canada 
Sepucha (2002) 
USA 
Brown (2001) 
Australia 
Total positive effects 
Discussion of QoL 
issues 
Actions taken 
Discussion of QoL 
issues 
Actions taken 
Communication 
barriers 
Questions asking 
Information needs 
Recall of information 
0/4 
Patient 
Professional 
Patient 
Patient 
Professional 
Patient 
Quality of life Duration of the visit 
Anxiety 
1/4 0/2 0/1 
Communication training for professionals 
Shilling (2003) 
UK 
Fallowfield (2002) 
UK 
Total positive effects 
Questions asking and + Patient 
unanswered - Professional 
questions 
Communication skills + 
e g focused 
questions, open 
questions 
0/2 0/1 
There is a significant difference between intervention group and control (p<0 05) favouring the intervention group, if more outcome measures are used within one 
category than half of the outcomes are significant 
Half of the outcomes are significant 
There is no significant difference between intervention group and control (p<0 05), if more outcomes measures are used within one category than half of the 
outcomes are significant 
Table 3. Effectiveness of the interventions in the coordination-of-care studies 
Author (year) 
Country 
Follow-up by nurses 
Ross (2005) 
Denmark 
Wells (2004) 
UK 
Moore (2002) 
UK 
McCorkle (2000) 
USA 
Helgesen (2000) 
Sweden 
Faithfull(2001) 
UK 
Brown (2002) 
UK 
Total positive effects 
Integrated Care 
Outcomes 
Carer burden 
Impact on community 
nurses 
More likely to die at + 
home 
Earlier recording of 
symptomatic progression 
Symptomatic progression 
Adverse events 
Self-assessment of + 
symptoms by the patient 
2/4 
Folllow-up by general practitioner 
Holtedahl (2005) 
Norway 
Grunfeld (1999) 
Canada/UK 
Grunfeld (1996) 
UK 
Total positive effects 
Time between first 
presentation of 
symptoms and 
confirmation 
0/1 
Satisfaction 
Patient 
Patient 
General 
practitioner 
Patient 
Patient 
Patient 
1/5 
Patient 
Patient 
1/2 
Subjective 
Health Outcomes 
Anxiety and 
Depression 
Well-being 
Quality of life 
+ Quality of life 
Anxiety and 
Depression 
+ Quality of life 
Quality of life 
Anxiety and 
Depression 
0/6 
Quality of life 
+ 
Quality of life 
Anxiety and 
Depression 
0/2 
Objective 
Health Outcomes 
Arm morbidity 
Survival 
Increased survival 
among late stage 
patients 
Morbidity 
1/4 
Other Outcomes 
- Costs 
Costs 
Use of resources 
+ 
Cost reduction + 
Cost reduction + 
2/4 
Author (year) 
Country 
Integrated Care 
Outcomes 
Satisfaction Subjective 
Health Outcomes 
Objective 
Health Outcomes 
Other Outcomes 
Case management 
Goodwin (2003) 
USA 
Rawl (2002) 
USA 
Appropriate treatment + Patient 
according guideline 
Total positive effects 1/1 1/1 
Psychosocial 
functioning 
Anxiety and 
Depression 
0/1 
Arm functioning 
1/1 
One-stop clinic 
Dey (2002) 
UK 
Harcourt(1998) 
UK 
Total positive effects 
Less Anxiety 
Less Anxiety and 
Depression 
2/2 
Costs higher for 
intervention 
Cost reduction 
There is a significant difference between intervention group and control (p<0 05) favouring the intervention group, if more outcome measures are used within one 
category than half of the outcomes are significant 
Half of the outcomes are significant 
There is no significant difference between intervention group and control (p<0 05), if more outcomes measures are used within one category than half of the 
outcomes are significant 
Table 4. Effectiveness of the interventions in the multidisciplinary care studies 
Author (year) Integrated Care Satisfaction 
Country Outcomes 
Multidisciplinary team 
Barry (2002) Agreement between CT- + 
UK stage and 
histopathological stage 
Subjective 
Health Outcomes 
Objective 
Health Outcomes 
Other Outcomes 
+ = There is a significant difference between intervention group and control (p<0 05) favouring the intervention group, if more outcome measures are used within one 
category than half of the outcomes are significant 
+ - = Half of the outcomes are significant 
- = There is no significant difference between intervention group and control (p<0 05), if more outcomes measures are used within one category than half of the 
outcomes are significant 
Table 5. Effectiveness of the interventions in the patient-centredness and coordination of care studies 
Author (year) Integrated Care Satisfaction Subjective Objective Other Outcomes 
Country Outcomes Health Outcomes Health Outcomes 
Shared care programme 
Nielsen (2003) Contact with GP + Patient + Quality of life 
Denmark 
Patient held record 
Williams (2001) Patient perceptions on - Quality of life - Use of Resources 
UK communication Consultation time 
+ = There is a significant difference between intervention group and control (p<0 05) favoring the intervention group, if more outcome measures are used within one 
category than > half of the outcomes are significant 
+ - = Half of the outcomes are significant 
- = There is no significant difference between intervention group and control (p<0 05), if more outcomes measures are used within one category than < half of the 
outcomes are significant 
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Discussion 
This is the first review describing interventions to improve integrated care for 
patients with cancer and their effects. A total of 33 studies met the inclusion 
criteria. The most promising interventions for improving patient-centredness (16 
studies) included the "provision of an audiotape of the consultation to the patient", 
"the provision of general information to patients", and the use of "decision aids". 
Nine studies had significant positive results for integrated care outcomes and/or 
satisfaction. Of the 14 studies that focussed on the coordination of care, effective 
interventions involved "follow-up provided by nurses or general practitioners", 
"case management" and "one-stop clinics". Seven studies showed positive 
improvements for one or more outcomes. The one study focussing on 
multidisciplinary care had positive results for integrated care outcomes, and one of 
the two studies focussing on both patient-centredness and coordination of care, a 
shared-care programme, had positive results for integrated care outcomes and 
satisfaction. 
Information is an important aspect of patient-centredness. The literature shows 
that failure to provide sufficient information about the disease and its treatment is 
the most frequent source of patient dissatisfaction61,62 and that further progress 
towards greater patient involvement in health-care decision-making is possible.63 
Our review shows that some interventions to better inform patients led to more 
questions, more knowledge among patients, and better recall of information. 
Regarding the coordination of care, we found only two kinds of interventions: 
"revision of tasks and responsibilities" (follow-up and case management) and 
"changes in settings" (one-stop clinic). The studies of follow-up show that follow-up 
by nurses or general practitioners can lead to equal or better outcomes than 
follow-up by specialists. This is in line with studies of the follow-up for other patient 
groups.64 The studies of "one-stop clinics" show that patients who visited the 
clinics were less anxious and depressed. There are very few studies of 
redesigning of processes.65 Further research should be done to evaluate such fast-
track programmes on outcomes more directly linked to the intervention, such as 
"waiting times". 
This review shows that the effect of interventions focusing on multidisciplinary care 
for cancer patients was hardly evaluated. We found one study of the effect of 
adding a specialized radiologist to the multidisciplinary team. Studies of other 
groups of patients, including patients with cancer receiving palliative care, show 
that a patient-care team that functions well leads to better outcomes.66"69 There are 
some studies regarding team functioning in cancer care.70,71 Haward shows that 
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team workload and the proportion of breast-care nurses positively predicted overall 
clinical performance and that there were significant correlations between individual 
team inputs, team composition variables, and clinical performance.70 Jenkins 
states that health professionals fulfilled the roles that the team expected of them. 
However, many more professionals were involved in major discussions without the 
team's knowledge. The professional consistently playing a major "unseen" role 
was the breast nurse specialist.71 Further research should be performed on 
composition, functioning, and impact of effective teamwork on integrated care and 
patient outcomes. 
The literature shows that multifaceted interventions targeting different barriers to 
change are more likely to be effective than single interventions.60 However, we 
found only two studies that evaluated combined interventions concerning patient-
centredness and coordination of care. In our opinion, to improve integrated care 
for patients with cancer, a multicomponent intervention programme that maintains 
all three principles of integrated care (patient-centredness, coordination of care, 
and multidisciplinary care) is needed. 
The strong points of our review are the clear inclusion criteria, the assessment of 
study quality, and the attention to classification of intervention types and 
outcomes. We only included studies with rigorous study designs (randomized 
controlled trials, interrupted time-series, and controlled before-and-after studies). A 
limitation may be that this review only included studies published since 1996. The 
reason for this is that new models for managing patients were first introduced in 
the 1990s, and our review of reviews of integrated care25 included studies which 
date mainly from the year 2000 or later. Further, we screened the reference lists of 
included studies, and this led to only one extra study. 
To improve all important aspects (patient-centredness, coordination of care, and 
multidisciplinary care) of integrated care for patients with cancer, a multi-
component intervention programme is needed. The promising interventions in this 
review should be part of this programme. This programme should be evaluated 
with rigorous methods and unequivocal outcome measures linked to the 
intervention. 
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Appendix. Key characteristsics and Quality Criteria of the included studies 
Author (year) 
Country 
Ross (2005) 
Denmark 
Peele (2005) 
USA 
Holtedahl 
(2005) 
Norway 
Walker (2005) 
USA 
Butow (2004) 
Australia 
Study 
design 
RCT 
RCT 
RCT 
RCT 
RCT 
Study 
population 
Sample Size 
(total: 
Intervention-
Control) 
Colorectal cancer 
(249: 125-124) 
Breast Cancer 
(432 250-182) 
Various Cancers 
(91:36-45) 
Breast Cancer 
(95; 48^7) 
Various Cancers 
(164; 80-84) 
Intervention 
(intensity; follow-
up) 
Home visits and 
telephone calls 
(10 visits, 2 years) 
Patient-specific 
decision aid about 
adjuvant therapy 
(once, ?) 
Patient invited by GP 
and invitation to 
further GP folllow-up 
(30 mm.; 6 months) 
Preparatory video for 
patients 
(once; 19 mm, 10 
days) 
Consultation 
preparation package 
for patients question 
prompt sheet, 
booklets on decision 
making; introduction 
to clinic (once: 1 
month) 
Control 
Usual care 
Usual care, 
written 
pamphlet 
only 
Usual care 
follow-up 
with 
specialist 
Usual care: 
written 
pamphlet 
only 
Only booklet 
on 
introduction 
to clinic 
Outcomes and Effects 
Intervention (1) - Control (C) 
Anxiety and Depression (HADS) 
n.s 
Well-being (QLQ-C30) n.s 
Treatment decision adjuvant 
therapy in low tumor severity cases 
l:58%-C:87% p<0.01 
Quality of life (QLQ-C30) η s 
Patient Satisfaction n.s. 
Distress: Anxiety (STAI), 
Depression (CESD), Helplessness 
(HH) n.s. 
Quality of life (FACT-G) η s. 
Satisfaction with orientation 
F(1,76)=4.01, p=0 049 ; overall n.s 
Questions Asking F(1,77)=3.97, 
p=0.05 
Anxiety (STAS) η s 
Satisfaction (Roter) n.s. 
Questions Asking (13 ν 9;t=-2.6, 
p=0 009) 
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making style η s 
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up) 
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needed, 1 year) 
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discharge 
after dram 
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and oral information 
and encouraged to 
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Communication skills 
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Control 
Usual care: 
only 
discharge 
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Usual Care 
Usual Care 
Outcomes and Effects 
Intervention (I) - Control (C) 
Quality of Life (QLQ-C30) n.s. 
Performance status (WHO) n.s. 
Satisfaction with cooperation I 
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decreased after six months 
Contacts with GP's I had more 
contacts both at 3 (p=0 049) and 6 
months (p=0 046) 
Anxiety (HADS) 24 hours I less 
anxious -5.7 p<0.0001 ; n.s. diff at 3 
weeks and 3 months 
Costs 32 pound more per patient 
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radiological staff costs) 
Communication Skills (e.g. focused 
questions, open questions) 
Improved 3 4 % (p=0.003) 
Quality Criteria * 
V) 
Q. 
S 
2 
o 
Li. 
D 
ND 
D 
E 
o 
υ 
η 
ra 
"δ 
α 
CM 
D 
D 
NC 
e 
.2 ra 
υ
 c 
Β E 
9 3 
ri 8 
NC 
D 
D 
C 
Φ 
1 ε 11 
* E 
ND 
D 
D 
o 
e 
rä ^ 
8 1 
8S 
ra = 
m ra 
D 
D 
D 
U) 
o 
8 
Ë 
M 
η 
_ l 
3/5 
4/5 
4/5 
Author (year) 
Country 
Moore (2002) 
UK 
Sepucha 
(2002) 
USA 
Davison (2002) 
Canada 
Study 
design 
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Control) 
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(202: 99-103) 
Breast Cancer 
132;42-52 
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749,367-367 
Intervention 
(intensity; follow-
up) 
Nurse-led follow up 
(monthly contact and 
if needed; 12 
months) 
Consultation 
planning session for 
patients (CP) 
(once; 20 min, ?) 
Computer generated 
Information and 
personal decision 
profile for patients 
(once, 15 min; 1 day) 
Control 
Usual Care-
conventional 
medical 
follow up 
Proactive 
listening 
Consultation 
with 
Research 
Nurse 
talking about 
general 
issues 15 
mm 
Outcomes and Effects 
Intervention (1) - Control (C) 
Quality of Life (QLQ-C30) 3/14 
items improved sign, in l-group at 
12 months 
Patient's satisfaction I higher at 
3,6,12 months p<0 01 
GP's satisfaction n.s 
Survival n.s. 
Costs η s 
Use of resources I more likely to die 
at home or hospice (p-0.04), fewer 
consultations with doctor first 3 
months (p=0 004), fewer 
radiographs during first 6 months 
(p=0.04) and mor radiotherapy in 
first 3 months (p=0 01) 
Communication barriers both sign 
reductions and n.s 
Satisfaction with intervention, I: 6.4 
-C:3.9p<0.001 
Physicians sign, higher satisfaction 
with CP; I· 4 . 4 - C : 3.1 p<0.01 
Satisfaction with medical 
consultation (PSQ) n.s. 
Achieved preferred decisional role 
(CPS) 
I 66%-C 80% 
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design 
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Study 
population 
Sample Size 
(total: 
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Control) 
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Breast, colon or 
lung cancer 
receiving 
chemotherapy 
125;55-54 
Breast Cancer 
stage 1 
61;30-31 
Intervention 
(intensity; follow-
up) 
Graphic summary 
profile with Quality of 
life information(QLQ-
C30) for patients and 
their physicians 
Computer-based 
nursing intervention 
for information, 
coordination and 
emotional support 
(9 visits (5 in person 
and 4 by 
telephone),! month 
after intervention) 
Patient-initiated 
follow-up· written 
information on signs 
and symptoms and 
advice to contact 
specialized nurse 
(?; 1 year) 
Control 
No HLQL-
information 
Usual Care; 
no extra 
visits 
Usual Care 
Standard 
clinical 
follow-up 
Outcomes and Effects 
Intervention (1) - Control (C) 
Discussion of Quality of life -issues; 
1:4.5-C:3.7p=0.01 
Physician's awareness of patients 
health problems (COOP and 
WONCA) n.s. 
Patient satisfaction n.s. 
Physician satisfaction with 
consultation was high in both 
groups n.s. 
Quality of life (SF-36) η s 
Duration of the visit η s 
Psychosocial funtionmg (SF-36) 
η s 
Anxiety (STAI) minor initial effect, 
not sign 1 month after intervention 
Depression (CESD-20) minor initial 
effect, not sign. 1 month after 
intervention 
Quality of Life (QLQ-C30) n.s. 
Anxiety and Depression (HADS) 
η s 
Satisfaction with follow-up η s. 
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Author (year) 
Country 
Barry (2002) 
UK 
Goel(2001) 
Canada 
Molenaar 
(2001) 
The 
Netherlands 
Faithfull (2001) 
UK 
Williams (2001) 
UK 
Study 
design 
RCT 
RCT 
CBA 
RCT 
RCT 
Study 
population 
Sample Size 
(total: 
Intervention-
Control) 
Gastric cancer 
110;60-50 
Breast Cancer 
(136.86-50) 
Breast Cancer 
stage I and II 
(180,92-88) 
Prostate and 
bladder cancer 
receiving radical 
radiotherapy 
(115:58-57) 
Various Cancers 
(501:251-250) 
Intervention 
(intensity; follow-
up) 
Radiologist working 
within a MDT 
Decision aid format 
audiotape and 
workbook 
(once; 6 months) 
Interactive CD-rom 
as decision aid for 
patients 
(7 mm, 9 months) 
Nurse-led follow-up 
(2x1 hour clinic visit 
and if needed; 12 
weeks) 
Patient-held booklet 
used by patients and 
professionals 
(once; 6 months) 
Control 
Usual Care: 
Radiologist 
not part of 
MDT 
pamphlet 
with identical 
information 
Usual Care: 
oral 
information 
and 
brochures 
Usual Care: 
routine 
medical 
follow-up 
Usual Care 
Outcomes and Effects 
Intervention (1) - Control (C) 
Agreement between CT-stage and 
histopathological stage 
T, 10 314 p=0.008 - C:0.088 
p=0.426 
Ν 1:0.350 p= 0.0001-C:0.102 
p=0.078 
M 0.255p=0.02-C-0.019 
p=0 808 
Anxiety (STAI) η s 
Knowledge (BCIT-r) n.s 
Decisional conflict (DCS) lower in 
l-group but not sign. 
Treatment decision n.s effect 
Satisfaction with information p<0.01 
Satisfaction with treatment decision 
p<0.00 
Quality of Life (MOS-20) p<0.01 
and specific (QLQ-BR23) p<0 05 
Morbidity (RTOG) η s 
Quality of Life (QLC-C30) n.s. 
Satisfaction with care (NSNS) both 
high I 97.5-C:85.0 p<0.002 
Costs I 3 1 % reduction p<0.001 
Quality of Life (QLQ-C30) π s 
Resource use n.s. 
Consultation time n.s. 
Quality Criteria * 
in 
a. 
1 
Ö 
Li. 
D 
ND 
D 
D 
ND 
in 
a 
E 
8 
3 
Ο 
η 
!3 
ω 
CM 
D 
D 
NC 
D 
D 
§ 1 
11 
o ra 
co o 
D 
NC 
D 
ND 
ND 
Έ 
Ι 1 
II 
^ E 
ND 
D 
D 
D 
D 
ο 
e 
υ 
E 
S e 
= •1 
8§ 
ro = 
m ra D 
D 
D 
D 
D 
in 
ê 
c 
8 
ra 
Ë 
_ l 
4/5 
3/5 
4/5 
4/5 
3/5 
Author (year) 
Country 
Brown (2001) 
McCorkle 
(2000) 
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The 
Netherlands 
Helgesen 
(2000) 
Sweden 
Study 
design 
RCT 
RCT 
RCT 
RCT 
Study 
population 
Sample Size 
(total: 
Intervention-
Control) 
Various Cancers 
(318.79-81-158) 
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older patients 
discharged after 
surgery 
(375 190-185) 
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(201 105-96) 
Prostate Cancer 
(400,200-200) 
Intervention 
(intensity; follow-
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1 Question promt 
sheet for patients 
(qps) and passive 
doctor 
2. qps and active 
doctor 
(15min;10days) 
Home visits and 
telephone calls by 
specialist nurse 
(3 home visits and 5 
times telephone 
contact, 44 months) 
Audiotape of 
consultation 
(once. 3 months) 
Follow-up by 
specialist nurse 
(every month for 6 
months,3 years) 
Control 
3 No 
question 
promt sheet 
Usual follow-
up care in 
ambulatory 
setting 
Taped but 
not given 
Usual Care 
follow-up by 
urologist 
Outcomes and Effects 
Intervention (1) - Control (C) 
Total numbers of questions asked 
n.s. diff in total but more on 
prognosis p=0.039 
Anxiety (SAS) n.s. 
Satisfaction both high n.s. 
Death 1. 2 2 % - C: 2 8 % 
Increased survival among late 
stage patients (p=0.002) 
Patient Satisfaction (PSQ) 1 higher 
F=2.39 p<0.05 
Recall of information 1 higher 9/9 
items p<0 01 
Quality of Life (RSC) n.s. 
Patient satisfaction n.s. 
Anxiety and Depression (HADS) 
η s 
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Safety complication frequency η s 
and lag time (symptom-
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Abstract 
Background: For the purpose of making improvements, we developed indicators of 
patient-centred cancer care and tested them on a population of patients with non-
small cell lung cancer (NSCLC). 
Methods: We extracted recommendations for patient-centred care from clinical 
guidelines and interviewed patients to develop indicators for assessing the patient-
centredness of cancer care. These indicators were tested with regard to some 
clinimetric characteristics on 132 patients with NSCLC treated in six hospitals in 
the east Netherlands. Data were collected with questionnaires among patients. 
Results: Eight domains of patient-centred cancer care were extracted from 61 
oncology guidelines and 37 patient interviews and were translated into 56 
indicators. The practice test among patients with NSCLC showed most room for 
improvement within the domains "emotional and psychosocial support", "physical 
support", and "information supply". Overall, 26 of the 56 indicators met all required 
clinimetric characteristics. 
Conclusion: Patient-centredness can be assessed with the set of indicators 
developed in this study. 
Practice implications: Developing a valid set of general patient-centred indicators 
is an initial step toward improving the patient-centredness of cancer care. The 
general set of indicators developed in this study may be useful for future quality 
assessments for patients with cancers and other chronic diseases. 
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Introduction 
As a cause of death in the US and Europe, cancer is exceeded only by 
cardiovascular disease.12 Earlier diagnosis, improved treatment modalities, and 
enhanced supportive care results in cancer more and more taking on the 
characteristics of a chronic disease.3 The management of care for cancer patients 
is complex. First, cancer has a very significant impact on the patient's physical, 
emotional, and social well-being. Second, various professionals are involved in 
prevention, diagnosis, treatment, and follow-up. This complexity can lead to 
suboptimal care and result in discontinuity and fragmentation of care.4"7 Integrated 
care can help to solve this problem.8"10 
The essence of integrated care is that care is organized around the physical, 
social, and emotional needs and preferences of patients (patient perspective 
style), and that patients are actively involved in their own care (patient activation 
style).11,12 This all has to do with patient-centredness. Important patient outcomes, 
such as satisfaction, physical health and well-being, and quality of life are related 
to the patient-centred approach.12,13 The 'patient perspective' style is associated 
with improved patient satisfaction and the 'patient activation' style is more closely 
associated with better physical health outcomes.11,12 
Literature shows that patient-centredness of cancer care can be improved in 
several ways, such as supportive care, communication, information supply, and 
cooperation among physicians.14"16 The first step in improving the quality of 
patient-centredness of cancer care is to reliably assess current practice.17 
However, assessing the quality of patient-centred care is not straightforward, and 
selecting appropriate indicators applicable to all patients with cancer, is difficult. 
Most evidence-based guidelines on cancer care provide some recommendations 
for good quality of patient-centredness. The available recommendations from 
these guidelines should be combined with opinions of the patients themselves to 
assess additional aspects for which evidence alone is insufficient or absent.18,19 To 
measure patient-centredness, "patient-centred"- recommendations in these 
guidelines and recommendations from patients need to be translated into - so-
called quality indicators. Quality indicators are measurable elements of practice 
performance for which there is evidence or consensus that they can be used to 
assess the quality of care.20 However, to our knowledge, quality indicators for 
measuring patient-centredness of cancer care, based on evidence based 
guidelines and opinions of patients do not exist. 
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For the assessment of their feasibility, the quality indicators should be tested for 
important clinimetric characteristics such as opportunity for improvement, 
applicability, and discriminating capacity.1819'21 Therefore, our aim was to develop 
a general set of quality indicators for measuring patient-centred cancer care on the 
basis of evidence-based cancer guidelines and the opinions of patients. The 
indicators were tested in a population of patients with non-small cell lung cancer 
(NSCLC) for various clinimetric characteristics, namely, room for improvement, 
applicability, discriminating capacity and reliability. 
Methods 
Development of indicators 
The development of indicators started with a search for evidence-based guidelines 
regarding the management of patients with all types of cancer. We searched the 
two largest English-language national databases for evidence-based guidelines 
[UK: National Institute for Health and Clinical Excellence (NICE); USA: Agency for 
Healthcare Research and Quality (AHRQ)] and the Dutch oncology database 
(Oncoline).22"24 One researcher extracted all the recommendations from the 
guidelines that had to do with organizing care around the physical, social and 
emotional needs and preferences of patients or with involving patients in their 
care. With a semi structured method, we interviewed 30 patients with head and 
neck cancer, as well as all seven patient representatives from the Dutch national 
association of patients with lung cancer. The patients and their representatives 
were asked to rate the importance of the patient-centred recommendations from 
the guidelines, on a nine-point Likert scale. They were also given a chance to add 
new items. All recommendations with a mean score of 8 points or more were 
included in the final set. Domains were extracted from the guidelines and two 
researchers classified all the recommendations into the domains of patient-
centredness. Two researchers translated the recommendations into indicators 
(Table 2). A panel of four researchers judged the translation process from 
recommendation to indicator (Figure 1). 
Practice test 
The indicators were reflected in a questionnaire for cancer patients. In the 
questionnaire patients were asked for their actual experiences with care and not 
for their satisfaction. The questionnaire was tested in a group of 132 patients with 
NSCLC. This practice test took place in six hospitals in the Dutch Eastern 
Comprehensive Cancer Centre region. After the ethics committee of the Radboud 
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University Medical Centre in Nijmegen, the Netherlands, approved the study, we 
included all consecutive patients newly diagnosed with NSCLC during a 6-month 
period from September 2004 to February 2005. The staff members of the Eastern 
Comprehensive Cancer Centre retrospectively included the patients by pathology 
diagnosis. The pulmonologist at each hospital screened patient records to check 
whether patients had died. The researchers sent the questionnaires to the 
patients, in a way that ensured patient anonymity, after the inclusion period had 
ended. The questionnaires were accompanied by a letter from each patient's own 
pulmonologist. A reminder was sent to each patient who had not replied after 2 
weeks. 
The following clinimetric characteristics of the patient-centred indicators were 
assessed: "room for quality improvement", "applicability", and "discriminating 
capacity".25 Indicators must be capable of detecting improvements in the quality of 
care. If, for example, indicator performance is invariably high, there is little room for 
improvement. We considered that room for improvement was limited when the 
score on an indicator was 90% or higher.21 Applicability was measured in the 
percentage of patients on which the indicator was applicable. Applicability was 
considered poor if this percentage was less than 75%.19'21 When the range 
between the lowest and highest hospital scores is broad (we assumed 20% or 
more), an indicator has discriminating potential and is sensitive in detecting 
differences.25 
Ultimately, all indicators that fulfilled the clinimetric criteria were tested on reliability 
regarding the eight domains of patient-centredness by calculating Cronbach's 
alpha coefficients for the domains. A Cronbach's alpha score of 0.7 or more is 
usually regarded as indicative of acceptable reliability.26 
Results 
Development of indicators 
We found 61 evidence-based oncology guidelines in the three databases, from 
which we extracted 56 recommendations. Patients or their representatives who 
were interviewed (n=37) found all the recommendations important (mean score of 
8 or more), so all of them were included.20 Adding patient opinions had added 
value concerning criteria for waiting times and information supply. The guidelines 
often recommended speeding up the diagnosis and starting treatment where 
possible. However, they provided hardly any concrete information about 
acceptable waiting times. The criteria for waiting and throughput times in our study 
came from the patient interviews as answers to the question of acceptable waiting 
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times. Furthermore, the patients added three specific information items, namely, 
"information about the possible course of the disease", "the possibility of a second 
opinion", and "information about the treatment option of no active therapy" (see 
note under Table 3). There were eight domains of patient-centredness: "access", 
"follow-up", "communication and respect", "patient and family involvement", 
"information", "coordination", "physical support", and "emotional and psychosocial 
support". The domains most often mentioned in the guidelines were "follow-up" 
(38%), "emotional and psychosocial support" (34%) and "multidisciplinary patient 
care team" (30%). The least mentioned domain was "paramedical support e.g. 
dietician" (10%; Table 1). 
Table 1. Patient-centred domains in 61 general oncology guidelines* 
Oncoline 
n = 14 
AHRQ NICE Total 
n = 36 / i=11 n = 61 
Access to care 
Follow-up 
Communication and respect 
Patient and family involvement 
Information 
Coordination 
Speciahsts/Multidisciplmary patient care team 
Oncology nurse with case management tasks 
Paramedical support 
Physical support (pain, nausea, etc ) 
Emotional and psychosocial support 
η 
1 
12 
2 
2 
4 
4 
2 
3 
3 
9 
% 
7 
Θ6 
14 
14 
29 
29 
14 
21 
21 
64 
η 
2 
13 
6 
4 
5 
5 
5 
4 
6 
% 
6 
36 
17 
11 
14 
14 
14 
11 
17 
η 
5 
6 
2 
2 
6 
9 
6 
3 
5 
6 
% 
45 
55 
18 
18 
55 
82 
55 
27 
50 
55 
η 
8 
23 
10 
8 
15 
18 
13 
6 
12 
21 
% 
13 
38 
16 
13 
25 
30 
21 
10 
20 
34 
*The table shows the number of times a patient-centred domain was mentioned in the guideline, e g recommendations 
on follow-up were mentioned in 38% of all guidelines (23 of 38) 
AHRQ, Agency for Healthcare Research and Quality, NICE, National Institute for Health and Clinical Excellence 
All the recommendations were translated into a set of 56 indicators (Figure 1). 
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Figure 1. Study design 
Search for evidence-based cancer guidelines NICE, AHRQ, Oncolme 
η = 61 
* 
Extraction of patient-centred recommendations 
π =56 
4 
Semi structured interviews with patients for patient opinions and additions 
Classification of the recommendations into patient-centred domains 
n = 8 
Translation of the recommendations into 56 indicators 
reflected in a questionnaire 
* 
Practice test of the 56 indicators on: 
improvement potential, applicability, and discriminating capacity 
ί 
26 Indicators met all required climmetric characteristics 
based on 26 recommendations 
Practice test 
Study population 
During the study period of six months a population of 276 patients with NSCLC 
could be included. However, as many patients with NSCLC die within months after 
diagnosis, we were only able to send 132 of the 276 patients a questionnaire. 
All patients received the questionnaire 2 to 6 months after their first visit to the 
pulmonologist. One hundred of the 132 returned the questionnaire (76%). The 
responders (n=100) and non-responders (n=32) did not significantly differ in sex, 
age, and disease stage. 
Clinimetric characteristics: room for improvement 
The least room for improvement was found within the domains "communication 
and respect" (mean score of 95% and all indicators in this domain scored 89% or 
more), followed by the domain "patient and family involvement" (mean score of 
84% and individual scores of 71% or more; Table 2). 
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Table 2. Scores and clinimetric characteristics of the patient-centred cancer care indicators 
Domains of patient-centred cancer care 
Total η = 100 
1.ACCESS (mean score 68 %) 
Waiting time lung specialist < 5 days 
Waiting time start treatment < 35 days* 
Waiting time diagnostic procedures < 21 days* 
Waiting time general practitioner < 2 days 
2.FOLLOW-UP (mean score 81%) 
Home care knows about the patient's situation 
Patient knows which activities are allowed at home* 
Patient knows which side effects to be aware of * 
Patient knows when to contact the primary care doctor or specialist* 
Patient knows at discharge which medication to take and why 
The primary care doctor knows about the patient's situation 
Patient follow-up takes place on an agreed schedule 
Specialist has enough time during consultations 
Patient can reach the specialist between consultations 
3.COMMUNICATION AND RESPECT (mean score 95%) 
Specialists showed interest in you as a person* 
Specialists talked to others as if you were not there 
Nurses talked as if you were not there 
Nurses showed interest in you as a person 
Patient trusts in the specialists 
Patient trusts the nurses 
Patient feels respected during treatment 
4.PATIENT AND FAMILY INVOLVEMENT (mean score 84%) 
Nurses involved family and friends during care and follow-up* 
Specialists involved family and friends during treatment and follow-up* 
Specialists shared the decision making with the patient* 
Family and friends had opportunities to ask the specialists questions* 
Family and friends had opportunities to ask the nurses questions* 
Patient had the knowledge and support to make decisions 
Patient had opportunities to ask questions * 
Specialists discussed aim and follow-up of treatment with the patient 
S.INFORMATION (mean score 68%) 
Patient received information on all 10 information items* 
Patient received written information* 
Patient received clear answers from the nurses 
Patient received contradictory information 
Patient received clear answers from the specialists* 
6.COORDINATION (mean score 71%) 
COORDINATION SPECIALISTS (mean score 87%) 
Specialists involved knew patient's history 
Patient knew how to reach specialists* 
Patient knew about being discussed in a multidisciplmary team of 
specialists* 
Specialists involved took care of the coordination* 
Patient knew which specialist is his mam contact person 
COORDINATION. SPECIALIZED NURSE(S) (mean score 55%) 
Oncology nurse was present during bad-news consultation* 
Existence of an oncology nurse was known by patient* 
Patient knew how to reach oncology nurse* 
Oncology nurses knew patient's history 
Oncology nurses took care of the coordination 
Score 
% 
49 
62 
71 
90 
46 
70 
73 
77 
89 
92 
95 
95 
94 
89 
95 
96 
96 
97 
97 
98 
71 
82 
82 
83 
86 
88 
89 
92 
19 
75 
77 
79 
90 
83 
84 
85 
87 
95 
36 
53 
53 
61 
71 
Room for 
improve­
ment % 
51 
38 
29 
10 
54 
30 
27 
23 
11 
8 
5 
5 
6 
11 
5 
4 
4 
3 
3 
2 
29 
18 
18 
17 
14 
12 
11 
8 
81 
25 
13 
11 
10 
17 
16 
15 
13 
5 
64 
47 
47 
39 
29 
Applica­
bility 
100 
100 
100 
100 
64 
91 
86 
98 
94 
93 
98 
100 
83 
99 
95 
93 
97 
98 
96 
99 
98 
97 
97 
94 
89 
97 
98 
99 
95 
99 
97 
94 
100 
94 
100 
100 
75 
100 
100 
93 
100 
29 
50 
Range 
% 
42-56 
40-80 
50-89 
82-100 
14-80 
57-86 
55-100 
57-100 
83-100 
83-100 
87-100 
93-100 
89-100 
67-100 
91-100 
91-100 
86-100 
91-100 
86-100 
91-100 
61-100 
73-100 
67-100 
60-100 
76-100 
82-100 
76-100 
87-100 
17-57 
64-86 
83-100 
85-100 
77-100 
75-94 
65-100 
67-100 
73-100 
87-100 
21-63 
33-86 
46-86 
38-100 
50-100 
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Domains of patient-centred cancer care 
Total η = 100 
COORDINATION PARAMEDICS (mean score 70%) 
Patient knew how to reach paramedic professionals 
Paramedic professionals involved knew patient's history 
Paramedic professionals involved took care of the coordination 
/.PHYSICAL SUPPORT (mean score 58%) 
Patient got support for daily activities at home 
Patient got support to control physical complaints* 
Patient got support for daily activities in the hospital 
8.EMOTIONAL AND PSYCHOSOCIAL SUPPORT (mean score 46%) 
Patient was offered contact with companion in distress* 
Patient was asked whether he had psychological complaints* 
Patient was asked whether he had problems with living conditions* 
Patient received support from specialized caregivers in mental health 
if needed 
Specialist asked patient about fear and mental state* 
Patient received emotional support from nurses if needed 
Patient received emotional support from specialists if needed 
Score 
% 
55 
76 
80 
36 
58 
80 
13 
34 
36 
39 
52 
74 
74 
Room for 
improve­
ment % 
45 
24 
20 
74 
42 
20 
87 
66 
64 
61 
48 
26 
26 
Applica­
bility 
61 
62 
43 
72 
89 
88 
100 
83 
85 
28 
88 
65 
60 
Range 
% 
36-100 
53-100 
50-100 
10-40 
25-78 
73-92 
0-43 
18-60 
23-60 
0-100 
32-100 
63-100 
46-100 
'Indicator that met all clinimetnc characteristics 
Most room for improvement was found within the domains "physical support", 
"emotional and psychosocial support", and "information". Patients did get physical 
support during hospital stay (80%), but hardly any at home (36%), and only 58% of 
the patients felt that they had received enough support to control their physical 
complaints of pain, suffocation, nausea, weight loss, insomnia, tingling, and blood 
coughs. About one-third of the patients stated that they were asked if they had 
psychological complaints or had problems with living conditions, but only 39% of 
the patients who needed support from specialized caregivers in mental health 
actually got this care (Table 2). Regarding information, only 19% of the patients 
stated that they received enough information about all 10 information items. The 
information items mentioned most often were "aim and follow-up of diagnostic 
procedures", "treatment options and pros and cons"; the items mentioned least 
were "availability of emotional support", "opportunity of contacting a companion in 
distress" and "the possibility of a second opinion". Overall, 44 of the 56 indicators 
(79%) had an improvement potential of 10% or more (Figure 2). 
Clinimetric characteristics: applicability 
We found that 10 of the 56 indicators were applicable on less than 75% of the 
population. Low applicability scores were found for some indicators regarding 
"oncology nurses", "patients in need of specialized mental care who actually 
received this support", "involvement of paramedical professionals", and 
"involvement of home care". Overall, 46 indicators had good applicability 
(Figure 2). 
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Figure 2 The 56 indicators and their clinimetnc characteristics 
Room for improvement η = 44 Applicability η = 46 
Range η = 36 
Clinimetnc characteristics discriminating capacity 
Our study showed that 36 indicators had scores with a range of 20% or more 
between the highest and lowest scoring hospitals (Figure 2) The largest ranges 
between the six hospitals were for the indicators "patients receive support from 
specialized caregivers in mental health if needed" (the lowest hospital score was 
0% and the highest, 100%) and "specialist asked patient about fear and mental 
state" (the lowest hospital score was 32% and the highest, 100%) 
Clinimetnc characteristics reliability 
The best indicators for quality improvement are those that have more than 10% 
room for improvement, good applicability (75% or more), and good discriminating 
capacities (at least 20% difference between lowest and highest scoring hospitals) 
In our study, 26 of the 56 indicators had all the required clinimetnc characteristics 
(Figure 2) They cover eight domains of patient-centredness as shown in Table 2 
The recommendations on which these indicators are based are shown in Table 3 
Seven of these eight domains had a Cronbach's alpha of 0 67 or more and the 
reliability is acceptable The domain "coordination specialists" had an alpha of 
0 22 (Table 3) 
70 
Measuring patient-centred cancer care 
Table 3. Recommendations for patient-centred cancer care tested on patients with non-small cell 
lung cancer 
Access 
• Patient receives all necessary diagnostic procedures within 21 days after his first visit to 
the specialist 
• Patient starts his treatment within 35 days after his first visit to the specialist 
Follow-up 
• Patient knows which side effects to be aware of at home 
• Patient knows which activities are allowed at home 
• Patient knows when to contact the primary care doctor or specialist 
Communication and respect 
• Specialist shows interest in the patient as a person 
Patient and family involvement 
• Nurses involve family and friends during care and follow-up 
• Specialists involve family and friends during treatment and follow-up 
• Specialists share the decision making with the patient 
• Family and friends have opportunities to ask the specialists questions 
• Family and friends have opportunities to ask the nurses questions 
• Patient has opportunities to ask questions 
Information 
• Patient receives information on all 10 items if applicable* 
• Patient receives written information on all applicable items* 
• Patient receives clear answers from the specialists 
Coordination: specialists 
• Patient knows how to reach the specialists 
• Patient knows being discussed in a multidisciplmary team of specialists 
• The specialists involved take care of the coordination 
Coordination: oncology nurse(s) 
• An oncology nurse was present during the bad-news consultation 
• Patient knows that nurses specializing in oncology exist 
• Patient knows how to reach the oncology nurse 
Physical support 
• Patient gets support to control physical complaints such as pain, suffocation, nausea, 
blood coughs, tingling, weight loss, and insomnia 
Emotional support 
• Patient is offered contact with a companion in distress 
• Patient is asked about psychological complaints 
• Patient is asked whether has problems with living conditions 
• Specialist asks the patient about possible fear and mental state 
Alpha 
coefficient 
0.87 
0.78 
0.85 
0.78 
0.22 
0.68 
0.67 
* Aim and follow-up of diagnostic procedures, treatment options and pros and cons, treatment option 'no active 
therapy', estimation of possible course of illness, possible loss of weight during treatment and the importance of 
eating well, options for pain medication, options for anaesthesia in case of operation, opportunities for emotional 
support, companion in distress, possibility of a second opinion 
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Discussion and conclusion 
Discussion 
Patient-centredness is an important principle for delivering high-quality integrated 
care. Before patient-centredneses can be improved it must be assessed with a 
valid set of indicators. 
The development of a valid set of patient-centred indicators applicable to all 
patients with cancer is an initial step toward improving the patient-centredness of 
cancer care. In our study we developed 56 patient-centred indicators covering 8 
domains of patient-centred cancer care. These domains were variably found in the 
guidelines included. The indicators were evaluated in a practice test on the 
following clinimetric characteristics: room for improvement, applicability, and 
discriminating capacity and reliability. Twenty-six of the 56 patient-centred cancer 
care indicators met all required clinimetric characteristics and were tested on 
reliability. 
The eight domains of patient-centred cancer care correspond to patient-centred 
care dimensions mentioned by others.27-28 We recommend that specific domains 
for patient-centredness should always be addressed in clinical guidelines for the 
management of patients with cancer, as for example the domains mentioned in 
this study. Although the literature shows that oncology guidelines have significantly 
higher scores for consideration of patients' views than guidelines for other patient 
groups29, we found a large variation within oncology covering patient-centred 
issues. The relatively few patient-centred recommendations in some guidelines 
may be due to the fact that patients are often not involved during guideline 
development. However, this is one of the key criteria for good clinical guidelines as 
proposed by the AGREE collaboration.30 We believe that involving patients both 
during guideline development and indicator development may improve patient-
centredness. In our study, involving patients during indicator development resulted 
in some additional information items that would not otherwise have been noticed 
as information items and criteria for waiting and throughput times. 
The literature provides only a few studies about indicator development3132, and our 
study is the first in which a general set of patient-centred cancer care indicators is 
developed and tested. Our study reveals the importance of subjecting a set of 
indicators to a practice test. The usefulness of a quality indicator depends on 
different clinimetric characteristics. Indicators that have invariably high scores have 
little room for improvement. Other criteria for good indicators are "applicable to a 
large part of the population" and "high variation between hospitals". 
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In line with other studies, our practice test regarding patients with NSCLC showed 
that patients reported poor management and evaluation of their physical 
symptoms and psychosocial problems, and they were also not fully informed.14"16 
Cancer is a serious and life-threatening illness, especially for patients with NSCLC, 
because the disease is most often incurable.33 The impact of lung cancer and its 
symptoms on the patient's psychological, social, and physical state should be 
identified early, and patients should be referred to the appropriate specialist for 
further assessment, if needed. The literature shows that screening lists for quality-
of-life issues could be helpful34, and that structured follow-up by nurses can 
improve psychosocial functioning.35 Failure to provide sufficient information about 
disease-related issues is the most frequent source of patient dissatisfaction.36 A 
good information supply has positive effects on patient satisfaction and quality of 
life.37 Suggested interventions in the literature to make sure that patients are 
informed properly include printed material38, consultation preparation packages39, 
and audiocassettes of consultations.40 
This study shows an original and innovative approach to the development and 
testing of indicators for patient-centredness in cancer care using recommendations 
from evidence-based guidelines and including opinions of patients. However, the 
patient-centred indicators were measured with questionnaires among patients. 
Obviously, the subjective opinion of patients may have biased the outcome to a 
certain degree. The outcome of treatment and the stage of the disease may have 
had a negative impact on the recall of initial conversations with the physician. To 
deal with this, we asked patients for their actual experiences of clinical care, as 
suggested in the literature and not for their satisfaction with care provided.41 It 
should be noted that the literature is contradictory about the influence of patient 
characteristics on their assessements of care.28 42'43 
Conclusion 
In conclusion, the development of a valid set of patient-centred indicators is an 
initial step toward improving the patient-centredness of cancer care. Indicators can 
be based on recommendations from guidelines but adding patient opinions leads 
to a more complete picture of patient-centredness. In this study we developed and 
tested a general set of patient-centred indicators; many of them appeared to be 
useful for patients with NSCLC. 
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Practice implications 
General oncology guidelines vary large covering patient-centred 
recommendations. The recommendations on which the set of indicators of this 
study is based should be incorporated in cancer guidelines. Our set of indicators 
may also be useful for future quality assessments for other patients with cancers 
or chronic diseases. Therefore, the indicators of this study should be tested in a 
practice test on other patient groups to see which indicators also apply to them. 
Our study showed that patient-centredness for patients with NSCLC can be 
improved especially within the domains "emotional and psychosocial support", 
"physical support", and "information supply". Successful activities to improve 
patient-centredness (e.g. follow-up by specialized nurses or consultation 
preparation for patients) should be implemented to improve care for patients with 
cancer. 
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Abstract 
Objective: To test the validity, reliability and discriminating capacity of an 
instrument to assess team climate, the Team Climate Inventory (TCI), in a sample 
of Dutch hospital teams. The TCI is based on a four-factor theory of team climate 
for innovation. 
Design: Validation study. 
Setting: Hospital teams in the Netherlands. 
Participants: 424 health care professionals; 355 nurses working in 22 nursing 
teams and 69 nurses and doctors working in 14 quality-improvement teams. 
Main outcome measures: Exploratory and confirmatory factor analyses, Pearson's 
product moment correlations, internal homogeneity of the TCI scales based on 
Cronbach's alpha, and the TCI capability to discriminate between two types of 
health care teams, namely nursing teams and quality-improvement teams. 
Results: The validity test revealed the TCI's five-factor structure and moderate 
data fit. The Cronbach's alphas of the five scales showed acceptable reliabilities. 
The TCI discriminated between nursing teams and quality-improvement teams. 
The mean scores of quality-improvement teams were all significantly higher than 
those of the nursing teams. 
Conclusion: Patient-care teams are essential for high-quality patient care, and 
team climate is an important characteristic of successful teams. This study shows 
that the TCI is a valid, reliable, and discriminating self-report measure of team 
climate in hospital teams. The TCI can be used as a quality-improvement tool or in 
quality-of-care research. 
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Introduction 
Optimal collaboration between professionals is important for offering continuous 
and coordinated care A patient-care team that functions well is crucial for 
providing high-quality care for patients.1^ Team functioning is not only determined 
by structural determinants such as workload, team size, or team composition5,6, 
but also by team processes. There is a large body of research on the relationship 
between team processes and team effectiveness7"14, which shows that a team 
climate in which team members are encouraged to develop and implement new 
ideas can lead to better health care and health care outcomes. 
West presents the most studied model of this "team climate aimed at innovation" 
and suggests that four climate factors, "vision", "participative safety", "task 
orientation", and "support for innovation", are essential for developing and 
implementing innovations.12 This theoretical model led to the development of a 
questionnaire to measure team climate, the Team Climate Inventory (TCI). The 
TCI has been used as an improvement tool for assessing team function to identify 
areas that could be improved.15,16 In addition, it has been used in research as an 
outcome measure of quality-improvement strategies or to predict the success or 
failure of such a strategy.51718 See appendix for practical examples. 
The TCI has been translated into several languages including Norwegian19, 
Swedish20, Finnish21, Italian22, and German23, and it has been tested on many 
different teams (e.g. management, social services, psychiatric, oil company, 
industrial, and primary care teams; Table 1). Given this utilization of the TCI-tool in 
multiple countries and industries, it may become a helpful vehicle in the translation 
of learning among countries and industries. However, none of these studies tested 
the questionnaire specifically for hospital teams. 
Delivering integrated care is becoming more and more important for hospital 
teams, and a good team climate is crucial for delivering high-quality care and 
quality improvement in health care. Therefore, it is important to determine the 
psychometric characteristics of the TCI in this specific setting. 
The present study extends the research work on the TCI by investigating the 
psychometric properties of a Dutch version of the TCI on a population of hospital 
teams. In this paper, we describe how we systematically assessed the validity, 
reliability, and discrimination capacity of the TCI in hospital teams. 
79 
Chapter 4 
Table 1. Overview of tested versions of the Team Climate Inventory and some psychometric 
characteristics 
Population and study Psychometric Results 
ENGLISH, Anderson and West (1998)24 
155 individuals on 27 hospital management teams 
971 individuals on 121 teams 
(35 primary health care teams, 42 social service 
teams, 20 psychiatric teams, 24 oil company teams) 
Internal homogeneity (Cronbach's alpha) 0.84-0.94 
Exploratory factor analysis: 61 items -> 5 factors; 4 
factors possible 
Confirmatory factor analysis. 38 items -> 5 factors 
(4 are possible) 
Criterion validity is acceptable 
NORWEGIAN, Mathisen (2004)" 
1487 and 1436 individuals on 
195 industrial teams and 106 public sector teams 
Internal homogeneity (Cronbach's alpha) 0.83-0.94 
Exploratory factor analysis -> 5 factors 
Confirmatory factor analysis -> 5 factors 
SWEDISH, Agrell & Gustafson (1994)" 
124 individuals on 17 teams 
(production or management teams in public and 
private organisations) 
Internal homogeneity (Cronbach's alpha) 0 86-0.91 
Exploratory factor analysis -> 4 factors 
Criterion validity is acceptable 
FINNISH, Kivimaki (1997)" 
2265 individuals (number of teams unknown) 
(local government employees in health care and 
social service departments) 
EXTRA, in high-complexity teams, 'interaction 
frequency' is an extra factor 
Internal homogeneity (Cronbach's alpha) 0 83-0.94 
Exploratory factor analysis -> 5 factors in one 
sample 
Exploratory factor analysis -> 5 OR 4 factors in 
another sample 
Confirmatory factor analysis -> 5 factors 
Criterion validity not estimated 
ITALIAN, Ragazzoni (2002)" 
199 individuals on 27 teams 
(health care/rehabilitation centres 
386 individuals on 48 company teams 
Internal homogeneity (Cronbach's alpha) 0.56-0.91 
Exploratory factor analysis -> 5 factors 
Confirmatory factor analysis-^ not done 
Criterion validity not estimated 
GERMAN, Brodbeck (2001)" 
810 individuals on 146 teams 
(industrial production and administration, youth and 
family care, 15 nursing teams, software 
development, students) 
Internal homogeneity (Cronbach's alpha) 0.81-0.89 
Exploratory factor analysis -> not done 
Confirmatory factor analysis •> best fit 5 factors; 4 
factors possible 
Criterion validity acceptable 
Methods 
The TCI questionnaire and the Dutch translation 
The original 116-item TCI of West underwent exploratory and confirmatory factor 
analyses, which resulted in a 44-item version.15'24'25 The 44-item TCI includes four 
scales, "vision", "participative safety", "task orientation", and "support for 
innovation" and 13 subscales (Figure 1). The questionnaire includes a fifth scale 
that was designed to detect socially desirable answers. Four people used Beaton's 
guidelines26 to systematically and independently translate and back translate the 
TCI. One translator was a native-English speaker fluent in Dutch, and the other 
three were Dutch researchers fluent in English. 
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Figure 1. The Original Structure of the 44-item Team Climate Inventory 
Scales Sub-scales Items 
(Factors) (questions and their number) 
Participative 
Safety 
Support for 
Innovation 
Vision 
> 
1 Information Sharing 
2 Safety 
3 Influence 
4 Interaction Frequency 
- * three items 1-16-23 
5 Articulated Support 
6 Enacted Support 
7 Clarity 
θ Perceived Value 
9 Sharedness 
-fr 10 Attainability 
two items 7-13 
three items 3-8-19 
- • four items 5-14-20-26 
four items 2-10-21-24 
-• four items 6-11-17-25 
two items 27-31 
four items 28-33-34-35 
• three items 29-30-37 
• two items 32-36 
Task Orientation 
11 Excellence 
12 Appraisal 
13 Ideation 
two items 43-44 
• three items 39-40-41 
Social Desirability 
14 Social Desirability 
Social Aspect 
15 Social Desirability 
Task Aspect 
two items 38-42 
three items 9-12-18 
- • three items 4-15-22 
TOTAL 44 items 
Anderson and West/ASE (1999) NFER-NELSON, Darvill House, 2 Oxford Road East, Windsor, Berkshire, UK 
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Study population 
On the basis of a 10:1 ratio of participants to items27 for each of the 38 items in the 
questionnaire (excluding the six items for social desirability), we aimed at including 
380 health care professionals. Two types of hospital teams were invited to 
participate: monodisciplinary teams of nurses and multidisciplinary quality-
improvement teams. We contacted all the head nurses of the nursing teams at one 
university hospital and invited their teams to participate in the study. We contacted 
the facilitators of quality-improvement teams participating in national breakthrough 
collaboratives. Participation was voluntary. 
Procedure 
The Dutch TCI was handed to the contact person of each participating team. All 
members completed the questionnaire individually and anonymously. The 
respondents were asked to indicate on a five-point scale to what extent they 
agreed with each item. Each respondent returned the survey in a sealed envelope, 
which was sent to the researchers. 
Analyses 
As in the preceding TCI psychometric studies, the six social desirability items were 
excluded from analyses. 
Factor structure and intercorrelations 
To test the validity of the TCI in health care teams, we performed exploratory 
(principal component factor analysis, including a varimax rotation, using SPSS 
version 12) and confirmatory factor analyses (using LISREL), to see which items 
cluster together. Confirmatory factor analyses tested the robustness of the factor 
solution. LISREL is a statistical programme for structural equation modelling, a 
form of multivariate data analysis that tests the goodness of fit of the empirical 
data and a specified or hypothesised model. In order to evaluate the fit of the 
models, we examined five most used criteria [the chi-square (χ2, lower scores 
means better fit); the ratio of maximum-likelihood chi square (x2/df, scores from 2 
to 5), the goodness-of-fit index (GFI > 0.90), the Comparative Fit Index (CFI > 
0.95) and the root-mean-square error of approximation (RMSEA < 0.10)]. The 
confirmatory factors for the total sample and for the nursing and quality-
improvement teams were analyzed separately. Once we had defined the structure, 
we computed the Pearson's product moment correlations of the factors with the 
subscales that we identified. 
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Internal homogeneity 
To assess the reliability of de TCI in health care teams, we calculated the internal 
homogeneity by calculating Cronbach's alpha coefficients for the scales emerging 
from the factor analyses. A Cronbach's alpha score of 0.7 or higher is usually 
regarded as indicative of acceptable reliability.28 
Discriminating capacity 
To see if the TCI discriminates between different types of health care teams, we 
tested its ability to discriminate between nursing teams and quality-improvement 
teams. We tested the difference in the TCI scores for nursing teams and quality-
improvement teams with mixed model analysis in which we corrected for clustering 
in teams. 
Results 
Study population 
The study participants consisted of 424 health care workers: 355 were part of one 
of the 22 monodisciplinary hospital teams of nurses and 69 were part of one of the 
14 multidisciplinary quality-improvement teams. The nursing teams came from 22 
specialities in surgery, internal medicine, and childcare, and each team consisted 
of 10 or more people (mean 16; range 6-36). The improvement teams were 
breakthrough collaborative teams aiming at improving care for patients with 
diabetes, perioperative care, and care for patients with head and neck cancer. The 
multidisciplinary teams consisted of a minimum of three people (mean 5; range 3-
13) and each included at least one nurse and one physician. 
Factor structure and correlations 
Exploratory factor analysis 
The principal component factor analysis indicated that there should be five factors 
instead of the original four factors. These five factors together accounted for 60% 
of the total variance. Table 2 presents the items of the scales and their factor 
loadings on the five-factor solution, after varimax rotation. Overall, all items from 
the scales "vision", "support for innovation", and "task orientation" load on their 
theoretical scale except for item 38 ("provide each other useful ideas") which 
loaded higher on the scale "participation safety". The original scale "participation 
safety" fell apart into two scales: the first part contained all items of the subscales 
"interaction frequency" and "information sharing" and item 3 ("we all influence each 
other"); the second part consisted of all items of the subscales "safety" and 
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"influence" except for item 3. Two items besides item 38 had high factor loadings 
(Λ > 0.4) on one other factor than their theoretical scale, namely, item 1 ("share 
information rather than keeping it to oneself') and item 7 ("people feel understood 
and accepted by each other"). 
Table 2. Factor loadings for the Dutch version of the Team Climate Inventory in health care teams 
Scales 1 2 3 4 5 
1 VISION 
29 How far are you in agreement with these objectives' 0.798 
33 How worthwhile do you think these objectives are to you' 0 782 
34 How worthwhile do you think these objectives are to the 0 782 
organization' 
28 To what extent do you think they are useful and appropriate 0 744 
objectives? 
35 How worthwhile do you think these objectives are to the wider 0.744 
society' 
36 To what extent do you think these objectives are realistic and can be 0.722 
attained' 
27 How clear are you about what your team objectives are? 0.672 
32 To what extent do you think your team's objectives can actually be 0 670 
achieved' 
30 To what extent do you think other team members agree with these 0.651 
objectives' 
31 To what extent do you think your team's objectives are clearly 0.631 
understood by other members of the team? 
37 To what extent do you think members of your team are committed to 0 624 
these objectives 
2 PARTICIPATIVE SAFETY: interaction and information sharing 
14 We interact frequently 0.866 
05 We keep in regular contact with each other 0.837 
20 We keep in touch with each other as a team 0 790 
26 Members of the team meet frequently to talk both formally and 0.661 
informally 
23 There are real attempts to share information throughout the team 0.547 
16 People keep each other informed about work-related issues in the 0.529 
team 
01 We share information generally in the team rather than keeping it to 0 437 0.443 
ourselves 
03 We all influence each other 0.374 
3 SUPPORT FOR INNOVATION 
25 Team members provide practical support for new ideas and their 0.683 
application 
06 In this team we take the time needed to develop new ideas 0.669 
24 This team is always moving towards the development of new 0.666 
answers 
10 The team is open and responsive to change 0.663 
02 Assistance in developing new ideas is readily available 0.656 
21 People in this team are always searching for fresh, new ways of 0 604 
looking at problems 
11 People in the team co-operate in order to help develop and apply 0.487 
new ideas 
17 Members of the team provide and share resources to help in the 0.318 
application of new ideas 
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Scales 1 2 3 4 5 
4 TASK ORIENTATION 
41 Does the team critically appraise potential weaknesses in what it is 0.755 
doing in order to achieve the best possible outcome? 
40 Are team members prepared to question the basis of what the team 0.669 
is doing? 
44 Does the team have clear criteria which members try to meet in 0 580 
order to achieve excellence as a team? 
39 Do you and your colleagues monitor each other so as to maintain a 0 577 
higher standard of work? 
43 Is there a real concern among team members that the team should 0 550 
achieve the highest standards of performance'? 
42 Do members of the team build on each other's ideas in order to 0 522 
achieve the best possible outcome? 
38 Do your team colleagues provide useful ideas and practical help to 0 348 0.470 
enable you to do the job to the best of your ability? 
5 PARTICIPATIVE SAFETY: safety and influence 
07 People feel understood and accepted by each other 0.415 0 567 
19 There is a lot of give and take 0.533 
08 Everyone's view is listened to, even if it is in a minority 0.483 
13 We have a 'we are in it together' attitude 0 413 
The items are numbered in accordance with the numbering of the original version of the inventory 
Items are classified to their best fitting factor by loading or content All loadings of 0 4 or higher on more than one factor 
are displayed 
Confirmatory factor analysis 
The results of the confirmatory factor analysis with LISREL indicated that the five-
factor model has the best fit (Table 3). The fit indices show that the five factors fit 
the model moderately. Further LISREL analyses of the models for nursing teams 
and improvement teams also suggested that a five-factor solution provides the 
best fit to the data for both groups. However, all fit indices of the improvement 
teams were lower than those for the nursing teams. 
Table 3. Fit statistics for the LISREL confirmatory nested models of the Team Climate Inventory 
Model 
TOTAL SAMPLE 
Nursing Teams 
Original four factors 
Four factors 
Five factors 
Original four factors 
Four factors 
Five Factors 
Improvement Teams 
Original four factors 
Four factors 
Five Factors 
x2 
2628 98 
2511 57 
2255.49 
2370.70 
2305.37 
2077 06 
952.35 
943 77 
915.09 
x'ldf 
3.99 
3.81 
344 
3.60 
3.50 
3.17 
1.44 
1.43 
1.40 
GFI 
0.75 
0.76 
0.78 
0.74 
0.74 
0.76 
0.58 
0.58 
0.59 
CFI 
0.96 
0 96 
0.97 
0.95 
0 95 
0 96 
0.90 
0 90 
0.90 
RMSEA 
0 084 
0 082 
0 076 
0 086 
0 084 
0 078 
0 081 
0.080 
0 076 
GFI, Goodness of Fit Index (>0 90), CFI, Comparative Fit Index (>0 95), RMSEA, root mean square residual (<0 05) 
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Intercorrelations 
All factors or scales are significantly and positively correlated (Table 4). Scale 
correlations range from 0.47 ("vision" and "interaction and information sharing") to 
0.72 ("support for innovation" and "participation safety"). The interitem correlations 
show adequate levels of interscale correlation for the factors "vision", "support for 
innovation", and "participation safety" (Table 4). The items of the factor "interaction 
and information sharing" all show high interitem correlations (> 0.37) except for 
item 3 ("we all influence each other"; score 0.18). The lowest interitem correlation 
within the factor "task orientation" was caused by item 38: "providing useful ideas 
and practical help". 
Table 4. Intercorrelations and reliabilities among Team Climate Inventory scales 
Items Alpha 
Scale 
1 Vision 11 
2 Interaction and Information sharing 8 
3 Support for Innovation 8 
4 Task Orientation 7 
5 Participation Safety 4 
Inter-item Correlations 
Coefficient (lowest-highest) 
0 93 
0 86 
0 88 
0 83 
0 84 
0 41-0 80 
0 37-0 84(03 = 0 18) 
0 34-0 62 
0 20-0 57(38=0 17) 
0 46-0 69 
Inter-Scale 
Intercorrelations 
1 2 3 4 
0 47* 
0 60* 0 65* 
0 55* 0 56* 0 67* 
0 50* 0 68* 0 72* 0 63* 
* correlation is significant at the 0 01 level (2-tailed) 
Internal homogeneity 
Cronbach's alpha analysis of the five scales revealed alphas between 0.83 and 
0.93 (Table 4), which indicates good reliability for all five factors of the instrument. 
Discriminating capacity 
The analysis of the difference between nursing and quality-improvement teams 
revealed significant TCI-score differences (Table 5). The mean scores of the 
improvement teams were significantly higher on all scales than those of the 
nursing teams. The greatest difference was on the scale "vision" and the least, on 
"participation safety". 
Table 5. Comparison of nursing teams and quality-improvement teams 
Scales 
Vision 
Interaction and Information sharing 
Support for Innovation 
Task Orientation 
Participation Safety 
* significant at 0 01 
Quality-Improvement teams 
mean SD 
46 1 5 0 
32 3 3 6 
31 0 34 
27 3 3 1 
160 18 
range 
11-55 
8-40 
8^0 
7-35 
5-20 
Nursing teams 
mean SD 
38 8 7 0 
29 8 3 9 
26 6 4 4 
24 2 4 1 
137 27 
range 
11-55 
8-40 
8-40 
7-35 
5-20 
p-value 
0 000* 
0 001* 
0 000* 
0 000* 
0 000* 
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Discussion 
This is the first study in which the Team Climate Inventory (TCI), an instrument for 
measuring team climate, is studied exclusively in a population of hospital teams. 
We found five factors in exploratory and confirmatory factor analyses, as did 
Anderson and West.24 However, their fifth scale consists of all items from the 
subscale "interaction frequency", while our scale "participative safety" fell into two 
subscales, namely, "information sharing and interaction frequency" and "safety 
and influence". The Cronbach's alpha scores in our study of 0.83 or more 
indicated good reliability and the significant differences found between nursing 
teams and quality-improvement teams show that all the TCI scales have 
discriminating capacity. 
A five-factor solution was found in all the validation studies, including Anderson 
and West's, except from the study in Sweden.19"23 However, all the studies that 
found a fifth factor identified it as the subscale "interaction frequency". Our study of 
health care teams is the first study to find another partitioning of the items. Further 
research should be done to see if this is specific for hospital teams. High scores on 
internal homogeneity that are as good or better than those of other studies 
highlight the reliability of our factor solution.19"23 The discriminating capacity of the 
TCI has not been tested before. 
A limitation of this study is that we only studied two types of hospital teams, 
namely, nursing teams and quality-improvement teams. It is unclear whether the 
differences in scores of these kinds of teams are influenced by their size or 
composition. All nursing teams were large monodisciplinary teams (consisting of 
more than 10 people each), and all improvement teams were small, 
multidisciplinary teams. Further research should be done to test the TCI on more 
hospital teams with various sizes and compositions. 
We also recommend research into shortening the TCI. The high interitem 
correlations may mean that different items actually measure the same 
phenomenon to a significant degree. For example, "how far are you in agreement 
with the objectives of the team" and "to what extent do you think these objectives 
are useful and appropriate", have an intercorrelation of 0.80. A short version of the 
Finnish TCI has already been developed29 but needs further testing in health care 
teams. 
Patient care teams are key components in the delivery of high-quality patient 
care.4,30 Studies show that team climate is an important characteristic of 
successful teams, either working in a microsystem of health care, as teams of 
nurses do, or coming together as a quality-improvement team.31,32 Our study 
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shows that the TCI is a valid, reliable, and discriminating measure of team climate 
among hospital teams. Further research within the health care setting is needed to 
estimate its usefulness as a quality-improvement tool or as a predictor of quality-
improvement outcome. 
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Appendix: Practical examples of the use of the TCI 
Box 1 Improving multidisciplinary team working in care for patients with head and neck 
cancer3 
The management of care for patients with head and neck cancer is very complex This type of 
cancer has a very significant impact on patients because of the location of the tumor, and needs 
to be managed by different disciplines in a multimodal treatment The multidisciplinary team 
(MDT) plays a crucial role in delivering high-quality of care for this group of patients The 
assessment of the team climate of the MDT using the TCI, showed overall high scores (74%) but 
also room for improvement regarding "information sharing", "safety of team members", and "task 
orientation" After some improvements, e g "adding extra experts to the team" and "redefining 
tasks and goals", the TCI scores improved with 11% 
Box 2 Improving team climate in teams of students 
In this study, the TCI was used in teams of students working together in research projects, to 
promote critical self-awareness about one's own attitudes and to help team members diagnose 
their team climate The teams were encouraged to take specific actions, based upon their TCI 
scores Aspects that were working well in a team were reinforced Regarding aspects that 
reflected a problem within a team, actions were taken Some teams, for example introduced 
meeting agendas in which time limits were set at the beginning of the meeting Other teams 
participated in communication skills training and tried to make effective use of communications 
technologies There were significant improvements in TCI scores after the improvement actions 
Box 3 Evaluating the effect of the use of integrated care pathways on team working in 
stroke care17 
A good team climate in multidisciplinary stroke rehabilitation teams is required to provide optimal 
care In a quasi-experimental (before-after) design it was evaluated if the use of an integrated 
care pathway by a multidisciplinary stroke rehabilitation team, would improve team working The 
TCI was used to explore attitudes to team working before and after introducing the of a integrated 
care pathway The evaluated intervention appeared to have little effect on improving staff 
attitudes regarding team climate External factors over which the team had no control (e g 
establishment of a new academic stroke unit nearby) may have been more important 
Box 4 Evaluating the effect of three forms of multidisciplinary team (MDT) care in stroke 
rehabilitation18 
The TCI was used in this study to evaluate the effect of three forms of MDT care a standard 
weekly MDT meeting using a standard form for documentation, a standard weekly MDT meeting 
using a newly devised form to enhance the documentation of patients' needs, their goals and their 
involvement with their rehabilitation, a weekly MDT ward round including the doctor and patients' 
relatives The TCI was applied to find out whether the different forms of MDT care resulted in 
improved team working The MDT ward rounds not only resulted in significantly better 
consideration of patients' needs and greater patient involvement It was also shown that this form 
of MDT care resulted in improved team working (measured using the TCI) compared to MDT 
meetings alone 
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Abstract 
Background: To improve the quality of integrated care, we developed indicators for 
assessing current practice in a large reference centre for head and neck oncology. 
Methods: We defined a set of indicators based on integrated care literature, 
national evidence-based guidelines for patients with head and neck cancer, and 
the opinions of professionals and patients. We tested this set regarding 
assessement of current practice and clinimetric characteristics. 
Results: The final set consisted of 8 integrated care indicators and 23 specific 
indicators for patients with head and neck cancer. Current practice assessment 
produced high scores for the integrated care indicators, but the specific indicators 
showed room for improvement. The practice test showed that 9 indicators had 
good clinimetric characteristics. 
Conclusions: The indicators, while based on evidence-based guidelines and the 
principles of integrated care, should incorporate patients' opinions and include a 
practice test. Our results show that the quality of integrated care for patients with 
head and neck cancer could be improved. 
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Introduction 
The management of care for head and neck cancer is very complex.1,2 First, this 
common type of cancer has a very significant impact on the patient because of the 
location of the tumour. Patients often have problems with speech, eating, and 
physical appearance due to treatment.3 Second, as head and neck cancers are 
heterogeneous and occur at several sites, they need to be managed by different 
disciplines in a multimodal treatment. Integration of care and integration of these 
disciplines are crucial for an optimal care outcome. However, many hospitals 
cannot guarantee such high quality.4 Literature shows that integrated care 
programmes can lead to higher patient satisfaction and quality of life and less 
hospitalization. Effects on mortality are unclear.5 
To improve the quality of integrated care for patients with head and neck cancer, 
current practice needs to be reliably assessed.4 However, assessing the quality of 
integrated care is not straightforward, and selecting appropriate indicators to 
assess integrated care is difficult. Evidence-based guidelines for patients with 
head and neck cancer and reflective literature on the subject both provide 
recommendations for good-quality integrated care. To measure the quality of 
integrated care, key recommendations in these guidelines and the literature need 
to be translated into the so-called quality indicators.6 Quality indicators are 
"measurable elements of practice performance for which there is evidence or 
consensus that they can be used to assess the quality of care".7 Most indicators 
are derived from either evidence or professional expertise; they are seldom based 
on the experience and preferences of the patients.7 
We undertook a study to develop indicators for measuring the quality of integrated 
care for patients with head and neck cancer. We were mainly interested in 
indicators regarding the process of care because they demonstrate clearly how 
providers can improve their outcomes. Besides, professionals are more 
accountable for the process of care than outcomes, which are affected by many 
other factors. The perspectives of both professionals and patients were used to 
develop the indicators and to test them empirically so that we could assess our 
current practice for patients with head and neck cancer and clinimetric 
characteristics of our set of indicators. 
Materials and methods 
Development of Indicators 
We used 2 strategies to develop the indicators (Figure 1). We systematically 
searched for integrated care recommendations in the literature, and we performed 
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a systematic consensus procedure based on evidence based guidelines and the 
opinions of professionals and patients. 
Figure 1. Process of indicator development 
Recommendations or 
components from literature on 
Integrated Care (4 items) 
National guidelines for patients with Mead and Neck Cancer 
(n = 85 items) 
3 
Pre-selection of key recommendations by three core professionals involved 
(over after selection: π = 30 items) 
Rating key recommendations on 
paper by all professionals 
involved 
Rating key recommendations by 
patients dunng interviews 
Formal feedback of group choices 
in a face-to-face panel meeting 
with all professionals involved 
ending in personal top-5 scores 
J 
Items were included in a final set of indicators if the mean score of patients and 
professionals was seven or higher or if the item was once mentioned in a top five 
Results 
18 recommendations rated by professionals and patients were included AND 
four recommendations from the literature on integrated care were included 
X 
Incorporation of the 22 key recommendations into 23 specific indicators and θ integrated-care indicators by defining 
numerators and denominators and definition of data sources 
Practice test of the set of indicators 
This systematic procedure that combines expert opinions and evidence is called 
the "RAND-modified appropriateness method".8 The following documents were 
selected as a starting point: the Dutch evidence-based guidelines for treatment 
and follow-up of patients with tumours of the larynx, oropharynx, and oral cavity; 
and the guideline of the Dutch Cooperative Head and Neck group for optimal 
waiting and throughput time.9"11 
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Three specialists involved in the treatment of patients with head and neck cancer 
extracted 30 key recommendations from these guidelines, which were clinically 
relevant to patients' health benefits and/or to the continuity and coordination of 
care. This set of 30 recommendations was sent to an expert panel that included all 
15 professionals involved in the care of patients with head and neck cancer at The 
Radboud University Nijmegen Medical Centre (RUNMC) (maxillofacial surgeons, 
radiotherapists, specialized nurses, pathologists, radiologists, consultants in 
nuclear medicine, dieticians). 
The panel was asked to judge the 30 preselected key recommendations for 
potential indicators on a 9-point Likert scale on the basis of the same criteria as 
used in the preselection. Professionals could add new items. Descriptive analysis 
was used to process the results of this first round, and feedback in the form of 
means of all recommendations was presented in a face-to-face panel meeting. 
During this meeting, the panel members discussed the potential indicators and 
listed a personal top-5. The scores of the first round and the top-5 scores of the 
panel meeting were considered for inclusion in the final set of indicators. 
To include the opinions of patients, 30 patients with head and neck cancer were 
individually interviewed for their opinions. Every third consecutive patient was 
selected from the consultation hours of 3 head and neck cancer consultants at the 
outpatient follow-up clinic of the university hospital. 
To ensure that a patient had the necessary experience, the follow-up period had to 
be at least 1 year starting from the patient's first visit to the clinic. The patients 
were asked to judge the recommendations on the basis of the same criteria that 
the professional expert panel used, except for the medical-technical items. The 
patients could also add new items. All 4 recommendations for integrated care were 
included in the final set of indicators (multidisciplinary patient care team, integrated 
care pathway, case management and patient involvement). To determine the 
specific indicators for the care of patients with head and neck cancer, the scores of 
the professionals on the potential indicators were compared with the preferences 
of the experienced patients. Recommendations were included in the final set when 
the combined, round mean scores of professionals and patients was 7 or more, or 
when the item was mentioned at least once in the professionals top-5. We 
incorporated the selected recommendations into indicators by defining numerators 
and denominators; data sources were also defined. 
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Assessment of current practice 
The final set of indicators was next tested to assess current practice for patients 
with head and neck cancer in the RUNMC. The RUNMC is an university hospital in 
the southeast of The Netherlands, accommodating 1 of the main reference centres 
for head and neck oncology (approximately 425 new patients per year). We tested 
the integrated care indicators, except for the indicators "patient involvement" and 
"contact with the case manager",' with questionnaires for professionals. All 
professionals of the head and neck working group at the RUNMC were asked to 
complete a questionnaire. The Team Climate Inventory (TCI) was used to assess 
team functioning.12 We used patient questionnaires and a survey of patient 
records to test the specific indicators for patients with head and neck cancer. After 
the medical ethics commission of the RUNMC gave her approval, we identified 
patients from clinic lists and sent a questionnaire accompanied by a letter from 
their consultants. 
All patients with head and neck cancer newly diagnosed in the period May to 
December 2003 were eligible to participate. These patients were approached 
regardless of disease stage or mode of treatment. Patients who had not 
responded within 2 weeks were reminded by telephone. The medical records of 
the patients who completed and returned the questionnaire were examined. 
Assessment of clinimetric characteristics of the indicators 
We examined the following clinimetric characteristics: feasibility, opportunity for 
quality improvement, and reliability. Feasibility was defined as the percentage of 
missing values per indicator. 
Feasibility was considered poor if this percentage exceeded 25%. Indicators must 
be capable of detecting changes in the quality of care. If indicator performance is 
already high, there is little opportunity for improvement. If there was less than 10% 
improvement potential on the indicators, there was considered to be too little room 
for improvement.13 Reliability of the patient survey was tested on the data 
extraction of the patient records by calculating the percentage of agreement 
between 2 data reviewers expressed in κ coefficients. 
Two independent data reviewers collected both a sample consisting of 10 records, 
and scores of 0.6 or higher were considered to be good.14 
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Results 
Development of indicators 
The researchers translated 4 recommendations about integrated care that were 
most often mentioned in the literature into 8 indicators, which were included in the 
final set to be tested in practice (Table 1). Regarding the development of the 
indicators specific to patients with head and neck cancer, the professionals gave 
14 of the 30 recommendations a mean score of 7 or more. All recommendations 
scored by patients had a mean score of 7 or more. We combined the results of 
both professionals and patients to include 18 recommendations in the final set. 
Table 1. Indicators for integrated care and their results in practice 
Indicator Results 
Multidisciplinary patient care team (MDPCT) 
1 Availability of a MDPCT 
2 Functioning of the MDPCT according to the 
Team Climate Inventory (TCI) 
There is an MDPCT with all professionals required 
three head and neck surgeons, two maxillofacial 
surgeons, two radiotherapists, one pathologist, one 
nuclear medicine consultant, one medical 
oncologist, and three specialized nurses 
According the TCI, there was room for improvement 
(score 7 on 1-10 scale) in the areas of information 
sharing, safety and influence of the members of the 
team, and a shared mission 
Integrated care pathway 
3 Availability of an integrated care pathway for 
patients with head and neck cancer 
4 The use of the clinical pathway for each patient 
with head and neck cancer 
There are medical and nursing guidelines and 
protocols, but no up-to-date integrated care 
pathway that is used in the medical record of each 
patient 
Not done 
Case management 
5 Availability of a case manager There are three specialized nurses that act as case 
managers 
6 The number of patients that had interaction with 53% of the patients had interaction with a case 
the case manager(s) manager 
Patient involvement 
7 Number of patients that feel involved in 
decisions regarding their treatment 
8 The number of patients that are well informed 
on all information items (see " under table 2) 
93% of the patients feel involved in decisions 
regarding their treatment 
Only 44% state that they had been given enough 
information about all relevant items 
Other items mentioned by professionals to improve the quality of integrated care 
- An electronic patient information system Partly 
- A budget of their own for the total chain of None 
patients with head and neck cancer 
- Support to improve the quality of integrated care Partly 
The researchers incorporated 18 recommendations into 23 indicators (Table 2). 
Adding the patients' opinions led to the inclusion in the final set of 5 
recommendations that would not have been included if the professionals had 
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selected them alone. These 5 recommendations were: "support for reducing 
alcohol consumption", "support to stop smoking", "speech and swallowing 
revalidation", and "the wish to undergo all diagnostic procedures on the day of the 
first visit to the RUNMC". 
Table 2. Specific indicators for patients (N=158) with head and neck cancer and their results in 
practice 
Indicators Results 
% 
Feasibility Improvement Reliability 
"% potential" % c 
PATIENT-ORIENTED ITEMS 
Coordination 
1 Number of patients who know who to talk to for 
information and questions 
Information 
2 Availability of an information protocol 
3 Number of patients who were well informed on 
all information items applicable to their situation e 
Emotional and social support 
4 Number of patients who said they were offered 
emotional support 
Contact with companion in distress 
5 Number of patients who were informed about the 
possibilities to contact companions in distress 
Reducing alcohol consumption 
6 Availability of a multidisciplmary alcohol 
abstinence protocol 
7 Number of patients who had been asked about 
alcohol use 
8 Number of patients with alcohol problems who 
were offered support 
Non-smoking policy 
9 Availability of a multi-disciplinary stop-smoking 
protocol 
10 Number of patients who had been asked about 
smoking behaviour 
11 Number of smokers who were offered support 
to stop smoking 
87(124/143)d 10 13 
None 
44(67/153)d 3 56 
21 (30/143)d 10 79 
27(41/150)d 5 73 
None 
94(131/139)d 12 6 
25(15/59)d 63 75 
None 
97(144/148)d 6 3 
35 (24/68)d 57 65 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
ORGANIZATIONAL ORIENTED ITEMS 
Waiting time first consultation 
12 Number of patients who could see a specialist 
1 day after referral 
Waiting time diagnostic procedures 
13 Number of patients who had all necessary 
diagnostic procedures on day of their first visit to 
the specialist 
Waiting time first treatment 
14 Number of patients who started their first 
treatment within 30 days after their first visit to the 
specialist 
- Operation 
- Radiotherapy 
- Chemotherapy 
24(29/121)' 23 
Median 5 days 
7(10/147)' 7 
Mean of all 
procedures 
11 days 
29(35/122)' 23 
Median 31 days 
Median 56 days 
Median 41 days 
76 
93 
71 
1 
06 
07 
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Indicators Results Feasibility Improvement Reliability 
% '_% potential" % c 
Continuity of care 
15. Number of patients who said that transition 86(112/130) 18 14 NA 
went seamlessly: 
- to the head and neck centre 83 (131/158)d 
- within the hospital between departments 97 (126/130)d 
- from the head and neck centre returning home 77 (104/135)" 
MEDICAL/TECHNICAL ORIENTED ITEMS 
Swallow revalidation 
16 Number of patients with swallowing problems 18(10/56)d 65 82 NA 
after leaving the hospital who were offered 
arrangements about follow-up 
Speech revalidation 
17 Number of patients who had a radical neck 21 (18/84)d 47 79 NA 
dissection or radiation in this area and with whom 
arrangements were made about follow-up 
regarding their speech revalidation 
Nutrition support 
18. Number of patients who were monitored 0(n=0/149)d 6 100 NA 
regarding their nutrition health status before, during 
and after their treatment 
Assessment of CT and MRI procedures 
19 Availability of a radiologist who had experience Available 
with patients with head and neck cancer 
20 Number of assessments of CT and MRI 66(40/61)' 61 34 NA 
procedures by this radiologist 
Focus-consultation by a maxillofacial expert 
team 
21 Number of patients with cancer of the mouth or 95% ^=76/80)' 49 5 0 6 
orofarynx who has been seen by a maxillofacial 
expert team 
Consultation pathologist 
22. Number of times clinicians had contact by Not measurable 
telephone with the pathologist in case of a negative 
biopsy with suspicion of malignancies 
Previous results 
23 Number of times all results of diagnostic Not measurable 
procedures performed earlier were available during 
the patient's first visit to the RUNMC 
NA not applicable 
Note The following 9 indicators had both low percentages of missing values and high percentages for improvement 1, 
3,4,5, 12, 13, 14, 15 and 18 
a
 Percentage of missing data per indicator (should be less than 25%) 
b
 Percentage of improvement potential per indicator (should be more than 10%) 
c
 Agreement between researchers expressed as kappa coefficient interobserver reliability κ 
d
 The absolute numbers of patient perceptions with a positive score on the indicator 
e
 Information items and within parentheses are the positive scores on the separate items course of diagnostic 
procedures and treatment options (94%), general information about hospital (92%), pros and cons of different 
treatment options (92%), narcosis (91%), side effects and complications (89%), course of the operation (88%), 
wound care (81%), mouth care and chewing problems (76%), possible course of the disease (73%), pain 
medication options (71%), diet prescriptions (68%), swallowing revalidation (66%), possible weight loss (65%), 
speech revalidation (52%), emotional and social support options (21%) 
' The absolute numbers of patient records with a positive score on the indicator 
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The patients added 2 information items to the professionals' set, namely, 
"information about the possible course of the disease" and "possible pain 
medication" 
Assessment of current practice 
We tested the set of indicators on a population of 189 newly referred patients with 
head and neck cancer at the RUNMC A total of 158 patients returned the 
questionnaire (84% response) The patient characteristics are shown in Table 3 
All medical records of the participants were examined Thirteen of the 15 
professionals completed the questionnaire 
Table 3 Characteristics of patients included in the practice test 
Characteristics 
Mean age 
Men % 
Mortality % 
Education % 
• High 
• Regular 
• Low 
Tumour location % 
• Larynx and hypharynx 
• Cavity of the mouth 
• Other 
First treatment % 
• Operation 
• Radiotherapy 
• Chemotherapy 
n=158 
62 years 
73 
9 
23 
23 
54 
38 
36 
26 
56 
37 
7 
The mean age of the professionals was 48 years, 8 of them were men, and they 
had a mean clinical experience of 18 years 
Table 1 shows the mtegrated-care indicators and their realization in practice at the 
RUNMC A multiprofessional patient-care team was available consisting of all 
professionals required All new patients were seen, and their cases were 
discussed during the weekly meeting of this team According to the TCI results, 
there was room for improvement within the team regarding information sharing, 
safety of team members, and task orientation Guidelines regarding care for 
patients with head and neck cancer exist, but they have not been translated into 
an up-to-date, mtegrated-care pathway Three different specialized nurses perform 
case-management tasks, yet only 53% of the patients said they had interacted 
with them The highest score was for patient involvement (93%) 
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Despite the fact that only 44% of the patients stated that they were thoroughly 
informed about relevant information items, 93% of the patients felt that they were 
sufficiently involved in decisions regarding their care The results of the 
assessment on the set of specific indicators for patients with head and neck 
cancer are shown in Table 2 The set of indicators could be divided into 3 
dimensions of quality of care patient-oriented quality of care, organizational quality 
of care, and medical/technical quality of care 
Regarding patient-oriented quality of care, the score was high for indicators for 
alcohol and smoking, and almost all patients were asked about their alcohol 
consumption (94%) and their smoking behaviour (97%) The score for support 
offered when necessary was low (25% and 35%, respectively) 
Patients knew who to talk to for information and to ask questions (87%), but the 
professions they mentioned were very different The patients reported that they 
were often not well-informed about important issues, and only 44% said they were 
completely informed Information about emotional and social support was 
especially lacking One-day referral in the dimension of organizational quality was 
only achieved for 24% of the patients Patients indicated they would like to have all 
the diagnostic procedures as soon as possible, preferably on their first visit or the 
day after This was almost never the case (7%) The mean waiting times were 9 
days for X-rays to 24 days for MRI scans The median waiting time from the first 
visit until the start of first treatment was 31 days or more Regarding 
medical/technical quality, "Focus consultation by a maxillofacial expert" had the 
highest score (95%) Fifty-three percent of the patients reported speech problems 
after operation or radiation, but in only 21% of the cases were arrangements made 
for follow-up 
About one third of the study population (35%) had swallowing problems, and 
arrangements were made for 18% of them None of the patients was structurally 
monitored for nutrition health status before, during, or after treatment Although an 
experienced radiologist is part of the patient care team, she only evaluated 65% of 
all CT and MRI procedures 
Assessment of clinimetric characteristics of the indicators 
By following the "Rand-modified appropriateness method" based on evidence-
based guidelines, the content validity of our set of indicators has been guaranteed 
Besides, the indicators for which the reliability could be determined all had 
acceptable κ values of 0 6 or higher Table 2 shows that the feasibility of 6 
indicators was low because they had more than 25% missing values 
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Fourteen indicators had an improvement potential higher than 10%. Nine 
indicators had both low percentages of missing values and high percentages for 
improvement. These indicators are reflected in a footnote to Table 2. Two 
indicators proved not to be measurable: clinicians never recorded whether they 
contacted the pathologist by telephone in case of a negative biopsy and while 
there still was suspicion of malignancy, and it was not noted whether all results of 
diagnostic procedures previously performed in other hospitals were available 
during the first visit. 
Discussion 
In order to improve the quality of integrated care for patients with head and neck 
cancer, we searched in this study for a valid set of indicators to assess current 
practice. Our set of indicators is founded on literature on integrated care, national 
evidence-based guidelines for patients with head and neck cancer, and opinions of 
professionals and patients. The present study shows that including the opinions of 
patients with head and neck cancer in the development process for indicators 
really makes a difference, especially for items like "lifestyle support", "information 
supply", and the wish for "1-day screening". The results that we found for the 
integrated care indicators in the reference centre for head and neck oncology at 
RUNMC show that the care for patients with head and neck cancer was 
reasonably well organized according to the principles of integrated care. With 
regard to the specific head and neck indicators, low scores were found for "waiting 
times for diagnostic procedures and treatment", "information supply", "emotional 
and social support", "lifestyle support", and "paramedical support for swallowing 
revalidation, speech revalidation, and nutrition". 
When we compare our findings with literature, we see that long waiting times for 
diagnostic procedures and treatment is a common problem for many cancer 
patients.15 For patients with head and neck tumours, it is shown that delay in the 
initiation of radiotherapy is associated with a decrease in local control.16 There is 
some evidence that process redesign interventions and diagnostic assessment 
units improve waiting times and in turn decrease patient anxiety and increase 
patient satisfaction.17-19 Failure to provide sufficient information about the disease 
and its treatment is the most frequent source of patient dissatisfaction.20 
Patient information records and decision aids can have positive effects on patients' 
knowledge and satisfaction with the decision process.21-23 Literature shows that 
about one third of patients with head and neck cancer have psychological distress 
and emphasizes the need to identify high-risk patients through psychosocial 
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screening in order to provide early intervention Alcohol abuse and smoking 
lead to more post surgical complications, reinforce the side effects of radiotherapy, 
and increase the risk on secondary tumours26 Therefore, improvement should be 
made to implement an active nonsmoking and anti-alcohol policy Loss of weight 
before an operation is a significant indicator for complications and prognosis 
Nutritional support by a dietician during treatment and follow-up are 
recommended2728 A significant part of patients with head and neck cancer 
undergoing radiotherapy develop speech and swallowing problems, and close 
follow-up is recommended 29 
In addition, our study reveals the importance of subjecting a set of indicators to a 
practice test The feasibility or usefulness of a quality indicator depends among 
others on the number of patients on which the indicator is applicable Another 
criterion is "room for improvement", indicators that have a score of 90% or higher 
do have little room for improvement The most successful indicators for quality 
improvement are indicators with much room for improvement and that are 
applicable on a large part of the population The strength of our study is the solid 
development and test process to define a valid set of indicators that is based on 
evidence and that includes the opinions of both professionals and patients The 
literature provides few studies about indicator development,133031 and none of 
them includes the patient's perspective However, it is known that professionals 
and patients have different opinions about good quality of care3233 It is very 
important to engage patients to achieve high-quality in integrated care 
The content validity of our indicators is guaranteed either because indicators have 
an evidence link to outcomes or they are judged by experts to be clinically relevant 
to patients' health benefits and/or to the continuity and coordination of care 
However, by following our process, the final set of indicators consists mainly of so-
called structure indicators (e g the availability of a multiprofessional team) and 
indicators regarding the process of care (e g speech revalidation) Information 
about these indicators is necessary to make changes to improve the quality of 
care For quality improvement process indicators and structure indicators are more 
useful than outcome indicators because outcome indicators have a long-time 
horizon and are strongly affected by many other factors 31 However, for studies 
directly interested in outcome indicators, adding a set of outcome indicators, such 
as mortality, morbidity, quality of life, functional health status, and patient 
satisfaction, could be considered 
In conclusion, an assessment of current practice based on a set of valid indicators 
should be made before attempting to improve the quality of integrated care for 
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patients with head and neck cancer. Indicator development requires a solid 
procedure agreed upon in advance. The set of indicators should be based on 
evidence-based guidelines and the principles of integrated care and should 
include patients' opinions. 
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Abstract 
Background: While developing and distributing clinical practice guidelines are 
important in optimising clinical health care, insight into actual care is necessary to 
achieve successful implementation. 
Developing quality indicators may be the first step to becoming aware of actual 
care. The Dutch national practice guideline "Non-small cell lung cancer: staging 
and treatment" is one of the first clinical, multidisciplinary guidelines for oncology in 
the Netherlands for which quality indicators were developed systematically. We 
describe indicator development based on this guideline as a practical experience. 
Methods: To develop a set of indicators for diagnosis and treatment of patients 
with non-small cell lung cancer, we systematically achieved consensus on basis of 
a national, multidisciplinary, evidence-based guideline and the opinions of 
professionals and patients. After the researchers extracted the recommendations 
from the guideline, we carried out a so-called "Rand-modified-Delphi procedure". 
This consisted of three rounds: a national panel of professionals and 
representatives of the national patient organization scored all recommendations, 
the professionals had a consensus meeting, and the final set of indicators was e-
mailed for a last check. Subsequently, some clinimetric characteristics of this final 
set were assessed in a practice test. 
Results: Thirty-two of 83 recommendations were selected in the first round. After 
the consensus meeting, 8 recommendations met the final criteria and were 
incorporated into 15 indicators, which were tested in practice. The most successful 
indicators for quality improvement are indicators that are measurable, have 
potential for improvement, have a broad range between practices and are 
applicable to a large part of the population. 
Conclusion: For successful implementation of evidence-based guidelines, each 
new guideline should be developed and tested with a set of indicators based on 
the guideline. The procedure we describe can serve as an example for other new 
guidelines. 
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Introduction 
The shift from consensus-based guidelines to evidence-based ones in the field of 
quality of care in the last 15 years is evident. The next important step to be taken 
is the development of evidence-based indicators. Indicators are necessary for 
measuring the application of evidence-based guidelines in daily practice. Although 
much about the need and the usefulness of indicators has been published in 
recent years1"3, good examples of procedures to be followed are rare.4 
This article describes how such a procedure should be worked out, and gives a 
unique practice example of the Dutch evidence-based multidisciplinary guideline 
for the diagnosis and treatment of patients with non-small cell lung cancer 
(available in English on www.oncoline.nl).5'6 
From consensus-based to evidence-based guidelines 
Research shows that some of the diagnostic procedures and treatments in health 
care are ineffective or even detrimental, whereas treatments with proven activity 
are sometimes not given.7,8 The consequences can be considerable, both 
personally and socially. To optimize the care for patients, several associations of 
medical specialists and supportive organizations, such as the Dutch Institute for 
Healthcare Improvement (CBO) and the Comprehensive Cancer Centres in the 
Netherlands, started to develop guidelines years ago. These guidelines were 
initially drawn from consensus texts. However, in recent years, the process of 
guideline development has been formalized more and more, scientifically 
grounded, and made transparent to meet the requirements of evidence-based 
medicine.9"11 This activates the precise and judicious use of the most recent 
scientific insights in medical decision-making in the care for individual patients. 
From evidence-based guidelines to quality indicators 
The availability of evidence-based guidelines does not mean that patients 
automatically get the care that is defined as the "best care" in evidence-based 
guidelines. Implementation of the best care needs more than the publication and 
distribution of these guidelines.12,13 Insight into the current care and into possibly 
obstructive and/or beneficial factors is required for successful implementation of 
the guideline.14"16 On this basis, an action plan can be tailor-made to increase 
guideline adherence. An important step to get insight into current care is the 
development of quality indicators, based on an evidence-based guideline. Quality 
indicators can be defined as: "measurable elements of practice performance for 
which there is evidence or consensus that they can be used to assess the quality 
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of care".17,18 Development of quality indicators requires a careful and systematic 
procedure to produce valid, reliable, and useful indicators that are accepted by the 
target group and are sensitive to changes in the quality of care.4,19 Such quality 
indicators can give a reliable reflection of the quality of the care provided and can 
lead to quality improvement activities.20 
Practice example: non-small cell lung cancer (NSCLC) 
Background 
In the 20th century, the incidence and mortality of lung cancer increased so 
dramatically in most European countries that it became one of the major epidemics 
of the century.21 In the Netherlands, approximately 9000 new patients are 
diagnosed with lung carcinoma every year.21 Approximately 80% of them have 
non-small cell lung cancer (NSCLC), and the incidence for women is increasing. 
One of 14 men and 1 of 30 women develops lung cancer. Only 25% of the patients 
with NSCLC qualify for curative surgery, which is effective in half of the cases. 
Curative surgery is not an option for the other patients, usually because the tumour 
has expanded or metastasized, or because the patients' condition is such that they 
cannot withstand surgery. In spite of diagnostic and therapeutic progress and 
improvements in clinical staging, the survival of patients with NSCLC has only 
improved slightly over the last 15 years. The median survival after diagnosis is 8 
months. 
Although three Dutch consensus guidelines already existed for the diagnosis and 
treatment of patients with NSCLC22"24 formal, multidisciplinary, evidence-based, 
guidelines for chemotherapy, surgery, support, and follow-up for patients with 
NSCLC were lacking. In 2004, the Dutch Association of Comprehensive Cancer 
Centres and the Dutch Association for Pulmonology took the initiative to develop 
an evidence-based guideline for both diagnosis and treatment of patients with 
NSCLC. A national multidisciplinary working group established the guideline. The 
lung-tumour working groups of the comprehensive cancer centres and all scientific 
and professional associations involved in the care for patients with NSCLC were 
represented by authorized members in the main national working group. 
After the guideline was completed, it had to be implemented. The directive was 
distributed and an article about the guideline was published.6 Further, the guideline 
was discussed in the regional lung-tumour working groups. The next important 
step was to acquire insight into the current adherence to the guideline and to see 
how it could be improved. A systematic procedure was carried out to develop a set 
of indicators and test some clinimetric characteristics of these indicators. The 
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development procedure was based on evidence, and both the perspectives of 
professionals and patients were incorporated. 
Methods 
Development of indicators from the professional's perspective 
The method used to develop quality indicators on the basis of the multidisciplinary 
guideline for NSCLC combines "evidence" from the guideline with expert opinion-
the so-called Rand-modified-Delphi method.25"27 It is unique to our procedure that 
the guideline developers themselves have developed the indicators. A 
representative panel of 17 professionals, who were also involved in developing the 
guideline, was approached to participate in developing the quality indicators: five 
pulmonologists, two surgeons, two radiotherapists, one radiologist, one 
pathologist, two medical oncologists, one primary care physician, one clinical 
psychologist and two specialized oncology nurses. The preconditions were that 
both all occupational professional groups and all regions of the Comprehensive 
Cancer Centres had to be represented. In addition, we have been experimenting 
with a method for involving patient representatives in indicator development. 
Figure 1 shows the steps followed. It took 3 months to carry out steps 1-7 without 
the practice test, which lasted another 3 months. 
Step 1. Extraction and classification of the recommendations from the evidence-
based guidelines 
Earlier research made it clear that professionals tend to choose recommendations 
for indicators that have to do with professional actions regarding diagnosis and 
therapy. Therefore, the researchers classified all 83 recommendations from the 
NSCLC guideline into three quality dimensions: professional quality (medical-
technical action for effective and safe care), organizational quality (continuity and 
coordination of care to enable efficient care) and patient-oriented quality (support 
and information for the patient). Then the panel of 17 experts took three rounds to 
select a set of core recommendations for quality indicators by dimension. 
Step 2. Written appraisal of recommendations by the expert panel: first round 
In the first round, the panel was asked to score the recommendations on the basis 
of the following criteria: professional quality: relevance to health benefit and/or 
treatment outcome for the patient; organizational quality: relevance to continuity 
and/or efficiency of care; patient-oriented quality: relevance to patient-orientation 
(attitude, information, support, etc.). A nine-point Likert scale ranging from "hardly 
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relevant" to "very relevant" was used for the answers. If a question could not be 
answered, then the answer category "cannot assess" could be used. The panel 
was asked to select the five best recommendations by quality category from the 
most important recommendations. There was also space for remarks about each 
recommendation or the addition of new items. 
Figure 1. Process of indicator development 
Multidisciplinary evidence-based guideline: 
Non-small cell lung carcinoma: staging and treatment 
STEP 1 
Extraction of recommendations from the guideline and classification of the 
83 recommendations into three quality dimensions: 
professional, organizational and patient-oriented 
* 
STEP 2 
Written appraisal of the 83 recommendations by the panel on relevance and selection 
of the five best recommendations by quality dimension 
i 
STEPS 
Processing the results of step 2 
32 of the 83 recommendations met the criteria 
STEP 4 
Consensus meeting expert panel ending in selection 
of the three best recommendations by quality dimension 
STEPS 
Processing the results of step 4: 
8 of the 32 recommendations met the criteria 
I 
STEP 6 
Determination of the core set of recommendations for the indicators and final 
comments of the expert panel by e-mail 
ι zz 
STEP 7 
Operationalization of the recommendations into indicators followed by a practice test: 
15 indicators have been developed from the 8 recommendations 
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Step 3. Processing the results of the first round 
Campbell's criteria were used to analyze the results of the first round25: 
(a) The panel members gave the criterion a score of 7 or more. 
(b) The questions were presented clearly and there was no discussion about the 
formulation. 
(c) There was no great difference of opinion [a difference of opinion was defined 
as the case in which 30% or more of the scores were on one end of the scale 
(1-3) and 30% on the other end of the scale (7-9)]. 
Since earlier research showed that these criteria often did not discriminate 
sufficiently (selection of too many recommendations), we added a fourth 
criterion.28 This criterion was based on the distribution of points for the top five 
recommendations, as follows: a recommendation that was first mentioned in the 
top five was given 5 points, one that was second was given 4 points, etc. After the 
summing up of the points by quality category, the recommendations were listed by 
the total number of points. Then we searched for a break-even point. There were a 
few recommendations with 5 points or more in the categories of professional, 
organizational, and patient-oriented care, followed by a lot of recommendations 
with 1 -4 points. Consequently our fourth criterion for selection was: 
(d) To be in the top five, a recommendation must score at least 5 points after the 
summing up of the top five appraisals by quality category of all the panel 
members. 
If this procedure is used for another guideline, the break-even point must be 
determined anew. The researchers processed the data from the first round and 
made a list of all the recommendations, with their scores, that met the four criteria. 
All new items suggested were included. The resulting memorandum was the main 
point for the second round (consensus meeting). 
Step 4. Consensus meeting: the second round 
The members of the expert panel and the researchers and consultants for 
implementation (researchers from the Centre for Quality of Care Research and 
consultants from the Comprehensive Cancer Centres North, East and South and 
the Dutch Institute for Healthcare Improvement) were present at the consensus 
meeting. The results of the first round were discussed. The panel was asked if 
they could approve the selection of recommendations from the first round with the 
relevancies for health benefit and/or the treatment outcome, continuity and/or 
efficiency of the care, and provision of patient-oriented care, as a main point. 
Measurability and improvement of the recommendations were discussed. At the 
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end of the meeting, the expert panel was asked to take the discussion into account 
and to again select the top three of most relevant recommendations by quality 
category. The criteria for relevance from the first round were used again. 
Sfep 5. Processing the results of the second round 
The top three results of each participant in the consensus meeting were processed 
in the same manner as the "top-five" results from the first round: a first place was 
given 3 points; a second place, 2 points; and a third place, 1 point. The 
recommendations were ordered by quality category on the basis of this score. All 
recommendations with 8 points (the break-even point) or more were presented for 
inclusion in the core set of recommendations. 
Step 6. Determination of the core set of recommendations for the indicators: the 
third round 
The results of the second round were e-mailed to everyone concerned for 
approval. Comments about obscurities in the formulation of the recommendation 
were requested. 
Step 7. Incorporation of recommendations into indicators and a practice test 
In the last step, the chosen recommendations were incorporated into definite 
indicators (i.e. converted into nominators and denominators) and tested in practice 
(see assessment of clinimetric characteristics of the indicators). 
Development of indicators from the patient's perspective 
Because the literature shows that professionals' opinions about "good quality of 
care" sometimes deviate from patients' opinions29"31, it seemed logical to involve 
patients in indicator development. We do not know which method is most suitable. 
As a first orientation, the following approach was chosen: seven members of the 
national board of patient representatives for lung cancer were approached to 
appraise the same 83 recommendations that the expert panel appraised as 
possible quality indicators. Appraisal took place on the basis of the same criteria 
that the professionals used. 
Assessment of clinimetric characteristics of the indicators 
The practice test took place in six hospitals in the Eastern Comprehensive Cancer 
Region, where 276 patients newly diagnosed with NSCLC were retrospectively 
included in a 6-month period. We assessed the following clinimetric characteristics 
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of the set of indicators: measurability, improvement potential, discriminating 
capacity, and feasibility. An indicator is measurable if the data needed to fill the 
indicator can be collected by searching medical records or by means of a patient 
survey. Indicators must be capable of detecting changes in the quality of care. If 
indicator performance is already high, there is little room for improvement. When 
the range between the lowest and highest hospital scores is broad, an indicator 
has discriminating potential. An indicator is more successful for quality 
improvement if it is applicable to a large proportion of patients; we refer to this as 
"feasibility". 
We extracted the indicator data regarding professional and organizational quality 
from the medical records of the 276 patients. The data for the indicators regarding 
patient-oriented quality were collected with questionnaires intended for the 276 
patients with NSCLC. However, because patients with NSCLC die shortly after 
diagnosis, we were able to send only 132 of the 276 patients a questionnaire. 
Results 
Development of indicators from the professional's perspective 
The guideline for diagnosis and treatment of patients with NSCLC contained 83 
recommendations for good quality of care. Researchers classified these 
recommendations into three dimensions of quality of care: professional quality: 60 
recommendations; organizational quality: 16 recommendations; and patient-
oriented quality: 7 recommendations. 
Fifteen of the 17 experts answered the questionnaire in the first round. Thirty-two 
of the 83 recommendations met our requirements: 15 for professional quality; 10 
for organizational quality, and 7 for patient-oriented quality. Eighteen new items 
were added. In the consensus meeting (second round), 10 of the 17 experts and 6 
consultants were present. Of the 32 recommendations chosen in the first round, 23 
were mentioned in the various top threes of the panel members. Eight of these 23 
recommendations had a score of 8 points (break-even point) or more: four for 
professional quality, two for organizational quality and two for patient-oriented 
quality. 
These eight recommendations were presented for inclusion in the core set of 
recommendations. No new item introduced in the second round met these criteria. 
All panel members approved the core set of eight recommendations that were 
presented by e-mail (third round). Table 1 shows the definite set of indicators. 
Fifteen process indicators have been developed from the eight recommendations. 
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Table 1. Indicators for NSCLC and some clinimetric characteristics 
Quality indicator Improvement 
potential per 
indicator (%) 
Range for 6 
hospitals (%) 
Feasibility-the 
indicator was 
applicable (%) 
Number of patients with specific clinimetric Total number of patients with corresponding 
characteristic general clinimetric characteristic 
Professional quality (total 276) 
58 Mediastinoscopy preceded by FDG-PET 66 
219 Cervical mediastinoscopy carried out according 260 
to the guideline criteria 
24 Cervical mediastinoscopy and biopsies of at 48 
least 4 of the 6 accessible lymph node stations 
1 Clinical stage III NSCLC for which a skeletal 29 
scintigraphy and a CT or MRI of the brain was 
done before the start of the combination therapy 
Locally advanced NSCLC with WHO 
performance status 0 or 1 that was treated with 
combination therapy 
Surgery 
Cervical mediastinoscopy 
Cervical mediastinoscopy 
Clinical stage III NSCLC treated with 
combination therapy4 
Locally advanced NSCLC and WHO 
performance 0 or 1 
12 
16 
50 
97 
Not 
measurable 
83-100 
68-100 
0-71 
0-20 
24 
94 
17 
11 
Organizational quality (total 276) 
189 Diagnostic trajectory completed within 21 239 
calendar days from first visit to pulmonologist 
(chest CT scan, bronchoscopy, FDG-PET) 
80 Patients started therapy within 35 calendar days 157 
from the first visit to the pulmonologist 
156 Lung cancer discussed in multidisciplmary 276 
consultation (available in 2 of 6 hospitals) 
Patients had diagnostic therapy 
Patients started therapy 
Patients had lung cancer 
21 
(with 
mediastino-
scopy: 23) 
49 
43 
71-84 
(with 
mediastino-
scopy: 58-73) 
38-66 
26-91 
87 
57 
100 
Patient-oriented quality (total 100) 
52 Patients with NSCLC reported that attention has 89 
been paid to physical symptoms: pain, 
suffocation, nausea, fatigue, weight loss and 
insomnia 
28 Patients with NSCLC reported that they were 83 
asked about psychosocial stress factors and 
psychological symptoms 
31 Patients with NSCLC reported that they were 85 
asked about psychosocial problems in family 
and problems at work 
Patients with NSCLC 
Patients with NSCLC 
Patients with NSCLC 
42 
66 
64 
25-78 
18-60 
23-60 
89 
83 
85 
Quality indicator 
Number of patients with specific clinimetric 
characteristic 
11 Patients with NSCLC needed psychosocial care 
from trained providers and received it 
97 Patients with NSCLC reported that they were 
treated adequately 
49 Patients with NSCLC reported that they were 
informed about the existence of a oncology 
nurse specializing in lung cancer 
18 Patients with NSCLC reported that they were 
informed adequately on all 10 aspects 
Total number of patients with corresponding 
general clinimetric characteristic 
28 
99 
93 
95 
Patients with NSCLC needed psychosocial 
care from trained providers 
Patients with NSCLC 
Patients with NSCLC 
Patients with NSCLC 
Improvement 
potential per 
indicator (%) 
61 
2 
47 
81 
Range for 6 
hospitals (%) 
0-100 
96-100 
33-86 
17-57 
Feasibility - the 
indicator was 
applicable (%) 
28 
99 
93 
95 
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Development of indicators from the patient's perspective 
Six of the seven patient representatives returned the questionnaire. All concerned 
indicated that the recommendations regarding medical-technical issues were too 
difficult for them to assess. Regarding the organization of care, all patient 
representatives mentioned the importance of the following items: "waiting time for 
diagnostic procedures", "waiting time for the start of treatment", and "discussion in 
the multidisciplinary consultation". The expert panel had already noted these 
items, and all of them were included in the definite set of recommendations. With 
regard to the patient-oriented recommendations, all the patient representatives 
mentioned the importance of offering psychosocial care. They were more specific 
than the professionals about the importance of paying attention to physical 
symptoms, follow-up, and support of family and friends, as well as offering support 
to a companion in distress. These items are listed in general terms under the 
subheading "psychosocial care" in the guideline. The complete recommendation 
about psychosocial care has thus been incorporated into the proposed set of 
recommendations. The specific suggestions from the patient representatives were 
included in the transition from recommendation to concrete indicators. 
Assessment of clinimetric characteristics of the indicators 
Table 1 shows some clinimetric characteristics of the set of indicators. The only 
indicator that proved to be not measurable was the "number of patients with locally 
advanced NSCLC and performance status 0 or 1 who were treated with 
combination therapy". Professionals wrote down the performance status (WHO or 
Karnofsky) in only 9% of the cases. Regarding improvement potential, the indicator 
on "searching for metastases of patients with clinical stage III NSCLC who were 
undergoing combination therapy" had the highest score (97%). However, the 
indicator was only applicable to 11% of the research population. Two of the 
organizational indicators, namely, "waiting time until the start of treatment" and 
"patients discussed in multidisciplinary consultation", had improvement potential of 
more than 40% and were feasible for 57 and 100% of the research population, 
respectively. The lowest variability between hospitals was found for "searching for 
brain metastases" (scores 0-3%) and "waiting times for diagnostic procedures" 
(scores 71-84%). Variability between hospitals of more than 60% was found for the 
"number of biopsies during cervical mediastinoscopy", "patients discussed in 
multidisciplinary consultation" and "patients in need of psychosocial care from 
trained providers". 
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The items concerning patient-oriented quality could only be measured for 132 of 
the 276 patients because some patients had already passed away. All but one 
("number of patients who reported that they were treated adequately"), patient-
oriented indicators had improvement potentials of 40% or more, and at the same 
time they were applicable to more than 80% of the participating patients. 
Discussion 
Systematic development of quality indicators based on evidence-based guidelines 
is a first step toward implementing a guideline. Measuring indicators gives insight 
into the current care and is a condition for developing a successful implementation 
strategy. Indicators can also be used for monitoring the quality of care, and they 
can contribute to a healthy self-regulation of the care because they transparently 
indicate improvement opportunities. 
The guideline Non-small cell lung cancer: staging and treatment is one of the first 
Dutch multidisciplinary cancer guidelines for which quality indicators were 
developed systematically. Eight of the 83 original recommendations were selected 
by an expert panel, which resulted in 15 indicators. Classifying the 
recommendations into various quality dimensions (professional, organizational, 
and patient-oriented) beforehand led to a final set of key recommendations that 
nicely reflect these three dimensions. 
Our process led to a final set of indicators that consists mainly of indicators 
regarding the process of care. This phenomenon has been also identified in a 
similar selection procedure for quality and efficiency indicators in family practices 
and gynaecological practices in the Netherlands.1428 Information about these 
indicators is necessary to make changes to improve the quality of care. Process 
indicators are more useful than outcome indicators for quality improvement 
because outcome indicators have a long time horizon2 and are determined by 
many other factors that are beyond the control of professionals (i.e. patient's age, 
lifestyle choices, risk factors, compliance, and health status). Because we are 
mainly interested in ways professionals can improve the outcomes of care, we 
focus mainly on indicators that are relevant to the process of care. Outcome 
indicators do not originate from our study procedure, and adding a set of outcome 
indicators, such as mortality, morbidity, quality of life, functional health status, and 
patient satisfaction could be considered. 
Our study reveals the importance of subjecting a set of indicators to a practice test. 
Indicators might not be measurable in practice and would therefore be unsuitable. 
The most successful indicators for quality improvement are indicators that are 
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measurable, have potential for improvement, have a broad range between 
practices, and are applicable to a large part of the population. 
Good quality of care can only be provided when the care has been organized 
around the needs and preferences of the patients.32 At the same time, we need to 
know the limits of such care. The limits will be ascertained in clinical research, but 
not everything can and will be realized in practical daily care. For this reason, it 
seems significant and advisable to involve patients in determining a set of core 
indicators for good quality of care. Our study clearly shows that patient 
representatives find it difficult to assess medical-technical quality issues. However, 
patient representatives can make a relevant contribution to selecting indicators on 
the basis of aspects that have to do with follow-up, support, and the organization 
of care. These aspects are included in the NSCLC guideline, but were only 
developed summarily. Such items are not likely to be specific for one tumour type. 
We recommend incorporating a generic set of items about patient-oriented care 
into each type of oncology and other guidelines. A patient survey is needed to 
review these items. The products of the Picker Institute, Europe, an organization 
that specializes in measuring the patient orientation of the care, could be useful. 
Further research in this area is desirable. 
Conclusion 
Systematic developing and testing of indicators for improving the quality of care is 
very important for good implementation of multidisciplinary evidence-based 
guidelines. This set of indicators should be based on the available evidence, cover 
all dimensions of care and include patients' and professionals' opinions. In this 
article, we have described a procedure as objectively as possible for developing 
quality indicators by means of the practice example of the guideline for patients 
with NSCLC. We recommend that it will become standard practice to follow each 
development of an evidence-based guideline with a systematic procedure for 
determining indicators. An expert panel consisting of representatives who are also 
involved in the development of the guideline can facilitate and accelerate this 
process. 
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Chapter 7 
Abstract 
Background: In the current study, the authors focused on determinants influencing 
the quality of care and variations in the actual quality of integrated care for patients 
with non-small cell lung cancer (NSCLC) to estimate whether there is room for 
improvement. 
Methods: The authors tested the quality of integrated care for 276 NSCLC patients 
with 14 quality indicators of professional (4 indicators), organizational (3 indicators) 
and patient-oriented quality (7 indicators). Patient characteristics and actual care 
data were derived from medical record data, patient-oriented care was derived 
from patient questionnaires, and professional and hospital characteristics were 
derived from questionnaires for professionals. The performance measure was the 
proportion of patients to whom the indicator applied who had positive scores on 
the indicator. Multilevel logistic regression analysis determined the influence of 
patient, professional, and hospital characteristics on care. 
Results: With regard to professional quality, the proportions of patients who 
underwent fluorodeoxyglucose-positron-emission tomography or cervical 
mediastinoscopy according to the guideline criteria were 88% and 84%, 
respectively. Only 50% of the biopsies were adequately obtained during 
mediastinoscopy, and in 3% of the patients with clinical stage III disease (based 
on the TNM classification) there was a search for brain metastases before the 
initiation of combination therapy. With regard to organizational quality, the 
diagnostic route of 79% of the patients was completed within 21 days; 51% started 
therapy within 35 days, and 57% were discussed during multidisciplinary 
consultation. All but one patient-oriented quality indicator scored 58% or less. 
Hospitals varied by 20% or more on 11 of the 14 indicators. The patient-related 
determinants "stage of disease", "age" and "co-morbidity" were found to influence 
the indicator scores most. 
Conclusion: The quality of integrated care (especially patient-oriented care) for 
NSCLC patients needs improvement. Patient characteristics appear to influence 
performance more than professional or hospital characteristics. 
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Background 
Lung cancer is the leading cause of cancer death in Europe and the United States, 
killing more patients than breast, colon, and prostate cancers combined 1 Lung 
cancers are classified into two mam categories small-cell lung cancer, which 
accounts for approximately 15% of the cases, and non-small cell lung cancer 
(NSCLC), which accounts for the other 85% Despite improvement in both the 
diagnosis and treatment, the overall prognosis for patients with NSCLC has hardly 
improved over time, the median survival is 8 months, and the 5-year survival is 
reported to be less than 15% 1 Patients with early stages I and II disease who 
undergo surgical resection have the best chance of survival To our knowledge, no 
curative treatment is currently available for patients with stage IV lung cancer 
Because the incidence of stage IV NSCLC is rather high, and the expected 
survival relatively short, this patient category requires a high quality of supportive 
and palliative care 
Quality of care depends largely on three perspectives professional quality, 
organizational quality, and patient-oriented quality An "integrated care" approach 
is obtained when patients receive the right diagnostic procedures and treatment 
options according to the best available evidence (professional quality), when the 
coordination of care is optimal, and cooperation between professionals is such that 
it minimizes duplications and speeds up throughput times (organizational quality), 
and when patients are optimally involved and supported in their care (patient-
oriented quality)2 Actual care in all three dimensions should be assessed to 
determine whether high-quality integrated care is being delivered to patients with 
NSCLC and to learn whether there is room for improvement 
To our knowledge, good data reflecting the actual care that encompasses the 
three perspectives are currently not available However, to meet the targets of 
integrated care, a good understanding of both actual performance and factors 
determining variation in performance are needed 3 Quality indicators are needed to 
measure performance Quality indicators are defined as "measurable elements of 
practice performance for which there is evidence or consensus that they can 
assess the quality -and therefore a change in quality- of the care provided"4 These 
indicators should be based on available evidence and include the three 
perspectives of professional, organizational, and patient-oriented quality Recently, 
we developed a set of quality indicators for patients with NSCLC based on 
evidence-based guidelines and opinions of professionals and patients 5 
Determinants of either high or low quality of care for patients with NSCLC can be 
related to patient, professional, or hospital characteristics, such as patient age6, 
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health status7, stage of disease, comorbidity8, years of experience of 
professionals9, their knowledge of guidelines and barriers to implementation of 
guidelines10,11, the size of the hospital and the patient volume treated1213, teaching 
activities in the hospital14, and the availability and functioning of a multidisciplinary 
lung cancer team or specialized nurses with coordination tasks.215 Insight into 
determinants that influence the quality of care can help to design targeted 
strategies with which to improve care. However, to our knowledge, such factors 
have never been studied with respect to patients with NSCLC. 
In the current study, we focussed on determinants influencing the quality of care 
and the variations in the actual quality of integrated care for patients with NSCLC 
in order to estimate whether there is room for improvement. 
Materials and methods 
Setting and study population 
The quality of integrated care for patients with NSCLC was assessed in six 
hospitals in the eastern region of the Netherlands: 1 university hospital, 4 teaching 
hospitals, and 1 non-teaching hospital. The mean numbers of patients seen 
annually who were diagnosed with NSCLC varied from 30 patients in the smallest 
hospital to 160 in the largest hospital.16 We selected patients with NSCLC (based 
on the World Health Organization [WHO] classification) using the pathology 
diagnoses collected by the East Comprehensive Cancer Centre (ECCC). All 
consecutive newly diagnosed patients with NSCLC were included in the study 
during a 6-month period from September 2004 to February 2005. All specialists 
and specialist nurses involved in the care for these patients were also included. 
The regional research ethics committee approved the study and permission to 
collect additional data was obtained from the contacts in each hospital. 
Quality indicators and data collection 
The quality of integrated care for patients with NSCLC was measured with a set of 
indicators, systematically developed and validated as described in a previous 
study.5 This set of indicators was based on national and international evidence-
based guidelines for diagnosis and treatment of patients with NSCLC, it includes 
patients' and professionals' opinions, and it consists of 14 indicators: 4 regarding 
professional evidence-based quality, 3 regarding organizational quality, and 7 
regarding patient-oriented quality (Table 1). 
The ECCC registration clerks extracted data that were needed to evaluate the 
selected recommendations. In summary, these data were: patient and disease 
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characteristics, dates of diagnostic procedures and treatment and whether patient 
care was discussed with at least one other specialist. For the indicator "carrying 
out a cervical mediastinoscopy according the guideline criteria", a thoracic surgeon 
extracted the data and recorded it on a special data-extraction form. We collected 
the data for the indicators of patient-oriented quality with patient questionnaires. 
The patient records had been screened to exclude any patients who had died. We 
sent questionnaires to only 132 of the 276 patients because 144 patients had 
passed away. A reminder was sent 2 weeks later. 
Determinants and data collection 
The potentially relevant patient characteristics measured in our study were: age, 
co-morbidity (chronic heart failure, chronic lung disease, diabetes mellitus, and 
other malignancies present more than 5 years previously) and disease stage 
(according to the TNM classification).17 The ECCC routinely extracted these data 
from the medical records. 
We collected the professional characteristics from the individual questionnaires 
sent to all 79 medical specialists and specialist nurses who were involved in the 
care for patients with lung cancer. The questionnaire consisted of four parts. The 
first part included demographic data (age and sex), professional background, and 
clinical experience of the specialist. Parts two and three included questions to 
assess "knowledge of the NSCLC guideline" and "barriers for guideline 
implementation". These questions were based on a validated questionnaire 
developed at our centre18: "knowledge of the NSCLC guideline" was assessed with 
nine items about attitudes toward the Dutch national NSCLC guideline and 17 
items about "barriers for guideline implementation". We assessed team climate 
among all the professionals involved in the care for patients with NSCLC by means 
of the short-form Team Climate Inventory (TCI) of Anderson and West.19,20 
We obtained the hospital characteristics from the routinely collected ECCC data 
(number of patients seen annually who were diagnosed with NSCLC) and from a 
structured interview with the contact person (a pulmonologist) at each hospital. 
The hospital characteristics consisted of teaching status, availability of a 
multidisciplinary team with all specialists present as reported in the NSCLC 
guideline, and the availability of one or more specialized nurses with coordination 
tasks. 
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Analysis 
We calculated the frequencies to evaluate scores on the 14 integrated care 
indicators and the variations among the six hospitals. Two indicators had high 
scores and less variation among the hospitals (Table 1; indicators 1 and 12) and 
two indicators involved less than 30 cases (Table 1; indicators 4 and 11). These 
indicators were excluded from determinant analysis. 
We studied the single correlations between adherence to the ten remaining quality 
indicators and all possible influencing determinants (at the patient, professional, 
and hospital levels) using univariate analysis (chi-square test and Student's f-test). 
The influencing factors that were found to be suitable for further analysis (p < 0.15) 
were tested on intercorrelations. If a correlation was detected between two 
independent variables (correlation coefficient > 0.4), only one variable was 
included in the multilevel analysis. We used multilevel logistic regression analysis 
to assess which determinants influenced the quality indicators. We constructed 
separate multivariate backwards stepwise logistic regression models in which each 
of the quality indicators formed the dependent outcome and all the patient, 
professional, and hospital characteristics that had bivariate associations with ρ < 
0.15 were the independent variables. We composed a random coefficient model 
with a Glimmix procedure using SAS software (SAS for Windows, version 8.2; 
SAS Institute Ine, Cary, NC). We calculated the percentage of variance that the 
determinants could explain for each quality indicator. We used a method based on 
a threshold model to compute the explained variance. Odds ratios (ORs) 
described the associations between characteristics and quality indicators. An OR 
greater than 1 means a positive association with the indicator. We considered two-
sided ρ levels less than 0.01 to be statistically significant. 
Results 
Study population 
A total of 276 patients were included in the current study. We measured the 
patient-centred indicators from the questionnaires that 100 of the 132 
questionnaire recipients returned (76% response). Of the 79 professionals 
involved in the care for patients with NSCLC, 55 returned the questionnaire (70% 
response). 
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Table 1. Quality indicator scores for patients with non-small-cell lung cancer and variation in 
scores in six hospitals 
Quality Indicator 
Number of patients with positive score 
Score 
(%) 
Total number of patients to whom the indicator was applicable 
Variation 
(lowest-
highest 
score in %) 
Professional quality (n=276) 
1 Patients with surgery who underwent mediastinoscopy 
preceded by FDG-PET (58) 8Θ 
84 
50 
Patients with surgery (66) 
2* Patients who had a cervical mediastinoscopy performed 
according to the guideline criteria (219) 
Total number of patients (260) 
3* Patients who underwent a cervical mediastinoscopy and biopsies of 
at least 4 of the 6 accessible lymph node stations (24) 
Patients who underwent cervical mediastinoscopy (48) 
4 Patients with clinical stage III NSCLC for whom skeletal scintigraphy and a CT or 
MRI of the brain was performed before the initiation of combination therapy (1) 3 
Patients with clinical stage III NSCLC who received combination therapy (29) 
Organizational quality (n=276) 
5* Patients who had the diagnostic course completed within 21 calendar days from 79 
first visit to the pulmonologist (chest CT scan, bronchoscopy, FDG-PET) (189) (67 with 
(with mediastinoscopy) mediasti-
Total number of patients who underwent diagnostic procedures (239) 
6* Patients who began therapy within 35 calendar days 
from the first visit to the pulmonologist (80) 
Total number of patients who began therapy (157) 
7* Patients discussed during multidisciplinary consultation 
(available in 2 of 6 hospitals) (156) 
noscopy) 
51 
57 
Total number of patients (276) 
Patient-oriented quality (n=100) 
8* Patients reporting that attention was been paid to physical symptoms pain, 
suffocation, nausea, fatigue, weight loss, and insomnia (52) 
Total number of patients (89) 
9* Patients reporting that they were asked about 
psychosocial stress factors and psychological symptoms (28) 
Total number of patients (83) 
10* Patients reporting that they were asked about psychosocial problems 
in family and problems related to living conditions (31) 
11 
12 
Total number of patients (85) 
Patients who were in need of psychosocial care from 
trained providers and received it (11) 
Total number of patients in need of psychosocial care from trained providers (28) 
Patients reporting that they were consulted adequately (97) 
Total number of patients (99) 
13* Patients reporting that they were informed about the existence of 
a oncology nurse specializing in lung cancer care (49) 
Total number of patients (93) 
14* Patients reporting that they were informed adequately 
about all 10 information aspects (18) 
Total number of patients (95) 
58 
34 
36 
39 
98 
53 
19 
83-100* 
68-100* 
0-71* 
0-20 
71-84 
(58-73) 
38-66** 
26-91" 
25-78** 
18-60** 
23-60** 
0-100" 
96-100 
33-86** 
17-57" 
Indicator included in multilevel analysis, "Variation of 20% or more between the lowest and highest scores in the 
six hospitals, CT, Computed tomography, FDG-PET, fluorodeoxyglucose-positron-emission tomography, MRI 
magnetic resonance imaging, NSCLC, non-small-cell lung cancer 
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Table 2 outlines the characteristics of patients, professionals, and hospital 
settings. The mean age of the patients was 67 years (range 34-91 years), 63% 
had one or more comorbid disorders, and 44% of the patients were classified as 
having stage IV disease. Of all the 276 patients listed, 26% had undergone 
surgery as the initial treatment. The professional characteristics showed that 40% 
of the professionals had more than 10 years experience as medical specialists, 
that most specialists were pulmonologists (36%), and that 60% were men. Only 
two of the six hospitals had a weekly multidisciplinary lung cancer meeting with all 
their professionals, which is required according to the guideline. One hospital had 
specialized nurses with coordinating tasks for patients with lung cancer. The mean 
score obtained on the TCI was 54 of the maximum 70 points (77%). There was 
little variation among hospital teams on TCI scores (highest and lowest scores: 57 
and 48). 
Quality indicators 
Table 1 shows the scores on the quality indicators and the variation in scores 
among the six hospitals. The highest score in the dimension of professional quality 
was the proportion of patients that had undergone fluorodeoxyglucose-positron-
emission tomography (FDG-PET) (88%) followed by the number of patients that 
had a cervical mediastinoscopy according the guideline (84%). The lowest scores 
were for "the number of patients with clinical stage III NSCLC for which skeletal 
scintigraphy and [computed tomography] CT or [magnetic resonance imaging] MRI 
of the brain was done before the start of the combination therapy" (score 3%; 
lowest score 0% and highest score 20%) and "number of patients who had a 
cervical mediastinoscopy and biopsies of at least four of the six accessible lymph 
node stations" (score 50%; lowest score 0% and highest score 71%). Regarding 
the organizational quality, almost 80% of the study population completed the 
diagnostic route within 21 calendar days after the first visit to the pulmonologist 
(score 79%; lowest score 71 and highest score 84%; score 67% if including 
mediastinoscopy), half of the patients started therapy within 35 days after the first 
visit (score 51%; lowest score 38% and highest score 66%) and 57% of the 
patients were discussed during multidisciplinary consultation (lowest score 26% 
and highest score 91%). 
All patient-oriented quality-of-care indicators regarding physical, emotional and 
psychosocial care and information supply had very low scores (58% or less) 
except the indicator "number of patients who reported that they were consulted 
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properly" (98%). There was a variation in scores of the patient-oriented indicators 
of more than 20% in six of the seven patient-oriented indicators (Table 1 ). 
Overall, there was a variation in quality scores among the hospitals of 20% or 
more for 11 of the 14 indicators. 
Table 2. Descriptive characteristics: patients, professionals, and hospitals 
Patients (n=276) 
Mean age in years 
Men 
One or more comorbidities* 
Disease stage 
I 
II 
III 
IV 
First treatment: 
Operation 
Radiotherapy 
Chemotherapy 
no therapy 
Professionals (n=55) 
Professional groups. 
Pulmonologists 
Surgeons 
Radiotherapists 
Pathologists 
Oncology nurses 
Nuclear specialists 
Radiologists 
Medical oncologists 
Mean age in years 
Men 
More than 10 years experience as a specialist, mean number of years 
Hospitals (n=6) 
Teaching hospital 
Hospital beds, mean (range) 
Lung cancer patients (NSCLC) seen per year, η (range) 
Availability of a multidisciplinary team for lung cancer 
Specialized nurse with coordination tasks 
Team climate, total mean score on the TCI** 
Number 
67 
185 
175 
57 
22 
74 
123 
71 
57 
78 
70 
20 
7 
7 
7 
6 
4 
3 
1 
45 
33 
22 
4 
630 
100 
2 
1 
54 
Percentage 
(lowest - highest) 
(34-91) 
67 
63 
21 
8 
27 
44 
26 
21 
28 
25 
36 
13 
13 
13 
11 
7 
5 
2 
(32 - 63) 
60 
40(0 5-31) 
67 
(200 - 960) 
(30-160) 
33 
17 
78 (48 - 57) 
'Sum score of four items chronic heart failure, chronic lung disease, diabetes mellitus, and other malignancy present 
longer than 5 years, "Maximum score on the TCI is 65 
NSCLC, Non-small-cell lung cancer, TCI, Team Climate Inventory 
Determinants 
Table 3 shows all the determinants that remained after multilevel regression 
analysis. None of the tested determinants was found to have a significant 
influence on indicators within the dimension of professional quality. For the other 
indicators, some had a significant influence on one or more quality indicators. The 
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3 indicators in the area of organizational quality were all significantly associated 
with one or two patient characteristics. 
Table 3. Determinants on quality indicators for patients with non-small cell lung cancer 
Quality indicator Predictor OR (95% CI) Significance Explained 
variance 
WL 
PROFESSIONAL QUALITY 
Cervical mediastinoscopy Greater knowledge of 0.34(0.11-109) 0.07 7.3 
performed according to the the guidelines 
guideline criteria 
ORGANIZATIONAL QUALITY 
Diagnostic trajectory completed Higher stage of disease 2.71(135-5.44) 0.005** 5 6 
within 21 calendar days from first 
visit to pulmonologist (chest CT 
scan, bronchoscopy, FDG-PET) 
Therapy initiated within 35 Higher stage of disease 2.83(138-5 82) 0 005" 5.9 
calendar days from the first visit to 
the pulmonologist 
Lung cancer discussed during Availability of a 8 80 (2.20 - 35.22) 0.002** 38.9 
multidisciplmary consultation multidisciplmary team 
Older age 0 94(0.92-0.97) 0 000" 
Higher stage of disease 0.19(0.09-0 42) 0.000" 
PATIENT-ORIENTED QUALITY 
Attention to physical symptoms Specialized nurses with 0.19(0.05-0.78) 0.02 9.9 
coordination tasks 
Attention to psychosocial stress > 100 patients seen a 0.46(0.17-1.21) 0.11 3 1 
factors and psychological year 
symptoms 
Attention to psychosocial problems Greater age 0 96 (0 92 - 0 99) 0 05 7.1 
in family and problems related to 
living conditions 
Patient informed about existence Comorbidity 0 24(0 09 -0 65) 0 005" 18 5 
of nurses specialized in lung More than 100 patients 0 26(0 08 -0 80) 0 02 
cancer 
seen a year 
Patient adequately informed Barriers to guideline 0.47(0.15-1.52) 0.20 3 7 
regarding 10 information aspects implementation 
'Explained variance for final regression model 
"Significant at 0 01 
An OR greater 1 means a positive association with the quality indicator, an OR less than 1 means a negative 
association 
CI, Confidence interval, CT, computed tomography, FDG-PET, tluorodeoxyglucose-positron-emission tomography, OR, 
odds ratio 
More patients with a higher stage of disease (stage III or IV) completed the 
diagnostic route within 21 days (odds ratio [OR], 2.71; 95% confidence interval 
[95% CI], 1.35-5.44) and began therapy within 35 days (OR, 2.83; 95% CI, 1.38-
5.82). As expected, the greatest predictor of patients being discussed during 
multidisciplmary consultation is the availability of a multidisciplmary team for lung 
cancer (OR, 8.80; 95% CI, 2.20-35.22). Older patients and those with a more 
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advanced stage of disease were less likely to be discussed in multidisciplinary 
consultation (OR, 0.94; 95% CI, 0.92-0.97 and OR, 0.19; 95% CI, 0.09-0.42, 
respectively). 
With regard to the association between determinants and patient-oriented quality 
indicators, the only characteristic that reached significance was "comorbidity of 
patients". Patients with comorbidity were less informed about the existence of an 
oncology nurse specializing in lung cancer care (OR, 0.24; 95% CI, 0.09-0.65). 
Discussion 
To our knowledge, the current study the first to examine the variation and 
determinants of quality of integrated care for patients with NSCLC that uses three 
dimensions of care: professional quality, organizational quality, and patient-
oriented quality. The results of the current study demonstrated there was a large 
variation between hospitals with regard to scores for the quality indicators, and 
that the quality of integrated care (especially patient-oriented care) for NSCLC 
patients needs improvement. Patient characteristics were proven to have more 
influence on the scores than professional or hospital characteristics; patients with 
more advanced disease went through the diagnostic course more quickly and 
began therapy earlier, but were less likely to be discussed during multidisciplinary 
consultation. Patients with co-morbidity were less informed about the existence of 
oncology nurses specializing in lung cancer. 
Mediastinoscopy is used for intrathoracic staging of the mediastinum and 
determining lymph node involvement. The results of the current study demonstrate 
a high score (84%) for performing (17%) or skipping (67%) mediastinoscopy 
according to the criteria provided in the guideline. This was higher than the results 
of another Dutch study, namely, adherence to the guidelines for approximately 
67% of the patients.21 A further analysis of the cases that deviated from the 
guideline criteria shows that the main reason for not performing a mediastinoscopy 
was the use of alternative forms for staging of the mediastinum [transbronchial 
needle aspiration (TBNA) or endoscopic ultrasound-guided fine-needle aspiration 
(EUS-FNA)].22,23 However, because of their recent appearance, these techniques 
have not been incorporated into the guidelines on which the indicators were 
based. Obviously, some physicians have already implemented these new 
techniques, though the guideline committee has not yet formally accepted them. 
The low score for adequate sampling of lymph nodes (50%) was in agreement with 
the results of another study in the Netherlands that shows that mediastinoscopy 
was performed according to guideline criteria in 40% of the cases.21 In addition, 
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this study shows that the hospital with the least patients had the lowest score. We 
also expected to find some positive influences on the professional quality scores of 
determinants like "years of experience of professionals" and "teaching status of the 
hospital", because there were large variations among the hospitals regarding 
adequate sampling scores. Although we did indeed find these correlations in our 
univariate analysis, they did not remain significant in our multivariate analysis. The 
small number of hospitals may play a part. 
In the current study, only 29 of the 69 patients with clinical stage III NSCLC 
received combination therapy, and only one patient had both a skeletal 
scintigraphy and CT or MRI of the brain before initiation of combination therapy. All 
six hospitals had very low scores for this indicator. Of the patients who had no 
skeletal scintigraphy, 50% had a PET scan, which is quite likely the reason why no 
subsequent bone scan was done. Possible other reasons for these low scores are 
the expected low gain of 5% - not everyone is convinced that this is a cost-
effective strategy24,25 - and waiting times for CT and MRI are usually long, which 
slows down the throughput times before treatment can be initiated. 
In agreement with the study of Salomaa et al., we found that only half of the 
patients started initial therapy within 35 days of their first visit.26 The variation 
among the hospitals of 28% showed possibilities for improving this aspect of care. 
Delays were found to be shorter for patients with more advanced cancer. The 
literature shows that long waiting times do not by definition lead to poorer 
survival.26 However, several studies report tumour growth during waiting times that 
eventually lead to patients with curative options becoming incurable.27,28 From the 
patient's point of view, long waiting times for diagnosis and treatment are 
unacceptable. There is some premature literature about positive effects of so-
called "early-diagnosis clinics" on shortening waiting and throughput times.29 
Only two of the six hospitals in our study had a multidisciplinary team for lung 
cancer, which is required by guideline criteria. This is the main reason for the large 
variation noted among the hospitals regarding patients being discussed in 
multidisciplinary consultations (the lowest score was 26% and the highest score 
was 91%). As expected, the results of this current study demonstrate that patients 
with a higher disease stage (stage III or IV) and presumably monodisciplinary 
treatment options are less likely to be discussed during multidisciplinary 
consultation. Although to our knowledge there is only limited evidence about 
effects of discussing patients in a multidisciplinary team on patient outcomes30,31, 
most cancer guidelines recommend that all patients with cancer need to be 
presented in a multidisciplinary team at least once.32"34 
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The seven patient-centred indicators were based on two recommendations from 
the guideline These recommendations were selected by an expertpanel as being 
most important for the patient-oriented quality of care The low scores on these 
indicators were striking Specifically for patients with lung cancer, palliative and 
supportive care is of great importance because most patients diagnosed with lung 
cancer have incurable disease In agreement with the literature, patients in the 
current study reported that, in their view, physical symptoms and psychosocial 
problems were poorly evaluated and managed 35 The impact of lung cancer and its 
symptoms on the patient's psychological, social, and physical state should be 
identified early, and patients should be referred to the appropriate specialist for 
further assessment, as required The literature shows that screening lists for 
quahty-of-life issues could be helpful36 and that structured follow-up by nurses can 
improve psychosocial functioning 37 
Patients with greater co-morbidity appeared to be less informed about the 
existence of a nurse specializing in lung cancer care The mam reason for this is 
that only one hospital actually had a specialized lung cancer nurse Another 
possible explanation could be that patients with co-morbidity probably have 
appointments with many specialists, which may be a reason to forget details from 
consultations 
The results of the current study demonstrated a high number of patient and 
professional responses to our questionnaires However, the finding that greater 
than half of the patients in the study group had died and therefore could not be 
questioned most likely affected the results for the patient-oriented quality 
indicators The literature appears contradictory regarding the possible effects of 
stage of disease on patients' assessements of care 6 7 38 
The scores on the indicator regarding "mediastinoscopy according guideline 
criteria" is a good example of the finding that a low score on an indicator does not 
automatically mean that there is a problem in the quality of care, but rather is a 
signal to further evaluate the matter There can either be new evidence that 
demands a change in recommendations, or care should be improved In the 
Netherlands, the results of the current study and new available evidence regarding 
staging the mediastinum led to adaptation of the national guideline An important 
message for the medical community is that indicators as well as guidelines should 
be periodically updated, as such we call it "having a living guideline" that is ideally 
being updated continuously as new evidence becomes available Low scores can 
also be a signal that care should be improved The results of the current study 
demonstrate that agreeing on best clinical practice does not automatically lead to 
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implementation of the recommendations in the field. The best guaranteed quality 
of care could only be achieved by measuring quality of care from different 
dimensions, followed by an implementation programme (e.g. giving feedback to 
professionals) and then by measuring the quality of care once again. 
We conclude that the quality of integrated care for patients with NSCLC can be 
improved in all dimensions of quality of care, but special attention to the patient-
oriented issues is needed. With regard to determinants that influence the quality of 
care, the results of the current study demonstrate that patient characteristics 
appear to have more influence than professional or hospital characteristics. The 
next step in improving the quality of care for patients with NSCLC is the 
development of improvement strategies. These implementation programmes 
should be targeted at specific subgroups. Especially for patients with curative 
treatment possibilities, diagnostic and therapeutic delays should be minimized, 
and particularly patients with comorbidities should be informed about the existence 
of oncology nurses specializing in lung cancer. 
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Abstract 
Background: The management of patients with head and neck cancer is very 
complex, and the quality of care needs permanent attention. 
Objective: To evaluate the impact of a programme for improving integrated care for 
patients with head and neck cancer. 
Design: Prospective before-after study. 
Setting: Clinic for head and neck oncology at a university medical centre. 
Patients: 311 adults with head and neck cancer. 
Intervention: The integrated care programme consisted of interventions to improve 
three quality dimensions of care: patient-oriented quality, organizational quality, 
and medical-technical quality. 
Measurements: Scores of 19 integrated care indicators covering three quality 
dimensions and three outcome indicators measured by examination of medical 
records and questionnaires for patients and professionals. 
Results: The implementation of the integrated care programme led to relevant 
improvements in all quality dimensions of care, e.g. "waiting time for diagnostic 
procedures less than 10 days" (+37%), "waiting time to first treatment less than 30 
days" (+25%), "support for stopping smoking" (+37%), "nutrition support" (+44%), 
"assessment of computed tomography and magnetic resonance imaging scans by 
a radiologist who was an expert in head and neck oncology" (+23%) and "number 
of patients in contact with the specialist nurses" (+37%). The programme had no 
relevant effects on the outcome indicators. 
Limitation: The patients were not randomly assigned to an intervention. 
Conclusion: The integrated care programme can improve several aspects of the 
management of patients with head and neck cancer. 
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Introduction 
The management of care for patients with head and neck cancer is very complex 
First, this common type of cancer affects patients significantly because of the 
location of the tumour Patients often have problems with speech, eating and 
physical appearance due to treatment effects 1 Second, as head and neck cancers 
are heterogeneous and occur at various sites, they need to be managed via 
various disciplines in multimodal treatment23 The care for head and neck cancer 
varies widely4, and many hospitals cannot guarantee high quality in all three 
quality dimensions of care, namely patient-oriented quality3, organizational 
quality5, and medical-technical quality6 Integration of care and integration of the 
activity of the disciplines are crucial for optimizing care and outcomes The basis of 
integrated care is a patient interacting with a prepared, proactive, and 
multidisciplmary team delivering care according to best evidence in optimal 
coordination 78 The literature shows that integrated care programmes can improve 
the quality of care for patients with chronic conditions 9 There are, however, no 
good examples of the impact of integrated care programmes on the care for 
patients with head and neck cancer 
To improve patient care, a systematic approach is important10 According to Grol 
and others, the following steps should be taken obtain insight into the actual care 
by developing a set of indicators and measuring the care with them, analyze 
barriers and facilitators (determine the problems in care provision and the factors 
that aid or hamper improvement), develop and implement an improvement 
programme, and continuously monitor care on the basis of the indicators 1012 The 
same approach can be used to implement an integrated care programme for 
patients with head and neck cancer 
Therefore, with the aid of evidence-based guidelines and opinions of professionals 
and patients, we developed a valid set of indicators for assessing the actual care 
for such patients 13 The results of interviews with all professionals involved in this 
care were analyzed to identify the barriers and facilitators of the care We took 
these analyses and the literature about effective integrated care interventions9 into 
account when we developed our integrated care programme for improving the 
quality of care The aim of this study was to assess the impact of this care 
programme on the quality of care for patients with head and neck cancer 
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Patients and methods 
Study population and setting 
The impact of the integrated care programme was assessed in a prospective 
before-after study that took place in a clinic for head and neck oncology at the 
Radboud University Nijmegen Medical Centre (RUNMC) in the Netherlands. The 
centre treats approximately 425 new cases of head and neck cancer annually. The 
patients with head and neck cancer were identified in the registry of the clinic for 
outpatient head and neck oncology. For the before-measurements, all patients 
who came to the clinic for their first consultation in the period May 2003 -
December 2003 were retrospectively included in the study. The integrated care 
intervention programme was implemented in the period January 2004 - November 
2005. All patients who came to the clinic for their first consultation in the period 
December 2005 - July 2006 were included for the after-measurements. 
Indicators for assessing the quality of integrated care 
The care before and after implementation of the integrated care programme was 
assessed with a set of 20 indicators that were developed in a previous study13, 
and three outcome indicators. The 20 indicators covered three quality dimensions: 
patient-oriented quality (indicators about information supply, emotional and social 
support, support for stopping smoking and alcohol consumption), organizational 
quality (indicators about waiting and throughput times and continuity of care), and 
medical-technical quality (indicators about speech and swallowing revalidation, 
nutritional support, assessment of computed tomography (CT) and magnetic 
resonance imaging (MRI) procedures and dental consultation). We added some 
structure indicators about specific integrated care requirements913 (availability and 
functioning of a multidisciplinary team and availability of an integrated care 
pathway, case managers, and a clinical leader). The three outcome indicators 
dealt with quality of life in general, quality of life for patients with head and neck 
cancer, and patient satisfaction. 
Integrated care programme 
The integrated care programme for improving the care for patients with head and 
neck cancer at the RUNMC was based on the actual care as assessed with a 
validated set of indicators13, national measurements of barriers during diagnoses 
and treatment in all head and neck reference clinics14, interviews about barriers 
and facilitators for improving the care with all the professionals involved in the 
RUNMC, and a systematic review of the effective integrated care requirements.9 
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These assessments showed that waiting times for diagnostic procedures and for 
the start of treatment, information supply and lifestyle support for patients, and 
support from allied health professionals could all be improved. Some requirements 
for the delivery of integrated care were not, or not adequately available such as 
integrated care pathways, head and neck specialist nurses for case management 
tasks, and a clinical leader with specific tasks regarding the management of the 
group of patients with head and neck cancer. 
Using the information just mentioned, we developed an integrated care 
programme that consisted of interventions covering the three quality dimensions of 
care: patient-oriented quality, organizational quality, and medical-technical quality. 
We added some requirements for integrated care to the programme. Table 1 
shows an overview of the components of the integrated care programme. 
Table 1. The components of the integrated care programme 
Quality dimensions Components 
Patient-oriented quality Patient information record with information about relevant issues 
Specialty nurses who gave extra support for stopping smoking and 
reducing alcohol consumption 
Organizational quality Optimahzation of the diagnostic process (intake day, arrangements 
about numbers of procedures needed) recorded in a clinical pathway 
and a checklist 
Medical-technical quality Monitoring of weight change and nutrition by a dietician 
Meetings for physicians, nurses, and allied health professionals about 
specific topics in the care for patients with head and neck cancer 
Extra radiologists specializing in head and neck cancer 
Integrated care requirements Multidisciplmary patient care team 
Specialist nurses 
Integrated care pathways 
Clinical leader 
Patient-oriented quality 
A patient information record had to be developed and implemented. The main goal 
of this record was to inform patients of relevant issues regarding their treatment 
and to make sure that patients would be better informed about the availability of 
emotional and social support and contact with a companion in distress. The 
intention was that all patients with head and neck cancer would receive this record 
from the specialist nurses during their first consultation at the clinic. The record 
had to contain basic information about head and neck cancer and contact 
numbers; relevant information could be added any time. The specialist nurses paid 
extra attention to alcohol use and smoking behaviour and offered support in 
stopping, if necessary. 
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Organizational quality 
To shorten the waiting times, the steps of the diagnostic process were optimalized. 
There was a special intake day once a week when a head and neck specialist 
nurse, a head and neck surgeon, a radiotherapist, and a maxillofacial surgeon saw 
the new patients. On the basis of the expected number of patients, arrangements 
were made for fixed numbers of diagnostic procedures. In accordance with 
recommendations in the guideline, the diagnostic process for a patient had to be 
completed within 10 days: on the day of the first consultation the patient could 
have a chest x-ray and could be seen for details of anaesthesia at the outpatient 
clinic if necessary, a CT scan and/or a MRI scan could be made on day 2, any 
necessary laryngoscopy or pharyngoscopy could be done while the patient was 
under general anaesthesia on day 3, and all results had to be available and 
presented for multidisciplinary discussion on day 10. 
Medical-technical quality 
To monitor and improve weight change and nutrition, a dietician had to consult 
with all patients with head and neck cancer during diagnosis, treatment, and 
revalidation as recommended by the Dutch national guideline.15 To improve 
aspects such as "swallowing revalidation", "speech revalidation", and "dental care", 
physicians, specialist nurses, and allied health professionals attended four 
discussion meetings. 
Integrated care requirements 
A multidisciplinary patient-care team in which all patients are discussed was 
already available. A second specialist radiologist was added to the team to help 
assess the CT and MRI procedures. This specialist radiologist was present at the 
multidisciplinary meetings. Specialist nurses were also available. To guarantee 
that a specialist nurse saw each patient, extra nurses received special training and 
joined the team. Furthermore, the details of the care process for patients with head 
and neck cancer were written down in a clinical pathway and checklists. 
Data collection 
The data for assessing the impact of the integrated care programme were 
collected using the quality indicators. The data for the indicators regarding patient-
oriented quality were collected with questionnaires. The indicators covered: 
"coordination", "information", "emotional and social support", "contact with a 
companion in distress", "support for stopping smoking and reducing alcohol 
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consumption", and "patient involvement" (Table 3). After the medical ethics 
commission of the RUNMC gave their approval, each patient was identified from 
the outpatient appointment lists and sent a questionnaire accompanied by a letter 
from his/her consultant. Patients who had not responded within 2 weeks were 
reminded by telephone. 
The data for all indicators regarding organizational quality except one were 
extracted from medical records ("waiting time for first consultation", "waiting time 
for diagnostic procedures", and "waiting time for first treatment").The data for the 
indicator "continuity of care" consisted of the opinions from the patient 
questionnaire (Table 4). 
The data for the indicators regarding medical-technical quality were collected from 
the patient questionnaire and from medical records. The data for the indicators 
about "swallowing revalidation" and "speech revalidation" were collected from the 
patient questionnaire; the other data within this dimension were extracted from the 
medical records ("nutrition support", "assessment of CT and MRI procedures", and 
"dental consultation with the oral and maxillofacial expert team" (Table 5). 
The data needed to assess the availability of the integrated care requirements 
were collected by direct observation except for "interaction with the case 
managers" which was an item in the patient questionnaire. The functioning of the 
multidisciplinary team was assessed with an instrument for measuring team 
climate, namely, the Team Climate Inventory.16 
All outcome indicators regarding the quality of life [European Organization for 
Research on Treatment of Cancer (EORTC) quality-of-life questionnaire (QLQ)-
C30 and QLQ-H&N35 1718] and patient satisfaction (our own list) were assessed 
with patient questionnaires. 
Data analysis 
SAS statistical software (version 9.1.3 SAS Institute, Gary, North Carolina) was 
used to compare the patient groups before and after the integrated care 
programme was implemented. A mixed logistic linear model was used to see if 
there were significant differences between scores before and after the 
intervention. A random effect model was used to correct for mutual dependency. 
We assumed a significant difference between the two groups of patients if the 
significance was less than 0.05. 
The influence of disease stage on the effect between the intervention and control 
group was tested by an interaction term in the model. 
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A clinically significant difference for the EORTC QLQ-C30 and EORTC QLQ-
H&HN35 and the satisfaction list was defined as a difference of 10 points or 
more.19 
Results 
In the before-measurement, 158 of the 189 patients (84%) returned the 
questionnaire. After the implementation of the integrated care programme, 153 of 
the 172 patients (89%) returned the questionnaire. All medical records for these 
patients were examined. Both groups of patients did not significantly differ in age, 
sex, education, tumour location, and disease stage (Table 2). All professionals but 
one (n = 13) returned the questionnaire about team climate. The interaction term 
was not significant so disease stage had no influence on the effect scores. 
Table 2. Characteristics of the study population before and after the intervention 
Mean age in years 
Men, in percentages 
Education, in percentages 
Higher 
Intermediate 
Vocational 
Tumour locations, in percentages 
Larynx and hypopharynx 
Oropharynx 
Oral cavity 
Other 
Stages, in percentages 
I 
II 
III 
IV 
Before (n = 158) 
65 
73 
23 
23 
54 
30 
5 
31 
34 
34 
19 
21 
26 
After (n = 153) 
66 
73 
23 
34 
43 
38 
8 
23 
31 
29 
22 
12 
37 
Patient-oriented quality 
The scores before the implementation of the integrated care programme for 
"coordination" and "asking patients about their alcohol consumption and smoking 
behaviour" were high (Table 3). These high scores did not change after the 
implementation period. The scores for "information supply", "emotional and social 
support", and "contact with a companion in distress" were 44% or less before the 
integrated care programme, and did not improve afterwards. More patients 
reported that they were offered support for their alcohol problems (+21%) and 
support for stopping smoking (+37%). The patients felt (93%) and kept on feeling 
(95%) involved in decisions regarding their treatment. More patients reported 
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interaction with a specialist nurse: +50% (otorhinolaryngology), 
(radiotherapy), and +22% (oral and maxillofacial treatment). 
+38% 
Table 3. Scores of indicators of patient-oriented quality before and after implementation of the 
integrated care programme 
Before After Significance 
Coordination 
Patients who know who to contact for information and 
questions 
Information 
Patients who were well informed on all information items 
applicable to their situation (Table 3) 
Emotional and social support 
Patients who said they were offered emotional support 
Contact with a companion in distress 
Patients who were informed about the possibilities of 
contacting companions in distress 
Reducing alcohol consumption 
Patients who had been asked about alcohol use 
Patients with alcohol problems who were offered support 
Non-smoking policy 
Patients who had been asked about smoking behaviour 
Smokers who were offered support to stop smoking 
Patient involvement 
Patients who feel involved in decisions regarding their 
treatment 
Case manager 
Availability of a case manager 
Patients interacting with the case manager(s) 
87% (124/143) 85% (115/136) 0 61 
44% (67/153) 50% (73/145) 0 37 
21% (30/143) 
27% (41/150) 
94% (131/139) 
25% (15/59) 
97% (144/148) 
35% (24/68) 
93% 
20% (27/133) 
15% (21/142) 
96% (138/144) 
46% (13/28) 
99% (143/145) 
72% (38/53) 
95% 
0 89 
0 01* 
054 
0 05* 
0 43 
0 000* 
0 58 
Available 
5 specialist 
nurses 
ENT 33% 
RT 48% 
OMS 74% 
Available 
8 specialist 
nurses 
ENT 83% 
RT 86% 
OMS 96% 
0 000* 
0 000* 
0 014* 
* Significarli difference p<0 05 
ENT = Ear Nose Throat Surgery, RT = RadioTherapy, OMS = Oral and Maxillofacial Surgery 
Organizational quality 
Regarding the organizational quality, there were no significant differences between 
the patient groups before and after the implementation of the integrated care 
programme regarding "waiting time for first consultation" and "continuity of care" 
(Table 4). Significant improvements were seen for "waiting time for diagnostic 
procedures" and "waiting time for first treatment". After implementation of the 
programme, 21% of the patients had all the necessary diagnostic procedures on 
the day of their first consultation in contrast to 7% at baseline. The proportion of 
patients who completed all the necessary diagnostic procedures within 10 days 
increased from 34% to 71%. The mean number of waiting days for diagnostic 
procedures decreased from 16 to 2; long waiting times remained for direct 
laryngoscopy and pharyngoscopy with the patient under general anaesthesia 
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More than half of the patients started therapy within 30 days after the first 
consultation, a significant improvement of 25%. 
Table 4. Scores of indicators of organizational quality before and after implementation of the 
integrated care programme 
Before After Significance 
Waiting time for first consultation 
Patients who could see a consultant 1 day after referral 24%(29/121) 21%(25/118) 0.61 
Mean 5 days Mean: 5 days 
Waiting time for diagnostic procedures 
Patients who had all the necessary diagnostic procedures 7% (10/147) 21% (32/153) 0.0009* 
the day of their first consultation with the consultant 
Patients who had all the necessary diagnostic procedures 34% (49/144) 71% (109/153) 0 0001* 
within 10 days after their first consultation with the consultant 
Mean: 16 days Mean· 2 days <0 0001* 
Chest radiograph 7 days 1 day 
CT thorax 14 days 2 days 
MRI 16 days 2 days 
Ultrasound 8 days 2 days 
Diagnostic procedures with patient anaesthetized 15.5 days 13 days 
Number of times patient went to the hospital during 3 2 2 2 " <0 0001 * 
diagnostic phase 
Waiting time for first treatment 
Patients who started their first treatment within 30 days after 29% (35/122) 54% (77/143) <0.0001* 
their first consultation with the consultant 
Mean 36 days Mean 29 days 0.0001* 
Operation 31 days 27 days 
Radiotherapy 45 days 36 days 
Chemotherapy 45 days 31 days 
Continuity of care 
Patients who said that the transition was seamless 
At the head and neck centre 83% (131/158) 90% (138/153) 0 10 
In the hospital 74% (112/152) 86% (115/134) 0 013* 
Returning home from the head and neck centre 77% (104/135) 74% (110/148) 0 74 
* Significant difference p<0 05 
CT, computed tomography, MRI, magnetic resonance imaging 
Medical-technical quality 
The greatest improvement in this area concerned the indicator "nutrition support" 
(Table 5). Forty-four percent more patients were monitored and offered support for 
their nutritional health status. Substantial change was also seen for the indicator 
"assessment of CT and MRI procedures by a radiologist experienced in head and 
neck cancer" (+23%). The score for "dental consultation with an oral and 
maxillofacial expert team" was already high (95%) and did not change significantly. 
The scores for swallowing and speech revalidation were low before 
implementation of the integrated care programme (27% and 21%, respectively) 
and did not improve afterwards. 
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Table 5. Scores of indicators of medical-technical quality before and after implementation of the 
integrated care programme 
Before After Significance 
Swallowing revalidation 
Patients with swallowing problems after leaving the hospital 27% (9/33) 36% (8/22) 0 49 
who were offered arrangements about follow-up 
Speech revalidation 
Patients who had radical neck surgery or radiation in this area 21% (18/84) 23% (12/53) 0 87 
and with whom arrangements were made about follow-up for 
their speech revalidation 
Nutrition support 
Patients whose nutrition health status was monitored before, 0% (0/147) 44% (61/139) 0 000* 
during, and after treatment 
Assessment of CT and MRI procedures by specialist 
radiologist 
Proportion of assessments of CT and MRI procedures 66% (40/61) 89% (93/105) 0 004* 
performed by this radiologists 
Dental consultation with an oral and 
maxillofacial expert team 
Patients with cancer of the mouth or oropharynx who had been 95% (62/65) 98% (60/61) 0 37 
seen by a maxillofacial expert team 
* Significant difference p<0 05 
CT, computed tomography, MRI, magnetic resonance imaging 
Integrated care requirements 
A multidisciplinary team for patients with head and neck cancer was already 
available and was extended with a second radiologist expert on head and neck 
cancer during the after-measurement. The functioning of the team with regard to 
team climate was already high (74%), but improved by 11%. The care of patients 
with head and neck cancer was analysed and redesigned, and the results were 
recorded in an integrated care pathway. A checklist based on this care pathway 
was available in every patient record after the implementation of the integrated 
care programme. The number of nurses specializing in head and neck cancer was 
increased from 5 to 8. It was agreed that, within each main specialism (head and 
neck surgery, oral and maxillofacial surgery, and radiotherapy) one consultant 
would be the contact person. The chairperson of the multidisciplinary meeting 
acted as the clinical leader and main contact person for the group of patients with 
head and neck cancer. 
Outcome 
The integrated care programme did not have any relevant effects on the quality of 
life or patient satisfaction. 
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Discussion 
In order to improve the quality of care for patients with head and neck cancer, we 
tested the impact of a systematically developed, integrated care programme on 
the quality of care. Although this study was not a randomized controlled trial, 
relevant improvements were seen, particularly in the aspects of the management 
of patients with head and neck cancer on which the programme was focussing. 
With regard to patient-centredness, patient information records can improve 
patient's knowledge and satisfaction with care.20"23 Our main intervention regarding 
the patient-oriented quality was the development and introduction of an 
information record for patients. Unfortunately, the development of the record took 
more time than expected. It seemed hard for the professionals involved to reach 
consensus about the final text. While the record was tested, the patients in the 
after-measurement group did not receive one. Smoking habits and alcohol 
consumption play an important role in the development and prognosis of head and 
neck cancer.24,25 In agreement with the literature, our study shows that special 
attention and offering support from specialist nurses at the time of intake can lead 
to relevant improvements.26,27 
Regarding the organization of care, the integrated care programme mainly 
focussed on the waiting times in the diagnostic phase. There were significant 
waiting time improvements, after the implementation of the programme. Long 
waiting times persisted for diagnostic procedures involving anaesthesia. 
Arrangements were made for an anaesthesiologist to see patients immediately on 
the intake day. However, patients often had co-morbidities and needed to be seen 
by other consultants as well. This lengthened the waiting time. The "waiting time 
for first treatment" was shortened, but almost half of the patients still could not start 
therapy within 30 days. Shortening the waiting times only in the diagnostic phase 
is not enough. Waiting times in both the diagnostic phase and the treatment phase 
should be shortened, possibly by enlarging the operation and radiotherapy 
capacities or by setting priorities. There are contradictory studies concerning the 
impact of waiting times on patient outcomes28 30, but from the patient's point of 
view, long waiting times for diagnosis and treatment are unacceptable. All patients 
sent to the head and neck centre were tertiary referrals, and almost all of them 
appeared to have cancer, so more effort should be made, to shorten the waiting 
times, particularly those for starting treatment. 
Regarding the medical-technical quality, the programme aimed at improving 
nutrition and reducing weight loss by scheduling appointments for dieticians to see 
patients before, during, and after treatment. Malnutrition of patients with head and 
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neck cancer, particularly patients with tumours of the oral cavity, oropharynx, or 
hypopharynx, is a common problem and can reduce survival and quality of life 3133 
Because of financial constraints, this part of our intervention programme could 
unfortunately only be realized for patients with tumours of the oral cavity and 
oropharynx This is why the indicator "seen by a dietician" led to a relevant 
improvement of 44% for the whole group of patients, while for this specific group 
the score was 82% The discussion meetings attended by physicians, specialist 
nurses and allied health did not lead to improvements regarding swallowing and 
speech revalidation As the literature supports the view that speech and language 
therapy is beneficial in the rehabilitation of patients with head and neck cancer 
34 35
, care should be improved by means of specific interventions that target the 
speech and language therapists themselves 
Most of the requirements for integrated care were present at baseline and the 
integrated care programme improved some aspects The importance of a 
multidisciplmary team for patient care that functions well is crucial for providing 
high-quality care for patients936 Team functioning is determined by structural 
elements such as workload, team size, and team composition3738, but also by 
team processes, such as the team climate Team climate scored high and 
improved slightly after the intervention programme All the necessary disciplines 
were present in the multidisciplmary team, but a second radiologist expert in head 
and neck cancer care joined the team, which automatically led to a relevant 
improvement in the assessment of CT and MRI scanning Although there is no 
evidence that specialist nurse support has an effect on the quality of life or 
survival, it is suggested in many guidelines by expert opinion and formal 
consensus 15394i:) in our study, extra nurses received specialty training This raised 
the number of patients who reported interaction with these nurses and improved 
the support for "reducing alcohol consumption" and "non-smoking" 
Indicators were used to measure the quality of integrated care Indicators can be 
related to structure, process or outcome of healthcare 41 Structural indicators focus 
on organizational aspects of service provision (e g availability of a case manager) 
Process indicators focus on the actual care delivered to and negotiated with the 
patients as well as communication with the patient Outcome indicators specify the 
ultimate goal of the care given, and can relate either to health status or patient 
evaluations of care 10 Our study shows no relevant improvements of the integrated 
care programme for the health outcome indicators (quality of life and patient 
satisfaction) In our opinion, process indicators and structure indicators are 
generally more useful than outcome indicators for quality improvement research 
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because they tend to be frequent, immediate, controllable and less likely to be 
confounded by other factors.42,43 
To assess the impact of the integrated care programme on patients with head and 
neck cancer, we did not randomly assign patients to an intervention. Within one 
centre, it is not possible to treat one patient according to the integrated care 
programme, but not another. This would lead to contamination. However, because 
our study showed relevant improvements, particularly for the indicators on which 
the programme focused, we may assume that this is, at least partly, caused by the 
integrated care programme. 
The present study shows that an integrated care programme can affect the 
management of patients with head and neck cancer in several ways. The 
programme shows no benefits for quality of life and patient satisfaction. Further 
research is needed to test the costs and effectiveness of the programme in cluster-
randomized trials and in other groups of patients with cancer. 
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INTRODUCTION 
The focus of this thesis was to explore principles of integrated patient care, and to 
search for instruments and interventions to measure and improve integrated care, 
particularly for patients with cancer Demands on health care have changed by 
sub-specializations and more diagnostic procedures and treatment modalities, by 
the aging of the population and by patients demanding being more and more 
actively involved in their care Integrated care or disease management has begun 
to receive greater support as approaches to improve the quality of care and to 
meet the needs of patients There is substantial literature on integrated care or 
disease management but an overview of principles and valid instruments to 
measure these principles are missing 
Theme I described studies that aimed to explore principles of integrated care in 
general (chapter 1) and integrated care for patients with cancer in particular 
(chapter 2), followed by a study that described the development of an instrument 
to measure the principle of "patient-centredness" (chapter 3) and a study about the 
validation of an instrument to measure "team climate in (multi)disciplinary teams" 
(chapter 4) 
Theme II described studies on the assessment and improvement of integrated 
care for patients with cancer Chapter 5 and 6 described the systematic 
development of a valid set of indicators to assess integrated care for patients with 
head and neck cancer (chapter 5) and patients with non-small cell lung cancer 
(chapter 6) In order to estimate room for improvement, determinants of variation in 
actual care for patients with non-small cell lung cancer were studied (chapter 7) 
To improve integrated care for patients with head and neck cancer, an integrated 
care programme was developed, implemented and evaluated on its effectiveness 
(chapter 8) 
In this general discussion the mam findings of these studies are presented and 
discussed, starting with 12 key messages that are categorized under theme I and 
theme II Subsequently, the most relevant methodological issues are reviewed 
This general discussion ends with some recommendations for practice and further 
research 
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KEY MESSAGES 
Theme I Principles and Instruments of Integrated Care 
1. Principles of integrated care 
- Basic principles of integrated care are: care is organized around the needs 
and preferences of patients, and patients are actively involved in their care 
(patient-centredness); care is given in optimal collaboration of all 
professionals involved (multidisciplinary care); and care is seamless and 
continuous, by optimal coordination of the total care process of the patients 
(coordinated care). 
2. Interventions maintaining the principles of integrated care 
- Integrated care for patients with chronic diseases can be maintained by a 
number of interventions: patient self-management support and information, 
arrangements about clinical follow-up, case management, introduction of a 
multidisciplinary patient-care team and a systematic evidence-based 
approach to change processes of care, for example by using clinical 
pathways. Additional requirements are: a supportive clinical information 
system, a shared mission on integrated care and leaders who express a 
clear vision on integrated care. 
- The most promising interventions to improve integrated care for patients 
with cancer are: "audiotaped consultation for patients", "information to 
patients", "decision aids for patients", "follow-up by nurses or general 
practitioner", "case management" and "one-stop clinics". These promising 
interventions should be part of integrated care programmes and should be 
evaluated using rigorous methods and unequivocal outcome measures 
linked to the intervention. 
3. Instruments for measuring the principles of integrated care 
- Patient-centredness must be measured before effective improvements can 
be made. The instrument developed in our study is a valid and reliable tool 
to measure patient-centred cancer care. 
- The Dutch translation of the Team Climate inventory (TCI), an instrument to 
measure team climate in (multidisciplinary) teams, is a valid, reliable and 
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discriminating self-report measure for hospital teams The Dutch TCI can be 
used as a quality-improvement tool, and as an outcome measure in 
evaluation studies 
Theme II Assessing and improving the quality of integrated care 
for patients with cancer 
4 Assessing integrated care for patients with cancer 
- Using clinical indicators for assessment of the quality of care is important for 
delivering high-quality integrated care, as this is the basis for continuous 
improvement of care Clinical indicators must be developed and tested with 
scientific rigour in a transparent process To get a balanced set of indicators, 
three dimensions of quality of care should be addressed patient-oriented 
quality (support and information for the patient), professional or medical-
technical quality (right diagnosis and treatment for effective and safe care) 
and organizational quality (continuity and coordination of care to enable 
efficient care) 
- Professionals and patients sometimes have different opinions about good 
quality of care Including the opinions of patients in the development process 
for indicators can make a difference, especially for items like lifestyle 
support, information supply and the wish for 1-day screening 
- Insight in determinants of variation in actual care is needed to target the 
improvement strategy on the right subgroup of patients Our study showed 
that patient characteristics, as co-morbidity and disease stage, have more 
influence than hospital or professional characteristics 
- Indicators play an important role in the process of quality improvement A 
low score on an indicator does not automatically mean that there is a 
problem in the quality of care, but is a signal to further explore the situation 
Low scores can be signals that care should be improved, but also that there 
is new evidence that demands changed recommendations Indicators as 
well as guidelines should be periodically updated to have "living" indicators, 
which are ideally continuously being updated as soon as new evidence is 
available 
162 
General discussion 
5. Improving integrated care for patients with cancer 
- There is much room for improving the quality of care for patients with 
cancer, on all quality dimensions (patient-oriented quality, professional or 
medical-technical quality and organizational quality), and regarding 
additional requirements for integrated care (e.g. multidisciplinary team, case 
managers, clinical pathways, clinical leader and clinical information system). 
While it is essential to raise the overall quality of care on all dimensions, 
improvement of the patient-oriented quality followed by the organization of 
care should be priorities. 
- Although it is known that patient's physical and mental state have a great 
impact on clinical outcomes and quality of life, not enough attention is paid 
to relieving symptoms. Possible interventions to improve care are: screening 
interventions for psycho-social and physical problems, follow-up by 
specialist nurses, information records for patients and communication 
training for professionals. 
- Integrated care for patients with head and neck cancer can be improved with 
a multi-component improvement programme. This programme should 
consist of interventions targeting at patients, professionals and the 
organization of care. 
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DISCUSSION OF THE MAIN FINDINGS 
Theme I Principles and Instruments of Integrated Care 
1. Principles of integrated care 
Our study on principles of integrated care (chapter 1) showed that patient-
centredness, multidisciplinary care and optimal coordination of care are the basic 
principles of integrated care. These principles are clear and logical and should be 
combined with the important principles of evidence-based medicine and 
continuous quality improvement. Evidence-based medicine is conscientious, 
explicit and judicious use of current best evidence in making decisions about the 
care of individual patients.1 Continuous quality improvement means continuously 
assessing and improving care by collecting data on indicators and improving care 
where necessary.2 Therefore, we assume that integrated care is based on five 
principles: patient-centredness, multidisciplinary care, coordination of care, 
evidence based medicine and continuous quality improvement. We consider the 
first three principles as being basic principles of integrated care.(Table 1) 
Table 1. Principles of integrated care 
Patient-centredness Organizing the care around the preferences and needs of the patients and 
actively involve patients in their care 
Multidisciplinary care Optimal collaboration of all professionals involved in the care for the patients 
Coordinated care Reducing fragmentation by optimal coordination of the total care process of 
patients 
Evidence-based medicine Delivering care according the best available evidence in making decisions 
about the care of individual patients 
Continuous quality Continuously assessing and improving care by collecting data on indicators 
improvement and improving care where necessary 
Our findings are in line with theories of others. The best known theory for the 
management of patients with chronic diseases is the chronic care model of 
Wagner and others.3"5 The chronic care model (CCM) is a guide to higher-quality 
chronic illness management within primary care. The model is based on 6 
interrelated components: self-management support, clinical information systems, 
delivery system redesign, decision support, health care organization, and 
community resources. Improvements within these components can produce a 
health care system in which informed, activated patients interact with prepared, 
proactive practice teams. Improvements to the CCM have been provided by the 
World Health Organization through the development of the Innovative Care for 
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Chronic Conditions (ICCC) framework. Another theory is of the Disease 
Management Association of America (DMAA).7 They consider six components in a 
"full service" disease management programme, including 1) population 
identification processes, 2) evidence based practice guidelines or performance 
standards of care, 3) collaborative practice models to include physicians and 
support service providers, 4) patient self-management education, 5) process and 
outcome measurement and 6) routine reporting and/or feed-back. Another theory 
on improving quality and safety of care is on Clinical Microsystems. Mohr and 
Batalden state that an effective microsystem has eight characteristics: 1) 
integration of information, 2) measurement, 3) interdependence of the care team, 
4) supportiveness of the larger system, 5) constancy of purpose, 6) connection to 
the community, 7) investment in improvement and 9) alignment of role and 
training.8 These theories can be of use for high quality of integrated care for 
patients but show no clear picture how the principles of integrated care can be 
assessed and improved in practice. 
2. Interventions sustaining the principles of integrated care 
Type of interventions 
To improve integrated care for patients, interventions are needed that support the 
principles of integrated care. In our review of reviews we found only 13 systematic 
reviews on integrated care and none for patients with cancer (chapter 1). We 
identified 33 studies in our review on integrated care interventions for patients with 
cancer, but no study evaluated integrated care programmes that sustained all 
three basic principles of integrated care (chapter 2). Interventions most commonly 
mentioned to improve integrated care were: patient self-management support and 
information, arrangements about clinical follow-up, case management, introduction 
of a multidisciplinary patient-care team and a systematic evidence-based approach 
to change processes of care, for example by using clinical pathways. Additional 
requirements mentioned were: having a supportive clinical information system, 
having a shared mission on integrated care and leaders that express a clear vision 
on integrated care and support its achievement.(See Table 2 for some examples) 
Table 2. Examples of interventions that sustain the principles of Integrated Care 
Patient-centredness 
Self-management support 
Decision aids 
Communication training for 
professionals 
Multidisciplinary care 
Revision of professional roles 
Multiprofessional collaboration 
Multidisciplinary teams 
Coordinated care 
Nurse-led follow up at the clinic 
Nurse case management 
Clinical pathways 
One-stop-clinic 
165 
General discussion 
Possible reasons for the small number of studies evaluating integrated care 
interventions and programmes, could be a number of methodological problems 
when evaluating these programmes 911 On the first place, there are hardly any 
valid and reliable instruments to measure the principles of integrated care such as 
for example patient-centred ness and team functioning Secondly, it is hard to 
evaluate overall effectiveness of integrated care programmes, because of the 
heterogeneity and multi-component nature of the programmes themselves 12 On 
the third place, it is difficult to set up a controlled study because it is a source of 
contamination if patients are randomized to the intervention programme within one 
clinic A cluster-randomized design would be possible but this requires more 
patients per clinic because patients cluster within one clinic 
Effectiveness 
Our reviews made clear that some interventions to improve integrated care for 
patients in general and patients with cancer in particular, show positive trends in 
effects (chapter 1 and 2) The most successful interventions were interventions 
that had the aim to improve information supply to patients and interventions 
regarding revision of tasks and responsibilities (follow-up and case management) 
Reported effects were mainly on outcomes regarding the process of integrated 
care and self-report measures as patient satisfaction and quality of life Objective 
health outcome measures as mortality or morbidity were often not used and if 
used, hardly any positive effects were found 
We argue that mortality, and some other objective health outcomes, are probably 
not the appropriate measures to evaluate mam effects of integrated care 
interventions There are studies that show relations between better processes of 
care and mortality or tumour growth 1314 However, better organization of care and 
a better-informed patient does not automatically lead to life extension for patients 
or a better quality of life To evaluate integrated care interventions it is better to 
use outcomes closer to the care process For example, giving patients an 
audiotape of their consultation has the intention to improve their recall of 
information In all studies using the audiotape for patients, the outcome "recall of 
information" improved significantly after the intervention1517 For integrated care 
programmes it might be useful to evaluate expected improvements in the 
performance of important process measures as for example "recall of information" 
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3. Instruments for measuring the principles of integrated care 
Patient-centredness 
To measure patient-centredness, one of the basic principles of integrated care, we 
developed an instrument and tested this on patients with non-small cell lung 
cancer (chapter 3). The indicators in the instrument were based on 
recommendations from evidence-based guidelines and opinions of professionals 
and patients. There was a large variation among guidelines as far as the domains 
of patient-centredness were addressed. 
Two principles of integrated care, patient-centredness and evidence-based 
medicine, might conflict here. Evidence-based medicine combines individual 
clinical expertise and external scientific evidence, offering clinicians the best 
available evidence about the most adequate treatment for their patients.1 
However, evidence-based medicine is disease-oriented, and not patient-oriented; 
the best performance in concrete conditions is presented for "all patients". The 
recommendations are mostly based on randomized controlled trials (RCTs). RCTs 
are performed under experimental (read artificial) conditions, while the results 
should also be applicable to "real-life-patients" who may not fulfil the inclusion 
criteria for participation in the study. Clinical evidence is derived from scientific 
research on populations and mostly not from patient's unique knowledge and 
experiences, neither from patients' individual needs and preferences.18 It is argued 
that evidence-based medicine is essentially a doctor-centred approach, as it 
focuses on the doctor's interpretation of evidence and ignores the importance of 
human relationships and the role of the patient.19 Sweeney made a plea for a third 
dimension in clinical decision making; beyond the statistical significance based on 
randomized clinical trials and clinical relevance that relies on doctor's intuition and 
experience, he added personal significance from the individual patient as the third 
complementary source of useful information. 
To solve the paradox between the principles of evidence-based medicine and 
patient-centredness, more recommendations regarding patient-centredness 
should be included in the guidelines, patients should be involved in the process of 
the development of guidelines and indicators, and professionals should make 
evidence-based medicine patient-centred by combining best evidence with their 
individual clinical expertise and the needs and preferences of patients. 
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Team climate 
Poor translation and testing processes of instruments may lead to an instrument 
that is not equivalent to the original questionnaire 20 To construct a valid and 
reliable Dutch version of the questionnaire to measure team climate (TCI), we 
followed the guidelines of Beaton 21 The validity test of the Dutch TCI into 36 
hospital teams showed acceptable reliabilities (chapter 4) 
The originally four-factor model, was not confirmed, we found a five-factor 
structure just as in previous studies22 24, however the distributions of items differed 
in our study The scale "participative safety" fell into two subscales, namely, 
"information sharing and interaction frequency" and "safety and influence" 
"Participative safety" is the scale with the most items and it is defensible that the 
items of the subscales "influence" and "safety" cluster When "everyone's view is 
listened to, even if it is in a minority", "people feel understood and accepted by 
each other" The same counts for the subscales "information sharing" and 
"interaction frequency" when "people interact frequently" it seems logical that 
"team members keep each other better informed" Further research should be 
performed to investigate if this structure of the TCI is specific for (Dutch) hospital 
teams 
Multidisciplmary teamwork is of great importance in delivering high-quality care, 
but there is little evidence on the functioning and effects of multidisciplmary 
teams25 The TCI has been used to assess team functioning and to identify areas 
that could be improved2627 In addition, it has been used in research as an 
outcome measure of quality-improvement strategies or to predict the success or 
failure of such a strategy2Θ 30 In our study on improving care for patients with head 
and neck cancer we used the TCI both as a tool to discuss and improve team 
functioning and as a measure for evaluation The results of the TCI were 
discussed in a multidisciplmary meeting with all professionals involved and 
arrangements were made for improvements The score on the TCI was already 
high before the intervention and we did not find any significant changes afterwards 
(chapter 8) We also found no influences of the TCI scores on the quality 
indicators, in the study on patients with non-small cell lung cancer (chapter 7) 
Further research should be performed to estimate if the TCI could be used as a 
useful outcome measure 
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Theme II Assessing and improving the quality of integrated care 
for patients with cancer 
4. Assessing integrated care for patients with cancer 
The studies on the development of indicators to assess integrated care for patients 
with cancer showed that a systematic development and testing procedure is 
needed (chapters 5 and 6). The procedure in both studies was roughly the same 
including the following steps: extraction of the recommendations from evidence-
based guidelines and structure indicators for integrated care from literature; written 
appraisal of the recommendations on health benefit, continuity of care and patient-
centredness, by an expert panel; feedback and formal consensus in a face-to-face 
panel meeting; translation of the recommendations into indicators followed by a 
practice test. In the practice test some clinimetric characteristics of the indicators 
were tested as measurability, feasibility, reliability and room for improvement. In 
both studies we experimented with methods for involving patients and patient 
representatives in the process of indicator development. 
Indicators: development 
There are many factors influencing the development of quality indicators.31,32 In 
our studies we experimented with some aspects as "composition of the expert-
panel", "classification of the recommendations into three quality dimensions", 
"adding a top-5 to decrease the total number of recommendations" and "including 
patient's opinions". 
It is known from literature that the composition of the expert panel can influence 
the indicator development process.31,32 In our studies we took care that all relevant 
professionals were involved in the consensus panel that performed the selection. 
But, in the study on patients with head and neck cancer we used a local panel 
from one hospital, and in the study on patients with non-small cell lung cancer we 
used a national panel. To determine the influence of panel composition, the same 
procedures should be followed with different panels. 
The aim of our study was to assess and improve care on all quality aspects and 
with special attention to interventions that sustain the principles of integrated care. 
For the development of the set of indicators for patients with head and neck 
cancer, we performed a pre-selection of the recommendations from the guidelines 
by a small expert panel. This lead to exclusion of some recommendations in the 
pre-selection that were assumed to be not measurable or improvable, but this was 
not tested in practice. Besides, we got a set of indicators mainly regarding the 
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organization of care To get a balanced set of indicators for the care for patients 
with non-small cell lung cancer, we classified all recommendations into three 
quality dimensions patient-oriented quality (support and information for patients), 
professional or medical-technical quality (right diagnosis and treatment for 
effective and safe care) and organizational quality (continuity and coordination of 
care to enable efficient care) This classification led to a balanced set of indicators 
and is recommended as part of the development procedure in case all quality 
dimensions should be addressed 
Earlier research on indicator development showed that selection on the chosen 
criteria (e g health benefit, continuity of care and patient-centredness) often did 
not discriminate sufficiently (selection of too many recommendations)33 34 
Therefore the panels in our studies were asked to judge all recommendations, but 
also to make a top five of the most important recommendations per quality 
dimension This worked out very well and should be considered if a core set of 
indicators is being aimed at 
In agreement with literature, our studies showed that professionals and patients 
have sometimes different opinions about good quality of care 3536 Therefore, it is 
necessary to involve patients, as experts, in indicator development, especially 
when improving integrated care is the mam aim There are no good examples of 
patient involvement in indicator development3738 In our studies we experimented 
with two methods interviewing patients (head and neck study) and written 
appraisal of all recommendations (non-small cell lung cancer study) Both methods 
tested are suitable, but patients and representatives for lung cancer reported 
difficulties in assessing medical-technical quality issues 
Indicators practice test 
Our studies reveal the importance of subjecting a set of indicators to a practice 
test Indicators are sometimes not measurable For example it proved to be not 
possible to measure the indicator "locally advanced NSCLC patients with WHO 
performance status 0 or 1 who were treated with combination therapy" because 
professionals wrote down the performance status in only 9% of the cases 
Collecting the data for the indicators was very labour-intensive and this is in our 
opinion a major barrier to the application of this type of quality indicators in the 
Netherlands The awareness of the necessity to collect performance data is 
increasing since the introduction of national, hospital-wide performance indicators 
for external review by the Dutch Health Care Inspectorate 39 However, it is our 
concern that policy makers and hospital administrators will only implement those 
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indicators that are most easy to collect but that do not necessarily reflect optimal 
quality of care. In spite of developments regarding external review by others, we 
think that professionals, represented in professional societies, should take the lead 
in assuring appropriate assessment of the quality of care by taking care of the 
development of valid and reliable indicators. The introduction of a national 
electronic patient file should anticipate on this and ideally contain necessary data 
to calculate quality indicators both for external and internal performance review. 
"Living" indicators 
Our study showed lower scores than to be expected on the indicator "cervical 
mediastinoscopy according the guideline criteria". A further analysis of the cases 
that deviated from the guideline criteria showed that the main reason not to 
perform a mediastinoscopy was the use of alternative forms for staging of the 
mediastinum (TBNA or EUS-FNA). However, because of their very recent 
appearance, these techniques have not yet been incorporated into the guidelines 
on which the indicators were based. The scores on the indicator "mediastinocopy 
according guideline criteria" is a good example of the fact that a low score on an 
indicator does not automatically mean that there is a problem in the quality of care. 
Low scores are signals to further explore the situation. Indicators as well as 
guidelines should be periodically updated, as such we propose to have "living 
indicators" which are ideally continuously being updated as soon as new evidence 
demands a change of recommendations. In the Netherlands, the results of our 
study and new available evidence on this point led to adaptation of the national 
guideline. 
5. Improving integrated care for patients with cancer 
The practice test for both patients with head and neck cancer and patients with 
lung cancer showed many possibilities for improvement regarding the patient-
oriented quality (support and information for the patient), the professional quality 
(medical-technical action for effective and safe care) and the organizational quality 
(continuity and coordination of care to enable efficient care) as well as regarding 
additional requirements for integrated care (e.g. multidisciplinary team, case 
management, clinical pathways, clinical leader). While it is essential to raise the 
overall quality of care on all dimensions, improvement of the patient-oriented 
quality followed by the organization of care should be priorities (chapters 5, 6 and 
7). 
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Improving patient-centredness 
Integrated care should be based on the needs and preferences of patients, and 
patients should be actively involved in their care Our studies on patients with head 
and neck cancer and non-small cell lung cancer showed that patient-centredness 
could be improved especially regarding care for physical symptoms, information 
and communication and psychosocial care 
Apparently, doctors are more focussed on attempts to treat the tumour and 
increase survival, than relieve the side effects of the cancer and of the treatment 
This is in agreement with literature the management of pain is being improving,40 
42
 but fatigue remains a largely unrecognized and poorly managed problem that 
affects the quality of life for patients Most physicians never even asked their 
patients about fatigue4344 
Literature shows that failure to provide sufficient information about the disease and 
its treatment is the most frequent source of patient dissatisfaction4546 Both our 
studies showed that patients were well informed on "the course of diagnostic 
procedures", "treatment options" and "side effects and complications" Patients 
were less or not informed about possibilities "for emotional support", "to contact a 
companion in distress", and "possibilities for lifestyle support" There are some 
interventions that have the potential to improve information supply to patients (e g 
audiotape of the consultation, use of question prompt sheets, patient information 
records)4™9 
Psychosocial problems as fear and depression are common in patients with 
cancer particularly in patients with lung cancer50 About one third of the patients 
with lung cancer have psychosocial problems50 51 Our studies showed that 
patients are often not asked about possible psychosocial stress factors and 
psychological symptoms An explanation can be that specialists do not consider 
this as their task Literature shows that structured follow-up of patients by 
specialized nursed can have positive effects on physical and psychosocial 
symptoms52 ^ Other supporting interventions are identification of patients with 
moderate or severe levels of fear and depression with screening lists54 and 
communication training for professionals 5556 
Literature shows that a more patient-centred approach is associated with improved 
clinical outcomes, increased patient satisfaction, increased patient safety and 
higher professional satisfaction 15175761 We argue that 'taking care of the needs 
and preferences of patients' also includes care for physical and psychosocial 
problems This is a common responsibility of the multidisciplmary team of health 
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care professionals in which the specialist can delegate some tasks, for example to 
specialized nurses. 
Improving organization of care 
The variation among hospitals showed possibilities for improving waiting times for 
diagnostic procedures and waiting times till start first treatment. In the Netherlands 
national norms for waiting times are formulated, the so-called "Treek-normen".62 
Maximum waiting times till start treatment should be 7 weeks and 80% of the 
patients should be treated within 5 weeks. However, cancer is a life-threatening 
disease and the "Signaleringscommissie Kanker van de KWF Kankerbestrijding" 
has formulated stricter norms of 10 days till end of diagnostic phase and another 
15 days till start treatment.63 Our studies showed that only half of the patients 
actually could start treatment within 30 days (patients with head and neck cancer) 
or 35 days (patients with non-small cell lung cancer) after their first visit. The 
intervention programme for patients with head and neck cancer reduced waiting 
times for diagnostic procedures, but special attention should be paid to waiting 
times till start treatment. Literature shows that long waiting times do not by 
definition lead to poorer survival.64 However, several studies report tumour growth 
during waiting times that eventually lead to patients with curative options becoming 
incurable.65,66 From the patient's point of view, long waiting times for diagnosis and 
treatment are unacceptable. 
Multi-component approach 
We assume that the most effective way to improve integrated care for patients is 
by means of a multi-component improvement programme. This programme should 
consist of interventions targeting at patients, professionals and the organization of 
care. 
Our study on the evaluation of an integrated care programme for patients with 
head and neck cancer showed promising results. The same strategy is currently 
being evaluated in a controlled clinical trial for patients with NSCLC. 
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INTEGRATED CARE MODEL 
Based on our literature studies and own practice research on assessing and 
improving care for patients with cancer, we suggest a comprehensive model for 
integrated care, the so-called "Tandem-Model for Integrated Care" (Figure 1) 
The model is based on the five principles of integrated care (see table 1 ) 
. Patient-centredness relates to the Patient 
. Multidisciplmary care relates to Professionals and Processes 
• Evidence-based medicine relates to Professionals 
• Coordination of care relates to Processes 
. Continuous quality improvement relates to Assessing and Improving care 
Patients 
Integrated care is based on the needs and preferences of the patient The key to 
successful doctor-patient partnerships is recognizing that patients are experts too 
Emphasis lays on shared information, shared evaluation, shared decision-making 
and shared responsibilities67 Patients have different preferences for involvement 
and not all are able or willing to play an active role Health professionals should be 
sensitive to individual patients' preferences to provide better patient-centred 
care 68 
Professionals 
Integrated care is multidisciplmary organized Most clinical professionals have 
specific expertise in a small field of science To deliver optimal care, health care 
professionals should broaden their focus to optimal multidisciplmary cooperation 
with all professionals involved in the care for patients69 
Professionals should make evidence-based medicine patient-centred by 
combining best evidence with their individual clinical expertise and the needs and 
preferences of patients 
Processes 
Integrated care is based on an optimal organization of care processes in which 
fragmentation of care is mmimahzed Care processes of patients are based on 
evidence-based guidelines and written down in integrated care pathways 7071 
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Assessing and Improving care 
To improve patient care a process is needed of continuous assessment of actual 
care with a balanced set of indicators on three dimensions of quality of care 
(patient-oriented quality, professional or medical-technical quality and 
organizational quality). Indicators should be systematically developed and tested 
and based on evidence or expert opinions of professionals and patients. 
Insight in determinants of variation in actual care is needed to target the 
improvement strategy. Integrated care can be improved with a multi-component 
improvement programme that consists of interventions targetting at patients, 
professionals and the organization of care. 
Figure. The Tandem-model for Integrated Care 
High-quality integrated care can be reached if the patient and the professionals 
work in tandem with each other. Together on a tandem they reach more than on 
single bikes. Processes should be optimally organized to support the patient and 
the professionals. Integrated care is the necessary connection between the 
patient, the professionals and the processes to obtain the best possible care by 
continuously assessing and improving actual performance. 
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METHODOLOGICAL CONSIDERATIONS 
Review of reviews 
In our first literature search we performed a review of systematic reviews The 
reason was the broad scope of our research question we searched for studies on 
integrated care programmes on all possible (chronic) diseases The mam limitation 
of this method is that, by using reviews, it is not possible to draw conclusions from 
the results of the original studies and that details of the individual studies are 
washed out In our systematic search for integrated care interventions for cancer 
patients our conclusions were based on original studies For both studies there 
was a risk of publication bias, because of the tendency for journals to publish 
positive results and suppress negative results 
Patient experiences 
All patient-centred indicators were measured with questionnaires among patients 
Obviously, the subjective opinion of patients or patient characteristics may have 
biased the outcome to a certain degree To deal with this, we asked patients for 
their actual experiences of clinical care, as suggested in the literature, and not for 
their satisfaction with care provided 72 A limitation during the assessment of actual 
care was that half of the patients with NSCLC in the study group had died and 
could not be questioned This probably affected the results for the patient-oriented 
quality indicators However, literature is contradictory about the direction of patient 
characteristics on patient's assessments of care 73 75 None of the patients with 
head and neck cancer died during the study period 
Process outcomes versus patient outcome 
The content validity of our sets of indicators is guaranteed either because 
indicators are closely linked to evidence or have been appraised by experts as 
being clinically relevant to patients' health benefits and/or to the continuity and 
coordination of care However, by following this procedure, the final set of 
indicators includes many so-called "structure indicators" (e g the availability of a 
multiprofessional team) and indicators regarding the "process of care" (e g 
nutrition support) This phenomenon has also been identified in similar selection 
procedures for indicators in family practices and gynaecological practices in the 
Netherlands3376 Outcome indicators did not originate from our study procedure, 
so adding a set of outcome indicators, such as mortality, morbidity, quality of life or 
patient satisfaction could be considered 
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Insurers, policy makers and consumers are usually more interested in outcome 
measures.77 However, outcome measures have main disadvantages: they usually 
have low incidence or prevalence, are often delayed, are difficult to control (e.g. 
also influenced by lifestyle choices of patients, compliance, health status) or are 
heavily confounded by for example disease stage.77 To take mortality as an 
outcome measure for the effectiveness of the integrated care programmes would 
be difficult.78 In contrast with health outcomes, process measures tend to be 
frequent, immediate, controllable and less likely to be confounded by other 
factors.31,79 That is the reason why process indicators are generally more useful for 
quality improvement research. A commonly raised criticism of the measurement of 
process indicators is related to the assumption that a difference in the process 
represents an important difference in health outcomes. For the reasons 
mentioned, it is difficult for researchers of quality improvement at organizational 
level to prove this link between process and outcome at the patient level.77 
Study design 
A rigorous study design is required to provide evidence about the (cost-) 
effectiveness of an intervention. A (cluster-)randomized controlled trial (RCT) is 
considered the "gold standard" in implementation research.80 Our study explored 
the concepts and interventions of integrated care followed by two studies to 
assess the impact and feasibility of our integrated care programmes. Further 
research should be performed to assess the cost-effectiveness of this programme 
in multi-centred cluster-randomized trials. 
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IMPLICATIONS FOR PRACTICE AND RESEARCH 
A variety of recommendations can be derived from the different studies in this 
thesis The recommendations are classified into three themes requirements for 
integrated care, assessing integrated care, improving integrated care This 
paragraph ends with some recommendations specific for further research 
Requirements for integrated care 
- The Dutch government has taken several stimulating measures to improve 
integrated care as investments in collaborative projects or allowing 
providers to spend a small percentage of their budget on care innovation 
However, such financial stimuli have constantly been undermined by the 
financial provision-led system, which cannot meet the needs of integrated 
care Professionals need each other to provide optimal multidisciplmary care 
and they are thus compelled to establish collaborative relationships, beyond 
the boundaries of their own department or health care system and in spite of 
the financial, structural barriers and the stimulated competition between 
health care providers 81 To promote integrated care the government should 
take consistent policy measures (financial stimuli and legislative measures) 
to create facilitating forces for collaboration 84 
- It is estimated that 10 to 20% of the population in the Netherlands suffers 
from one or more chronic disorders 82 Our study on determinants on quality 
of care showed that patient-characteristics, such as co-morbidity, influence 
the performance scores most An integrated but essentially disease-specific 
approach may disrupt the continuity of care towards individual patients with 
multiple disorders The use of one or more case managers can facilitate this 
care and anticipate on the multiple needs of patients 
- Case managers may play an important role in delivering high-quality 
integrated care especially concerning the coordination of care and 
psychosocial and lifestyle support The use of case managers should be 
(financially) supported and the background, tasks and responsibilities of 
case managers should be further investigated 
- The barrier for good team functioning mentioned most by professionals in 
our studies was not getting enough or the right information from colleagues 
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Information and communication technology should facilitate multidisciplinary 
discussion meetings, patient follow-up, and continuous quality improvement. 
Data should easily be retrieved across systems or sites of care for example 
by means of an electronic patient file. 
- A more patient-centred approach is positively related to patient outcomes 
such as satisfaction, physical health and well-being. We strongly 
recommend that specific domains for patient-centredness should always be 
addressed in clinical guidelines for the management of patients with cancer. 
If evidence is insufficient or absent, these recommendations should be 
based on the expert opinions of patients and professionals. 
Assessing integrated care 
- Professionals, represented in professional societies, should take the lead in 
assuring appropriate assessment of the quality of care by taking care of the 
development of valid and reliable indicators. 
- To facilitate the process of indicator development we suggest that the 
guideline developers also go through the process of indicator development, 
and that a set of indicators is a fixed part of clinical guidelines. 
- Low scores on an indicator do not automatically mean that there is a 
problem in the quality of care. Low scores are signals to further explore the 
situation. 
- Indicators, just as guidelines, should be periodically updated. 
Improving integrated care 
- Integrated care for patients with cancer can be improved especially 
regarding patient-centredness. The impact of cancer and its symptoms on 
the patient's psychological, social, and physical state should be identified 
early, and patients should be referred to the appropriate specialist for further 
assessment, if needed. 
- From the patient's point of view, long waiting times for diagnosis and 
treatment are unacceptable. Our study showed that an integrated care 
programme focussed on reducing waiting times could be successful. So 
179 
General discussion 
effort should be made to implement this programme for all patients with 
cancer 
Implications for further research 
- Research has shown the efficacy of some interventions of integrated care 
programmes, more research should be performed to evaluate the efficacy of 
multi-component integrated care programmes that consist of interventions 
covering all principles of integrated care patient-centredness, organization 
of care, multidisciplmary cooperation, evidence based medicine and 
continuous quality improvement A cluster-randomized trial would be an 
appropriate approach 
- Research on the cost-effectiveness of integrated care interventions is very 
limited and further research should be done in this area 
- To improve patient-centredness of care a reliable assessment of actual care 
is necessary Our instrument for measuring the patient-centredness of 
cancer care can be used, and should be further tested on patients with other 
types of cancer 
- The Dutch translation of the TCI, an instrument to measure team climate, 
seemed to be valid and reliable in Dutch hospital teams Further research 
should be performed to investigate if the found 5-structure of the TCI is 
specific for (Dutch) hospital teams 
- The optimal procedure for the development of clinical indicators needs to be 
explored further Questions to be answered are related to composition and 
size of the expert panel and methods for including patient's opinions 
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Summary 
The focus of this thesis is to explore principles regarding integrated care, to search 
for instruments to measure integrated care and for interventions that improve 
integrated care, and to apply these findings in the care for patients with cancer. 
A review of systematic reviews is performed in chapter 1 to explore principles of 
integrated care, interventions used in integrated care programmes, and effects 
reported. Thirteen reviews are included involving patients with chronic diseases 
like heart failure, diabetes mellitus, rheumatoid arthritis, cardiovascular diseases, 
stroke and chronic obstructive pulmonary diseases. This review shows that 
integrated care programmes have widely varying definitions and use many 
different interventions. The term used most frequently to describe the management 
of integrated patient care is "disease management". Other terms are "care 
management", "case management" and "coordinated care". Although the aims of 
the programmes are very similar, namely to reduce fragmentation and improve 
continuity and coordination, the focus and content of the programmes differ widely. 
Based on these findings we conclude that the definition of integrated care is based 
on five principles: patient-centredness, multidisciplinary care, coordination of care, 
evidence-based medicine and continuous quality improvement. We consider the 
first three principles as being basic principles of integrated care, the other two are 
general principles for delivering high quality of care. Interventions mentioned in the 
reviews that sustain these principles focus on health care providers and/or the 
organization of care, while patient education had often been added. The most 
commonly mentioned interventions are: "patient self-management", "support and 
education", "arrangements about clinical follow-up", "case management", 
"introduction of a multidisciplinary patient-care team" and "a systematic evidence-
based approach to change processes of care", for example by using clinical 
pathways. Additional requirements mentioned are: "having a supportive clinical 
information system", "having a shared mission on integrated care" and "leaders 
that express a clear vision on integrated care and support its achievement". 
Integrated care programmes show some positive effects on hospitalization rate, 
quality of life and process outcomes, as compliance and adherence to guidelines. 
However, these effects hardly reach significance. Effects on mortality remain 
unclear, and few systematic analyses are performed on the cost-effectiveness of 
integrated care programmes. 
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In chapter 2 a systematic review on integrated care programmes for patients with 
cancer is described, because such a systematic review was not performed before. 
A total of 33 studies met the inclusion criteria: 16 studies focus on patient-
centredness (48%), 14 on the coordination of care (42%), one study on 
multidisciplinary care and two studies on both patient-centredness and 
coordination of care. We found no studies that focussed on all tree principles of 
integrated care. There is a large variation in interventions reported, and in 
outcomes used for evaluation. In 76% of the studies the outcome measures are 
directly linked to the intervention (e.g. improvement of knowledge in case of an 
extra information session). Outcomes measures as "satisfaction" and subjective 
health outcomes as "quality of life" were both used in 67% of the studies. Objective 
health outcomes as "morbidity" and "mortality" were only assessed in 15% of the 
studies. The most effective interventions to improve integrated care for patients 
with cancer are: "provision of an audiotape of the consultation to the patient", 
"provision of information to patients", "use of a decision aid" (support for patients 
while taking decisions), "follow-up provided by a nurse or a general practitioner", 
"case management" (allocation of coordination tasks to an appointed individual, 
the case manager) and "one-stop clinics" (diagnostic procedures and results on 
one day). We conclude that to improve integrated care for patients with cancer a 
multi-component intervention programme is needed focussing on patients, 
professionals and the organization of care. The promising interventions found in 
this review should be part of this programme. These programmes should be 
evaluated using rigorous methods and unequivocal outcome measures linked to 
the intervention. 
In Chapter 3 a method is described to develop an instrument to measure one of 
the basic principles of integrated care, patient-centredness, applied to patients 
with cancer. Patient-centred recommendations are extracted from guidelines on 
the management of patients with cancer, out of relevant Dutch and English 
databases. On basis of the guideline information and patients' and professionals' 
views, 56 indicators are developed for assessing the patient-centredness of 
cancer care. The validity and reliability of this set of indicators are assessed on a 
population of 132 patients with non-small cell lung cancer. The results of this test 
show that of the 56 indicators, 26 are valid to assess the patient-centredness of 
cancer care: they have more than 10% improvement potential, are applicable on 
more than 75% of the population and have good discriminating capacities (at least 
20% variance between lowest and highest scoring hospitals). 
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A (multidisciplinary) patient-care team that functions well is another basic principle 
for providing high quality of integrated care. Team functioning is determined by 
size and composition but also by team processes like team climate. Chapter 4 
describes a study on the translation and validation of the most studied model of 
team climate, the so-called Team Climate Inventory of Anderson and West. A 
careful translation and validation process was undertaken, followed by a test of the 
Dutch version of the TCI in 36 hospital teams. The study shows that the Dutch 
translation of the TCI is a valid, reliable and discriminating self-report measure for 
team climate in hospital teams. The TCI can be used as a quality-improvement 
tool or as a predictor of quality-improvement outcome in evaluation studies. 
The study described in chapter 5 aims to demonstrate how a valid set of quality 
indicators can be developed for patients with head and neck cancer. The set of 
indicators was based on integrated care literature, national evidence-based 
guidelines for patients with head and neck cancer, and the opinions of 
professionals and patients. To develop such a set, a "Rand-modified-Delphi 
procedure" was performed. An expert panel scored individually the 
recommendations extracted from the guidelines on health benefit and benefit for 
integrated care, followed by a consensus meeting. The final set consisted of 8 
integrated care indicators and 23 specific indicators for patients with head and 
neck cancer. The set is tested regarding assessment of current practice on 158 
patients with head and neck cancer from one academic centre for head and neck 
cancer care and clinimetric characteristics are assessed. The following 
characteristics are assessed: measurability, improvement potential and 
applicability. Two indicatore are not measurable: it is not recorded if there was 
contact with a pathologist in case a patient is suspected of cancer but the 
pathology results were negative and also not if all results of previous diagnostic 
procedures were available during the first consultation in het head and neck 
centre. The assessment of current practice shows high scores for the integrated 
care indicators (e.g. "availability of a multidisciplinary team", "team climate" and 
"availability of case managers"), but the specific indicators for head and neck 
cancer care show room for improvement (e.g. "information supply", "emotional and 
social support", "lifestyle support regarding smoking, alcohol use and nutirition" 
and "waiting- and throughput times"). The practice test showed that 9 indicators 
had good clinimetric characteristics this is measurable, more than 10% room for 
improvement and applicable on at least 75% of the research population. 
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Insight into actual care is necessary to achieve successful implementation of 
clinical guidelines, and developing indicators may be the first step to become 
aware of actual care. In chapter 6 a set of quality indicators is systematically 
developed on basis of the Dutch national practice guideline "Non-small cell lung 
cancer: staging and treatment". To develop a set of indicators for diagnosis and 
treatment of patients with non-small cell lung cancer (NSCLC), the same 
procedure was followed as for patients with head and neck cancer. There are two 
differences: the expert panel consisted of national experts instead of local experts 
and there was a classification of all recommendations into three dimensions of 
quality of care, patient-oriented, professional or medical-technical (= evidence 
based practice) and organizational. Of the 83 recommendations 8 
recommendations are selected by the experpanel on basis of relevancy regarding 
health benefit and benefit for integrated care delivery. These recommendations 
are incorporated into 15 indicators, which are tested in practice. The practice test 
is on 276 patients with non-small cell lungcancer from 6 hospitals in the East 
Comprehensive Cancer Care region. The most successful indicators for quality 
improvement are indicators that are measurable, have potential for improvement, 
have a broad range between practices and are applicable on a large part of the 
population. One indicator was not measurable: the peformance status of patients 
was only recoreded in 9% of the cases so it was not possible to measure if 
patients with locally advanced NSCLC and performance status 0 or 1 were treated 
with combination therapy. The practice test shows many possibilities for quality 
improvement regarding all three quality dimensions of care: patient-oriented 
quality (e.g. support for physical and psycho-social symptoms and information for 
the patient), professional or medical-technical quality (e.g. biopsies taken during 
cervical mediastinoscopy and performing a CT or MRI of the brain before start of 
combination therapy) and organizational quality (e.g. waiting time till start 
treatment and discussed in multidisciplinary consultation) and regarding the 
interventions that sustain the principles of integrated care (case management, 
clinical pathways, clinical leader, multidisciplinary team). Seven indicators had 
good clinimetric characteristics: 10% or more room for improvement, applicable on 
75% or more of the population and a variation of 20% or more between hospitals. 
In chapter 7 more information will be given on the indicator scores, the variation 
between hospitals and possible influencing factors. 
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Chapter 7 describes a study on actual quality of integrated care for patients with 
NSCLC in six hospitals in the IKO-region and which determinants on the level of 
patients, professionals or the organization, influence the variation in scores 
between the hospitals. The quality of integrated care for 276 NSCLC patients, 
treated in six different hospitals, is tested with the 15 quality indicators described in 
chapter 6. These indicators cover three dimensions of quality: patient-oriented (7), 
professional or medical-technical (=evidence based practice)(5) and organizational 
(3). Patient characteristics and actual care are derived from medical record data, 
patient-oriented care from patient questionnaires, and professional and hospital 
characteristics from questionnaires for professionals. The performance measure is 
the proportion of patients to whom the indicator applied who had positive scores 
on the indicator. Multilevel logistic regression analysis determined the influence of 
patient, professional, and hospital characteristics on care. 
Regarding professional quality, the proportions of patients who underwent 
fluorodeoxyglucose-positron-emission tomography or cervical mediastinoscopy 
according to the guideline criteria were 88% and 84%, respectively. Only 50% of 
the biopsies were adequately taken during mediastinoscopy, and in 3% of the 
patients with clinical stage III there was a search for brain metastases before start 
of combination therapy. Regarding organizational quality, the diagnostic route of 
79% of the patients was completed within 21 days; 51% started therapy within 35 
days, and 57% were discussed in multidisciplinary consultation. All but one 
patient-oriented quality indicator scored 58% or less. 
Hospitals varied by 20% or more on 11 of the 14 indicators. No determinant shows 
a significant influence on the indicators regarding professional quality. The 
organizational indicators all relate to one or two patient characteristics. Patients 
with a higher stage of disease (stadium III or IV) complete their diagnostic 
trajectory more often within 21 days and start their first treatment more often within 
35 days than patients with a lower stage of disease (stadium III or IV). However, 
they are less often multidisciplinary discussed. The best predictor for patients 
being multidisciplinary discussed is the availability of a multidisciplinary team 
meeting for patients with lung cancer. The only determinant that influences the 
patient-oriented indicators is "co-morbidity of patients": patients with co-morbidity 
less often know the existence of an oncology nurse specializing in lung cancer. 
This study shows that patient-related determinants as "stage of disease" and "co-
morbidity" influence the indicator scores most. 
189 
Summary 
Chapter 8 describes a study with the aim to improve integrated care for patients 
with head and neck cancer. The systematic approach for improving patient care of 
Grol and others was followed: developing a set of indicators for assessing actual 
care; analysing barriers and facilitators by performing interviews with all 
professionals involved; developing and implementing an integrated care 
programme on basis of these analyses and literature on effective integrated care 
interventions. The integrated care programme focusses on patients, professionals 
and the organization of care. The impact of the programme is assessed using the 
the indicators of wich the development was described in chapter 5. All indicators 
are measured by examination of medical records and questionnaires for patients 
and professionals. The implementation of the integrated care programme led to 
relevant improvements in all quality dimensions of care, e.g. "waiting time for 
diagnostic procedures less than 10 days" (improvement of 37%), "waiting time to 
first treatment less than 30 days" (+25%), "support for stopping smoking" (+37%), 
"nutrition support" (+44%), "assessment of computed tomography and magnetic 
resonance imaging scans by a radiologist who was an expert in head and neck 
oncology" (+23%) and "number of patients in contact with the specialist nurses" 
(+37%). The programme shows no relevant effects on the outcome indicators 
"quality of life" and "patient satisfaction". On basis of this study it is concluded that 
an integrated care programme can improve several aspects of the management of 
patients with head and neck cancer. 
In the general discussion the main findings of our studies are presented and 
discussed. The key messages are categorized under two themes (and five 
subthemes) theme I: Principles and Instruments of Integrated Care (principles of 
integrated care, interventions maintaining the principles of integrated care and 
instruments for measuring the principles of integrated care) and theme II: 
Assessing and Improving the Quality of Integrated Care for Patients with Cancer 
(assessing integrated care for patients with cancer and improving integrated care 
for patients with cancer). Subsequently, the most relevant methodological issues 
are reviewed and the general discussion ends with some recommendations for 
practice and further research. 
Based on our literature studies and own practice research on assessing and 
improving care for patients with cancer, we suggest a comprehensive model for 
integrated care: the so-called "Tandem-model for Integrated Care" (see figure). 
190 
Summary 
Figure: The Tandem-model for Integrated Care 
This thesis shows that integrated care is based on the principles of: patient-
centredness, multidisciplinary care, coordination of care, evidence based medicine 
and continuous quality improvement. Before care can be improved, a reliable 
assessement of actual care is necessary on basis of a systematically developed 
set of indicators. Our studies show that there is room for improving the quality of 
care for patients with cancer (especially regarding patient-centredness and 
organization of care) and that the implementation of an integrated care programme 
can lead to relevant improvements. 
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Samenvatting 
Dit proefschrift behandelt de principes van integrale zorg, presenteert 
instrumenten om integrale zorg te kunnen meten en activiteiten om de kwaliteit 
van integrale zorg te verbeteren, toegepast op patiënten met kanker. 
Hoofdstuk 1 beschrijft een kritische analyse van systematische reviews over 
definities van integrale zorg, elementen van verbeterprogramma's voor integrale 
zorg en de gerapporteerde effecten hiervan. De dertien reviews die zijn 
geïncludeerd hebben betrekking op patiënten met chronische ziekten zoals 
hartfalen, diabetes, reuma, hart- en vaatziekten, beroerte en chronisch obstructief 
longlijden. Uit het review blijkt dat er veel verschillende termen zijn voor 
programma's gericht op het verbeteren van integrale zorg en dat de 
verbeterprogramma's uit veel verschillende elementen bestaan. De term, die het 
meest in de engelstalige literatuur voorkomt is "disease management". Andere 
genoemde termen zijn "care management", "case management" en "coordinated 
care". De focus en de inhoud van de programma's variëren sterk. Echter, de 
doelstellingen van deze programma's zijn eenduidig, namelijk het reduceren van 
fragmentatie en het verbeteren van de continuïteit en coördinatie van zorg. Op 
basis van de bevindingen uit het review concluderen wij wat betreft de definitie van 
integrale zorg dat deze gebaseerd dient te zijn op een vijftal principes: 
patiëntgerichtheid, multidisciplinaire zorg, coördinatie van zorg, "evidence-based-
medicine" en continue kwaliteitsverbetering. De eerste drie principes zijn de basis 
principes van integrale zorg; de andere twee zijn algemeen geldende principes 
voor het leveren van goede kwaliteit van zorg. Elementen uit de 
verbeterprogramma's die de basis principes ondersteunen zijn gericht op zowel de 
zorgverleners als op de organisatie van de zorg. Tevens is educatie van patiënten 
vaak onderdeel van het programma. De meest genoemde elementen zijn: 
ondersteuning van de zelfzorgactiviteiten van patiënten, educatie van patiënten, 
afspraken over follow-up van patiënten, inzetten van een case manager (persoon 
met coördinerende taken), instellen van een multidisciplinair team van 
zorgverleners en systematische benaderingen van zorgprocessen bijvoorbeeld 
door het gebruik van integrale zorgpaden die zijn gebaseerd op "evidence-based" 
richtlijnen. Overige elementen die worden genoemd in de literatuur zijn: een 
ondersteunend klinisch informatie systeem, een gedeelde visie op integrale zorg 
en leidinggevenden of ketencoördinatoren die een voortrekkersrol vervullen. 
Verbeterprogramma's voor integrale zorg hebben hebben een positief effect op 
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kenmerken van "hospitahsatie" (zoals ligduur en het aantal ziekenhuisbezoeken), 
"kwaliteit van leven" en procesuitkomsten zoals "nchtlijnadherentie" De 
gerapporteerde effecten zijn echter vaak met significant Het effect op "overleving" 
is onduidelijk en er zijn weinig studies over de kosten-effectiviteit van deze 
programma's 
In hoofdstuk 2 worden de resultaten beschreven van een systematisch review 
over verbeterprogramma's voor integrale zorg, nu toegepast op patiënten met 
kanker Een dergelijk review was nog met beschikbaar In totaal zijn 33 studies 
gemcludeerd 16 studies zijn gericht op het verbeteren van de patiëntgerichtheid 
van de zorg (48%), 14 op de coördinatie van zorg (42%), één studie op het 
verlenen van multidisciplinaire zorg en twee studies op het verbeteren van zowel 
de patiëntgerichtheid als de coördinatie van zorg Er zijn geen studies gevonden 
die gericht waren op alle drie de basis principes van integrale zorg Er bestaat een 
grote variatie in het soort activiteiten om de kwaliteit van integrale zorg te 
verbeteren en in gehanteerde uitkomstmaten In 76% van de studies zijn 
uitkomstmaten gehanteerd die een directe link hadden met de interventie 
(bijvoorbeeld toename van kennis in geval van een extra informatie gesprek) 
Daarnaast werden uitkomstmaten gehanteerd als "tevredenheid" (67%) en 
subjectieve gezondheidsmaten zoals "kwaliteit van leven" (67%) Objectieve 
gezondheidsuitkomsten zoals "morbiditeit" en "mortaliteit" zijn slecht gemeten in 
15% van de studies De meest effectieve activiteiten voor het verbeteren van 
integrale zorg voor patiënten met kanker zijn "weergave van het consult door 
middel van een geluidsband voor de patient", "mondelinge of schriftelijke 
informatie voor de patient", "decision aid voor de patient" (ondersteuning bij het 
nemen van een beslissing), "follow-up uitgevoerd door een gespecialiseerd 
verpleegkundige of de huisarts", "case management" (toewijzen van 
coördinerende taken aan een daarvoor aangewezen persoon, de case manager) 
en "one-stop-climcs" (diagnostiek en uitslag op 1 dag) Op basis van de reviews in 
hoofdstuk 1 en 2 concluderen WIJ dat het verbeteren van integrale zorg voor 
patiënten met kanker dient te gebeuren met een verbeterprogramma dat bestaat 
uit meerdere elementen Dit programma moet zijn gericht op zowel patiënten als 
zorgverleners en de organisatie van zorg De veelbelovende elementen uit de 
reviews dienen onderdeel te zijn van een dergelijk programma De programma's 
dienen te worden geëvalueerd met degelijke onderzoeksmethoden en eenduidige 
uitkomstmaten die een direct verband hebben met de elementen uit het 
programma 
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Hoofdstuk 3 beschrijft de ontwikkeling van een instrument voor het meten van 
één van de basis principes van integrale zorg namelijk patiëntgerichtheid 
toegespitst op patiënten met kanker. Uit relevante Nederlandse en Engelse 
databases zijn aanbevelingen, die betrekking hebben op de patiëntgerichtheid van 
de zorg, geselecteerd uit richtlijnen over de zorg voor patiënten met kanker. Op 
basis van deze aanbevelingen en de meningen van patiënten en zorgverleners 
zijn 56 indicatoren ontwikkeld waarmee de patiëntgerichtheid van de zorg voor 
patiënten met kanker kan worden gemeten. De validiteit van deze indicatoren is 
bepaald door middel van een meting bij 132 patiënten met een niet-kleincellig 
longcarcinoom. De resultaten laten zien dat van de 56 indicatoren er 26 valide zijn 
voor het beoordelen van de patiëntgerichtheid van de zorg voor patiënten met 
longkanker. Onder validiteit wordt in deze verstaan dat er meer dan 10% 
verbetering mogelijk is, dat de indicatoren toepasbaar zijn op 75% of meer van de 
onderzoekspopulatie en dat de indicatoren discrimineren (ten minste 20% of meer 
variatie tussen het laagt en hoogst scorende ziekenhuis). 
Een goed functionerend (multidisciplinair) team is een belangrijke voorwaarde 
voor het leveren van goede kwaliteit van integrale zorg. Het functioneren van 
teams wordt bepaald door de grootte en samenstelling van het team maar ook 
door het teamklimaat. Onder teamklimaat wordt verstaan de gedeelde percepties 
binnen het team en de wijze van samenwerking. Hoofdstuk 4 beschrijft een studie 
waarin het vertalen en valideren van een vragenlijst voor het meten van het 
teamklimaat centraal staat, de zogenaamde "Team Climate Inventory" (TCI). Deze 
vragenlijst is gebaseerd op het meest bestudeerde model voor teamklimaat van 
Anderson en West. Een zorgvuldig vertaal- en validatieproces is uitgevoerd, 
gevolgd door een praktijktest van de Nederlandse versie van de TCI in 36 
ziekenhuisteams. De studie toont aan dat de Nederlandse vertaling van de TCI 
een valide, betrouwbare en discriminerende zelfevaluatie-vragenlijst is voor het 
meten van teamklimaat in ziekenhuisteams. De TCI kan worden gebruikt voor 
kwaliteitsverbetering van teamfunctioneren en als uitkomstmaat in evaluatie 
studies waarin gekeken wordt of de invoering van een innovatie effect heeft op het 
teamklimaat. 
De studie die beschreven wordt in hoofdstuk 5 laat zien hoe een valide set van 
kwaliteitsindicatoren kan worden ontwikkeld voor patiënten met hoofd-hals 
tumoren. Allereerst is op basis van literatuur over integrale zorg, nationale 
"evidence-based" richtlijnen over de zorg voor patiënten met hoofd-halstumoren 
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en de meningen van zorgverleners en patiënten, een potentiële set van 
indicatoren samengesteld. Voor de ontwikkeling van de uiteindelijke set 
indicatoren is de zogenaamde "Rand-modified-Delphi"-procedure gevolgd. Leden 
van een lokaal expert panel beoordeelden individueel via een vragenlijst, de 
potentiële set van indicatoren op gezondheidswinst voor de patiënt en de winst 
met betrekking tot de principes van integrale zorg. In een consensusbespreking 
zijn de resultaten uit de vragenlijsten bediscussieerd. De uiteindelijke set 
indicatoren bestaat uit 8 indicatoren op het gebied van integrale zorg en 23 
indicatoren die specifiek zijn voor patiënten met hoofd-halstumoren. Voor het 
bepalen van een aantal klinimetrische eigenschappen van deze indicatoren zijn 
deze indicatoren gemeten in de praktijk, bij 158 patiënten met een hoofd-
halstumor afkomstig uit één academisch centrum. Benodigde eigenschappen van 
indicatoren zijn onder andere: ze zijn meetbaar in de praktijk, ze laten ruimte zien 
voor verbetering en ze zijn van toepassing op een groot deel van de 
onderzoekspopulatie. Twee indicatoren bleken niet meetbaar: er wordt niet in de 
status vastgelegd of er contact is geweest met de patholoog wanneer een patiënt 
verdacht wordt van een tumor maar de biopsie is negatief en er wordt ook niet 
vastgelegd of alle resultaten van eerder uitgevoerd onderzoek ook daadwerkelijk 
aanwezig zijn tijdens het eerste consult in het hoofdhalscentrum. De praktijktest 
laat hoge scores zien voor de 8 indicatoren op het gebied van integrale zorg (zoals 
aanwezigheid van een multidisciplinair team, teamklimaat en aanwezigheid van 
case managers). De specifieke hoofdhalsindicatoren laten echter duidelijk ruimte 
zien voor verbetering, bijvoorbeeld met betrekking tot informatievoorziening, 
emotionele en sociale ondersteuning, ondersteuning bij het stoppen met roken en 
alcoholgebruik, beoordeling van CT en M RI door een gespecialiseerde radioloog, 
wacht- en doorlooptijden en ondersteuning met betrekking tot voeding). Bij negen 
indicatoren is er meer dan 10% ruimte voor verbetering mogelijk en tevens zijn 
deze indicatoren van toepassing op 75% of meer van de onderzoekspopulatie. 
Inzicht in de huidige zorg is noodzakelijk voor een succesvolle implementatie van 
klinische richtlijnen of andere zorginnovaties. Het ontwikkelen van indicatoren is 
daarbij een eerste stap. In hoofdstuk 6 is een set van kwaliteitsindicatoren 
ontwikkeld op basis van de Nederlandse richtlijn "Niet-kleincellig longcarcinoom: 
stadiëring en behandeling". Voor de ontwikkeling van de set indicatoren is in grote 
lijnen eenzelfde procedure gevolgd als voor patiënten met hoofd-halstumoren. Er 
zijn twee belangrijke verschillen tussen beide procedures: het expertpanel voor de 
indicatoren voor patiënten met een niet-kleincellig longcarcinoom bestond uit 
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experts uit het hele land in plaats van lokale experts en vooraf zijn alle 
aanbevelingen uit de richtlijn ingedeeld naar de drie dimensies van kwaliteit: 
patiëntgerichte kwaliteit, professionele of medisch-technische kwaliteit 
(= "evidence-based" handelen) en organisatorische kwaliteit. Acht van de 83 
aanbevelingen uit de richtlijn worden door het expertpanel geselecteerd op basis 
van de criteria gezondheidswinst voor de patiënt en als zijnde van belang voor 
integrale zorg. De aanbevelingen zijn omgezet in 15 indicatoren. Vervolgens zijn 
deze indicatoren getest in de praktijk op een aantal klinimetrische eigenschappen. 
Deze praktijktest vond plaats onder 276 patiënten met een niet-kleincellig 
longcarcinoom (NSCLC) komend uit 6 verschillende ziekenhuizen in de regio van 
het Integraal Kankercentrum Oost (IKO). Benodigde eigenschappen van 
indicatoren die in deze praktijktest zijn bepaald zijn: meetbaarheid, ruimte voor 
verbetering, toepasbaarheid op de onderzoekspopulatie en discriminerend 
vermogen tussen ziekenhuizen. Uit de meting blijkt dat één indicator niet meetbaar 
is namelijk "het aantal patiënten met een lokaal uitgebreid NSCLC en een 
performance status van 0 of 1 dat is behandeld met combinatietherapie met een 
curatieve intentie". De performance status van de patiënt is namelijk in slechts 9% 
van de gevallen genoteerd in de status. Uit de meting blijkt dat er veel ruimte voor 
verbetering is op alle drie de kwaliteitsdimensies: patiëntgerichte kwaliteit 
(aandacht voor fysieke symptomen, aandacht voor psychosociale zorg en 
informatievoorziening), professionele of medisch-technische kwaliteit (aantal 
biopten afgenomen tijdens mediastinoscopie en verrichten van een CT of MRI 
scan van de hersenen voordat patiënten met stadium III starten met een 
combinatietherapie) en organisatorische kwaliteit inclusief randvoorwaarden voor 
integrale zorg (wachttijd tot start therapie, bespreking in multidisciplinair overleg, 
aanwezigheid van een multidisciplinair team, teamklimaat, aanwezigheid van 
casemanagers, benoemen van een keteneigenaar). Bij zeven indicatoren is er 
meer dan 10% ruimte voor verbetering mogelijk en tevens zijn deze indicatoren 
van toepassing op 75% of meer van de onderzoekspopulatie. Er bestaat tevens 
een variatie tussen ziekenhuizen op deze indicatoren van 20% of meer. In 
hoofdstuk 7 wordt verder ingegaan op de indicatorscores, de variatie in scores 
tussen de ziekenhuizen en mogelijke determinanten die hierop van invloed kunnen 
zijn. 
In hoofdstuk 7 wordt een onderzoek beschreven waarin de huidige kwaliteit van 
integrale zorg voor patiënten met NSCLC is gemeten in 6 ziekenhuizen in de IKO-
regio en waarin gekeken is welke determinanten, op patiënt-, zorgverlener- of 
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ziekenhuisniveau, mogelijk van invloed zijn op de variatie in scores tussen de 
verschillende ziekenhuizen. De kwaliteit van zorg is gemeten bij 276 patiënten aan 
de hand van de 15 kwaliteitsindicatoren waarvan de ontwikkeling en validatie 
beschreven is in hoofdstuk 6. Deze indicatoren zijn verdeeld over de 3 dimensies 
van kwaliteit: patiëntgerichte kwaliteit (7), professionele of medisch-technische 
kwaliteit (= "evidence-based" handelen) (5) en organisatorische kwaliteit (3). Data 
over patiëntkenmerken en data voor de indicatoren met betrekking tot 
professionele kwaliteit en organisatorische kwaliteit zijn verkregen uit medische 
dossiers. Data voor de indicatoren over patiëntgerichte kwaliteit zijn verkregen via 
vragenlijsten voor patiënten en kenmerken van ziekenhuizen en zorgverleners zijn 
verkregen via vragenlijsten voor de zorgverleners. De score op een indicator is het 
aantal patiënten dat voldoet aan de teller van de indicator gedeeld door het totaal 
aantal patiënten waarop de indicator van toepassing is. Logistische multilevel 
analyses zijn uitgevoerd om te bepalen wat de invloed is van kenmerken van 
patiënten, zorgverleners of ziekenhuizen op de indicatorscores. 
Alle indicatoren in de dimensie patiëntgerichte kwaliteit scoren 58% of lager. In de 
dimensie professionele kwaliteit scoort het deel van de patiënten dat een PET-
scan krijgt en een mediastinoscopie volgens de richtlijn respectievelijk 88% en 
84%. Slechts in 50% van de gevallen zijn er tenminste 4 van de 6 klierstations 
gebiopteerd en in slechts 3% van de gevallen kreeg een patiënt met een klinisch 
stadium III die behandeld werd met een combinatietherapie, voorafgaand aan de 
behandeling een CT of MRI onderzoek van de hersenen voor het vaststellen 
hersenmetastasen. Met betrekking tot de organisatorische kwaliteit laat de meting 
zien dat 79% van de patiënten de benodigde diagnostiek krijgt binnen de gestelde 
limiet van 21 dagen, dat 51% start met de eerste behandeling binnen de gestelde 
limiet van 35 dagen en dat slechts 57% van de patiënten multidisciplinair wordt 
besproken. 
Op 11 van de 14 indicatoren liet de meting een variatie tussen ziekenhuizen zien 
van 20% of meer. Geen van de determinanten die zijn meegenomen hebben een 
significante invloed op indicatoren op het gebied van de professionele kwaliteit. De 
organisatorische indicatoren hangen alledrie significant samen met één of twee 
patiëntenkenmerken. Patiënten met een hoger ziektestadium (stadium III of IV) 
hebben vaker binnen 21 dagen alle diagnostiek afgerond en starten vaker binnen 
35 dagen met hun eerste therapie dan patiënten met een lager ziektestadium. 
Echter, ze worden wel minder vaak besproken in multidisciplinair overleg. De 
belangrijkste voorspeller of patiënten multidisciplinair worden besproken is de 
aanwezigheid van een multidisciplinair overleg voor patiënten met longkanker. Het 
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enige kenmerk dat van invloed is op de patiëntgerichte indicatoren is co-
morbiditeit. Patiënten met co-morbiditeit zijn minder goed op de hoogte van het 
bestaan van een gespecialiseerd verpleegkundige longoncologie. Deze studie 
toont aan dat patiëntenkenmerken zoals ziektestadium en co-morbiditeit 
indicatorscores het meer beïnvloeden dan zorgverlener of ziekenhuiskenmerken. 
In hoofdstuk 8 wordt een studie beschreven die tot doel heeft integrale zorg voor 
patiënten met hoofd-halstumoren te verbeteren. Hierbij is het stapsgewijze model 
gevolgd van Grol en anderen voor het systematisch verbeteren van patiëntenzorg: 
ontwikkelen van een set van indicatoren en meten van de huidige zorg; 
analyseren van bestaande knelpunten door middel van interviews met betrokken 
zorgverleners; ontwikkelen en implementeren van een verbeterprogramma voor 
integrale zorg op basis van voorgaande analyses en literatuur over effectieve 
activiteiten voor het verbeteren van integrale zorg; evalueren en continue 
monitoring aan de hand van indicatoren. Het verbeterprogamma voor integrale 
zorg bestaat uit activiteiten die zijn gericht op patiënten, zorgverleners en de 
organisatie van zorg. Het effect van het programma is geëvalueerd aan de hand 
van de indicatoren waarvan de ontwikkeling is beschreven in hoofdstuk 5. Alle 
indicatoren zijn gemeten via dossieronderzoek en vragenlijsten voor patiënten en 
zorgverleners. Het verbeterprogramma voor integrale zorg heeft geleid tot 
relevante verbeteringen: e.g. "wachttijd voor diagnostische onderzoeken is minder 
dan 10 dagen" (verbetering van 37%), "wachttijd tot 1e behandeling is minder dan 
30 dagen" (+25%), "ondersteuning voor stoppen met roken" (+37%), 
"ondersteuning bij voeding" (+44%), "beoordeling van CT en MRI door een 
gespecialiseerd radioloog in hoofd-halsoncologie" (+23%) en "aantal patiënten dat 
contact heeft gehad met de gespecialiseerd verpleegkundigen hoofd-hals 
oncologie" (+37%). Het verbeterprogramma laat geen relevante verbeteringen zien 
op de uitkomstindicatoren "kwaliteit van leven" en "patiëntentevredenheid". Deze 
studie toont aan dat met een programma gericht op het verbeteren van integrale 
zorg voor patiënten met hoofd-halstumoren, de verschillende aspecten van de 
zorg daadwerkelijk verbeterd zouden kunnen worden. 
In de algemene discussie worden de meest belangrijke bevindingen van de 
studies samengevat en besproken, gevolgd door een aantal beperkingen en 
aanbevelingen voor de klinische praktijk en verder onderzoek. 
De bevindingen zijn gecategoriseerd onder twee hoofdthema's (en 5 subthema's): 
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Thema I: Principes en instrumenten voor integrale zorg (principes van integrale 
zorg, verbeteractiviteiten voor integrale zorg en instrumenten voor het meten van 
principes van integrale zorg) en Thema II: Meten en verbeteren van de kwaliteit 
van integrale zorg voor patiënten met kanker (meten van integrale zorg voor 
patiënten met kankeren verbeteren van integrale zorg voor patiënten met kanker) 
Op basis van de literatuurstudies en de eigen praktijkstudies over het meten en 
verbeteren van integrale zorg voor patiënten met kanker, wordt een voorstel 
gedaan voor een integraal zorg model dat breder toepasbaar is dan op patiënten 
met kanker alleen: het zogenaamde "Tandem-model voor Integrale Zorg". 
Figuur. Het Tandem-model voor Integrale Zorg 
De studies in dit proefschrift laten zien dat integrale zorg is gebaseerd op de 
principes van patiëntgerichtheid, multidisciplinaire zorg, coördinatie van zorg, 
"evidence-based-medicine" en continue kwaliteitsverbetering. Voor het verbeteren 
van integrale zorg is een betrouwbare meting van de huidige zorg noodzakelijk 
aan de hand van systematisch ontwikkelde indicatoren. Uit de in deze studie 
ontwikkelde en toegepaste methodiek blijkt dat er veel ruimte is voor het 
verbeteren van integrale zorg voor patiënten met kanker (met name met 
betrekking tot de patiëntgerichtheid en de organisatie van zorg) en dat de 
invoering van een programma voor het verbeteren van integrale zorg kan leiden 
tot relevante verbeteringen. 
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Prof. dr. Grol 
Beste Richard, voordat ik begon aan dit promotie onderzoek in 2002, hebben onze 
wegen elkaar al een keer gekruist, ongeveer 10 jaar daarvoor. Ik werkte bij de 
toenmalige bestuursstaf aan een onderzoeksproject met als titel "de patiënt 
centraal in het kwaliteitssysteem van het Radboud". Jij suggereerde dat het 
mogelijk was om er een promotietraject van te maken. Dat is er toen niet van 
gekomen maar ik ben heel erg blij dat ik nu promoveer op een onderzoek waarin 
wederom het leveren van integrale zorg aan patiënten centraal staat. Jij bent een 
autoriteit op het gebied van kwaliteit van zorg onderzoek en ik vind het een 
voorrecht om bij jou te mogen promoveren. 
Prof. dr. H. Marres 
Beste Henri, in onze zoektocht naar een geschikte patiëntengroep voor het 
toepassen van de principes van integrale zorg voor patiënten met kanker, kwamen 
we al gauw uit bij patiënten met hoofd-halstumoren. De zorg voor deze 
patiëntengroep is zowel landelijk als binnen het Radboud ziekenhuis al jarenlang 
een goed voorbeeld van het leveren van multidisciplinaire ketenzorg. De kennis 
die we hebben opgedaan bij het meten en verbeteren van de zorg voor patiënten 
met hoofd-halstumoren hebben we daarna nogmaals toegepast in de zorg voor 
patiënten met longtumoren. Je was tijdens het hele onderzoekstraject de link naar 
de klinische praktijk. Veel dank daarvoor. 
Dr. H. Wollersheim 
Beste Hub, jij bent degene die het sluimerende gevoel van een onderzoeker in 
mijn naar boven hebt gehaald. We zaten samen in de sollicitatiecommissie voor 
het aanstellen van een onderzoeker voor dit promotietraject maar vonden geen 
geschikte kandidaat. Jij vroeg toen aan mij of het niet iets voor mij was. Dit bleek 
voor mij precies de juiste vraag op het juiste moment. Na 10 jaar praktisch bezig te 
zijn geweest met kwaliteitsverbetering was ik toe aan een verdiepingsslag: wat is 
er bekend over succesvolle innovaties in de zorg en hoe kun je deze optimaal 
implementeren? Mijn eerdere ervaringen op het gebied van kwaliteitszorg leidden 
er regelmatig toe dat ik nieuwe mogelijkheden zag of dwarsverbanden wilde 
leggen. Jij remde mijn neiging tot uitbouwing en verbreding van het onderzoek niet 
af maar liet me door reflectie zien waar de beste kansen en mogelijkheden lagen. 
Dank voor de ruimte die ik hierbij van jou kreeg. 
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Dr. R. Hermens 
Beste Rosella, toen ik begon met mijn onderzoek zat jij net voor je eigen 
verdediging en nu zijn Miranda en ik je eerste twee promovenda! In het ziekenhuis 
was ik senior beleidsmedewerker maar wat onderzoek betreft begon ik als een 
echte junior. Schrijven dat kon ik wel, tenminste dat dacht ik. Jij hebt mij doen 
inzien dat het schrijven van beleidsnotities en voor Nederlandstalige bladen heel 
iets anders is dan het schrijven van een internationaal "peer-reviewed" artikel voor 
een vakblad. Het schrijven van wetenschappelijke artikelen heb ik van jou geleerd. 
Je was mijn steun en toeverlaat tijdens mijn hele promotietraject. Dank voor de 
wekelijkse begeleiding en naar het einde toe zelfs ook in de avonden en 
weekenden. 
Dr. M. Hulscher 
Beste Marlies, je hebt meegeschreven met het onderzoeksvoorstel voor dit 
onderzoeksproject en bent vanaf het begin nauw betrokken geweest. Je zat in de 
begeleidingscommissie en jouw kennis en expertise hebben het onderzoek 
richting gegeven. We hebben samen twee mooie artikelen geschreven en ik 
bewaar goede herinneringen aan ons bezoek aan John Ovretveit in Londen waar 
we onze onderzoeken hebben gepresenteerd. Ik ben er trots op dat jij mijn 
paranimf wilt zijn. 
Drs. S. Vonk 
Beste Saskia, we kwamen elkaar tegen tijdens de ISQUA in Amsterdam en ik 
vertelde van ons onderzoek over integrale zorg voor patiënten met kanker. Na het 
traject bij patiënten met hoofd-halstumoren hadden we net de eerste contacten 
gelegd voor het meten en verbeteren van integrale zorg voor patiënten met 
longtumoren. Het contact met jou heeft geleid tot een zeer vruchtbare 
samenwerking, zowel voor het ontwikkelen van een set van landelijke indicatoren 
voor de zorg voor patiënten met longtumoren, als voor het meten ervan door 
registratiemedewerkers van het IKO. Dank voor je enthousiaste en 
resultaatgerichte samenwerking. Ik ben vereerd datje mijn paranimf wil zijn. 
Prof.dr. V. Tjan-Heijnen 
Beste Vivianne, ten tijden van het onderzoek was jij voorzitter van de regionale 
longtumor werkgroep van het IKO. Dankzij jou hadden we een goede ingang voor 
het meten van de kwaliteit van integrale zorg voor patiënten met longtumoren in 
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ziekenhuizen in de IKO-regio. Dank voor je bijdrage in de begeleidingscommissie 
en commentaar op mijn artikelen. 
Drs. R. Termeer 
Beste René, graag wilden we het integrale zorgprogramma bij een andere 
patiëntengroep met kanker uittesten in een groot perifeer ziekenhuis. Na een 
eerste contact met jou bleek jij zeer gedreven om de kwaliteit van zorg voor 
patiënten met longkanker te verbeteren. Naar mijn idee ben jij een ideale 
ketencoördinator. Bedankt voor de prettige samenwerking tijdens het uitvoeren 
van het verbeterprogramma. 
Drs. A. Verhagen 
Beste Ad, de aanbeveling "terecht inzetten of achterwege laten van een 
mediastinoscopie voor patiënten met een niet-kleincellig longcarcinoom", was één 
van de geselecteerd kernaanbevelingen uit de richtlijn. Een aanbeveling 
selecteren bleek gemakkelijker dan het meten ervan. Jij hebt me bij het meten van 
deze aanbeveling geweldig geholpen, dank daarvoor. 
Drs. R. Akkermans 
Beste Reinier, we hebben heel wat overleg gepleegd over de analyses die ten 
grondslag liggen aan de vragenlijst "teamklimaat". Het is inmiddels een bruikbaar 
instrument gebleken voor de praktijk. Dank voor je ondersteuning, adviezen en 
multi-level analyses. 
Leden van de hoofd-halswerkgroep, UMC St Radboud 
De hoofd-halswerkgroep stond al bekend als een goed functionerend 
multidisciplinair team en dit bleek ook uit de metingen; een dergelijk team ben ik 
mijn verdere onderzoek niet meer tegengekomen. Veel dank voor jullie 
medewerking aan het onderzoek. Dankzij jullie eigen inspanning bleek de zorg 
voor patiënten met hoofd-halstumoren nog verder verbeterd te kunnen worden. 
Marianne Arts, speciaal jou wil ik van harte bedanken voor je inzet tijdens dit 
onderzoek. Je bent een verpleegkundig specialist en je hield niet van het woord 
"case manager", maar voor mij ben jij de verpersoonlijking van een deskundig en 
betrokken persoon die de coördinatie van het totale zorgproces van de patiënten 
overziet en waar de patiënten altijd terecht kunnen voor support en informatie. Met 
recht een case manager dus. 
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Betrokkenen in de zorg voor patiënten met longtumoren, CWZ 
Jullie betrokkenheid bij de zorg voor patiënten met longtumoren bleek al direct uit 
de grote opkomst tijdens de eerste bijeenkomst waar de resultaten van de 
metingen en voorstellen voor verbeteringen werden besproken. Jullie hebben een 
aantal mooie verbeteringen doorgevoerd (zoals verbreden van het multidisciplinair 
team, inzetten van "case managers", optimaliseren van de doorlooptijden en 
verbeteren communicatie) en worden beschouwd als "best practice" in het 
landelijke doorbraakproject longtumoren. Mariël, erg leuk dat jij in het landelijke 
expertteam zit en dat we regelmatig samen over jullie verbeterproject mogen 
vertellen. Dank aan jullie allen voor medewerking aan het onderzoek. 
Registratiemedewerkers IKO 
Dankzij jullie medewerking zijn we in staat geweest om de huidige zorg te meten 
voor patiënten met longtumoren in alle ziekenhuizen in de IKO-regio. Tijdens mijn 
onderzoek is het mij duidelijk geworden dat goede dataverzameling niet eenvoudig 
is; jullie zijn daarin de experts. Marjorie en Marina dank jullie wel voor de 
coördinatie van de metingen en jullie allen voor de prettige samenwerking. 
Contactpersonen 
Miep van der Drift (UMC St Radboud), Marietje Oudijk (Gelderse Vallei), Gerrit 
Bosman (Slingeland Ziekenhuis), René Bunnik (Pantein Ziekenhuis) en Hans Smit 
(Rijnstate), hartelijk dank voor jullie medewerking aan de metingen van de zorg 
voor patiënten met longtumoren in jullie ziekenhuis. 
Patiënten 
Er ontstaat geen totaal beeld van de kwaliteit van zorg wanneer niet gevraagd 
wordt naar de mening en ervaringen van patiënten zelf. Naast dossieronderzoek 
zijn er vragenlijsten gestuurd waarop bijna 600 patiënten hebben gereageerd. Zij 
wisten dat hun eigen zorg er niet per definitie beter van zou worden, maar wel dat 
de verzamelde informatie de zorg voor toekomstige patiënten zou helpen te 
verbeteren. Hartelijk dank aan deze patiënten die onder moeilijke omstandigheden 
de moeite hebben genomen om de vragenlijsten in te vullen. 
Collega's en kamergenoten 
Van Bureau Kwaliteit naar de Afdeling Kwaliteit van Zorg. Hetzelfde thema maar 
twee verschillende culturen. Gelukkig kwam ik op de kamer terecht bij Jeroen en 
Raymond, internist en huisarts in spe. Vele discussies hebben we gevoerd over 
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het verbeteren van de zorg in de praktijk en het doen van goed wetenschappelijk 
onderzoek dat ons inziens beter moest aansluiten bij de dagelijkse praktijk. Heren, 
ik ga ervan uit dat we deze discussies zo nu en dan blijven voeren en ideeën 
blijven implementeren en evalueren in de praktijk. Lianne en Marjan, jullie namen 
de plekken over van Raymond en Jeroen. Naast discussies over werkgerelateerde 
zaken, stonden we, en staan we nog steeds, elkaar met raad en daad bij ook in 
persoonlijke zaken zoals relaties, huizen kopen en verkopen en schoonfamilies. 
Annelies, bedankt voor je secure werk als onderzoeksassistente. 
Jolanda bedankt voor het editen van mijn proefschrift. 
Alle overige collega's binnen Bureau Kwaliteit en de afdeling Kwaliteit van Zorg 
van harte bedankt voor jullie persoonlijke support en aandacht. 
Henriette dank voor het doorlezen van mijn proefschrift en Marcel voor het 
ontwerpen van de omslag. Sylvia bedankt voor het controleren van engelse tekst. 
Lieve Grete, Kiki, Lia, Maud, Irene, Marieke en Hans. Jullie zijn niet direct 
betrokken bij mijn onderzoek maar wel een heel belangrijk klankbord voor mij de 
afgelopen 12 jaar tijdens onze intervisiebijeenkomsten. 
Lieve Tjitske, Irma, Wiese en Myrka. We zitten in een drukke periode van ons 
leven maar ik weet dat onze vriendschap voor het leven is. 
Lieve papa en mama, dank jullie wel voor het leven. Ik zie het leven als een 
kostbaar geschenk waar je op een verantwoorde manier het optimale moet 
proberen uit te halen. Ook bezinning en genieten horen daarbij. Misschien dat 
jullie vonden dat het genieten er de laatste tijd een beetje bij inschoot. Maar toch, 
ik deed het onderzoek graag en mede dankzij jullie liefdevolle aanwezigheid en 
opvang van de kinderen heb ik nooit het gevoel gehad dat ik iemand echt te kort 
deed. Mijn proefschrift draag ik uit liefde aan jullie op. 
Lieve zus, ik heb altijd gezegd, als ik mocht kiezen tussen een broer en een zus, 
dan koos ik een zus. Wij weten dat we altijd bij elkaar terecht kunnen en voor 
elkaar klaar staan. Mijn kinderen zijn er ook voor jou! 
Lieve René, we hadden samen halverwege 2002 besloten dat het een mooie 
uitdaging voor mij zou zijn om promotie onderzoek te gaan doen op mijn 
vakgebied "kwaliteitszorg". Vanaf dat moment heb je me in alles gesteund om dat 
doel ook te kunnen bereiken. We hebben vele discussies gevoerd over een goed 
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model voor integrale zorg en over hoe de kwaliteit van zorg kan worden verbeterd. 
Jij putte daarbij vaak uit ervaringen van je eigen reumatologie praktijk. De zorg 
voor de kinderen op zaterdagen kwam de laatste jaren vooral op jou neer. Jij deed 
dat zonder klagen want je bent een echte "family-man" en we hadden een 
gezamenlijk doel voor ogen: voor de zomer 2007 het boekje naar de 
beoordelingscommissie. Dat doel is behaald en het kan haast geen toeval zijn dat 
zich nu het volgende project aandient: het bouwen van een eigen huis. Er komt nu 
tijd vrij om samen jouw jongensdroom te verwezenlijken. 
Lieve, Rens, Maxime en Richelle, 
Dat ik jullie vader ben tegengekomen en dat jullie zijn geboren is het beste dat me 
ooit is overkomen. Jullie enthousiasme en kijk op het leven laten me elke dag 
genieten. Blijf dicht bij jezelf dan vinden jullie de weg. 
Laten we vandaag 
Een Weg gaan zoeken 
Die ons naar morgen brengt 
En dan die Weg opgaan, 
Een Weg als stromend water 
We laten alles achter 
Wat met ter zake doet 
En gaan ons leven richten 
Op waar het echt om gaat 
We nemen de tijd, 
Om weer te ontdekken 
Wat het ware leven biedt 
Misschien vinden we terug 
Wat we al lang vergeten waren 
Als een vriend 
Die trouw blijft tot het eind 
Zal het ons verder helpen 
De zon staat hoog, 
De weg is breed 
En begint waar WIJ nu staan 
Niemand weet 
Hoever hij gaat 
Want de weg is zonder einde 
HIJ gaat maar verder 
En voorbij, 
Voorbij aan wat WIJ weten 
HIJ stroomt maar verder en voorbij 
Als water, niet te meten 
(Knorretje uit de Tao van Poeh van Benjamin Hoff) 
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Rens, Richelle, Maxime en René 
spelen Poeh-stokjes op de Pooh-bridge' 
Ashdown Forest, Engeland 
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' studentassistent deeltijdstudenten begeleid. In 1992 
behaalde zij haar diploma met een afstudeeronderzoek op het gebied van het 
meten van kwaliteit van zorg. Voor het verkrijgen van meer affiniteit met de 
dagelijkse praktijk van de zorgverlening startte zij direct hierna met een speciaal 
doorstroom programma HBO-V aan de Hogeschool Sittard. Toen zich in 1993 een 
kans voordeed om een onderzoek uit te voeren in het UMC St Radboud naar het 
opzetten van een kwaliteitssysteem waarin de patiënt centraal stond, is deze 
studie tijdelijk stopgezet. Na afloop van dit onderzoek werd werken als ambtelijk 
secretaris van de Meldingscommissie (MIP) gecombineerd met het lopen van 
stages onder andere in het Radboud. In 1995 werd het diploma HBO-V behaald. 
Haar werkzaamheden op het gebied van kwaliteit van zorg binnen het UMC St 
Radboud breidden zich uit, eerst als stafmedewerker kwaliteitszorg tot later 
coördinator kwaliteitsontwikkeling. Zij heeft aan de wieg gestaan van het 
ziekenhuisbrede project "Kwaliteit in omloop". Dit project resulteerde in februari 
2002 in de eerste ziekenhuisbrede NIAZ-accreditatie. Naast het werk in het 
Radboud was Mariëlle actief als organisatieadviseur op het gebied van kwaliteit 
van zorg in andere zorginstellingen. Zij hield zich onder ander bezig met 
beleidsontwikkeling, scholing, verbeterprojecten en kwaliteitsystemen en heeft 
hierover verschillende nationale publicaties op haar naam staan. In 2002 is zij 
gestart met het onderzoek waarvan dit proefschrift het resultaat is. Momenteel 
werkt zij bij Bureau Kwaliteit aan de ontwikkeling en uitvoering van een intern 
auditsysteem en bij de afdeling Kwaliteit van Zorg is zij betrokken bij verschillende 
onderwijsactiviteiten. 
Mariëlle is getrouwd met René Traksel, reumatoloog met een praktijk in het 
Maxima Medisch Centrum in Eindhoven. Samen hebben zij drie kinderen: 
Rens (1998), Maxime (2000) en Richelle (2001). 
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Stellingen behorende bij het proefschrift: 
Integrated Care for Patients with Cancer 
1. Integrale zorg is patiëntgericht, multidisciplinair, optimaal georganiseerd en gebaseerd op 
"clinical evidence" terwijl de kwaliteit continu wordt gemeten en verbeterd, (dit proefschrift) 
2. De zorg voor patiënten met hoofd-halstumoren leek een "best practice" van integrale 
zorg. Echter, zelfs deze "best practice" behoeft verbetering met name wat betreft de 
organisatie van zorg en de patiëntgerichtheid, (dit proefschrift) 
3. De grote variatie in scores tussen ziekenhuizen laat zien dat het verbeteren van integrale 
zorg voor patiënten met een niet-kleincellig longcarcinoom mogelijk is. (dit proefschrift) 
4. De ontwikkeling van geschikte indicatoren vereist een doordacht selectieproces gevolgd 
door een praktijktest. (dit proefschrift) 
5. Het betrekken van patiënten bij de ontwikkeling van indicatoren voor integrale zorg is 
noodzakelijk, (dit proefschrift) 
6. The key to successful doctor-patient partnerships is to recognize that patients are experts 
too. (Angela Coulter, 1999) 
7. Aanbevelingen uit richtlijnen vinden niet zonder meer hun weg naar de dagelijkse praktijk 
en moeten daarom zorgvuldig worden geïmplementeerd. (Grol, 2006) 
8. Samenwerken is een kwestie van gewoon doen, ongeacht de organisatiestructuur. 
Omdat de klant dat van je verlangt of wenst of omdat je je collega nodig hebt om je werk 
goed te doen, of je collega jou. (Lohman, 2007) 
9. Als je voor elke positie de beste speler kiest, heb je nog geen sterk elftal maar een team 
dat als los zand uiteen valt. (Cruijff) 
10. Geen tijd voor kwaliteit is zonde van de tijd. (Verheggen, 1965-2007) 
11. Veel medici zien "Integrated Care" als "Integrated Cure" (Marres, 2007) 
12. Kansen moet je grijpen indien deze zich voordoen, sommigen noemen dat geluk 
(Ouwens, 2007) 
13. All models are wrong, some are useful. (Deming 1900-1993) 
14. Samen op een tandem bereik je meer dan ieder op een eigen fiets. 
Mariëlle Ouwens 
4 december 2007 



